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Abstract  
In bacteria, extracellular peptides are not only a source of nutrients but also play 
important roles in cell-cell communication. The primary mode of uptake of these 
peptides in bacteria is via ATP Binding Cassette (ABC) transporters. The substrate-
binding protein (SBP) of these transporters captures extracellular peptides and 
delivers them to membrane-bound components for transport. Bacterial peptide-
binding SBPs that function in ABC transporters have evolved predominantly to 
function as generalists, recognising peptides of particular lengths but with low or no 
sequence specificity. However, within the peptide-specific SBPs are examples that 
appear to have evolved subsequently to recognise specific peptides.  
Here we have provided the first biophysical evidence, using native electrospray mass 
spectrometry, for the binding of a specific peptide to an Escherichia coli SBP. This 
peptide is a cell wall component named murein tripeptide (Mtp, L-Ala- -D-Glu-
meso-Dap) and is transported by an ABC transporter containing the SBP MppA. We 
demonstrate that MppA recognises Mtp specifically and with high affinity (KD ~ 250 
nM), as determined by protein fluorescence spectroscopy and isothermal titration 
calorimetry. The crystal structure of MppA in complex with Mtp has been solved in 
order to understand the structural basis of specific binding of Mtp to MppA. 
Comparison of the structure of MppA-Mtp with structures of general tripeptides 
bound to oligopeptide binding protein OppA, reveals close similarity in the protein 
chains which fold to form an enclosed interdomain pocket in which the respective 
peptides reside. The peptide ligands superimpose remarkably closely given the 
profound differences in their structure. Strikingly, the effect of the D-
stereochemistry, which projects the side chain of residue 2 in Mtp in the direction of 
the main chain in a conventional tripeptide, is compensated by the side chain γ-
linkage of the carboxylate of the D-Glu to the amino group of diaminopimelic acid. 
The resulting amide linkage mimicks the peptide bond between residues 2 and 3 of a 
conventional tripeptide. Specificity for Mtp is conferred by a series of ionic and 
polar residues of MppA which make charge-charge and dipole-charge interactions 
with the highly ionised peptide.  
Analysis of multiple bacterial genomes revealed that mppA is often situated near a 
gene called mpaA which encodes a putative amidase enzyme which is thought to 
hydrolyze murein tripeptide. This genetic organization is conserved among -
proteobacteria and suggests that mppA and mpaA function together and are a part of 
peptide catabolic pathway. The MpaA enzyme from E. coli was purified to 
homogeneity as a His-tagged form, and its kinetic properties and parameters were 
determined. MpaA was found to hydrolyze Mtp efficiently but it did not cleave 
murein tetrapeptide. Replacement of meso-Dap by L-Lys in the tripeptide resulted in 
much lower efficiency. Mass spectrometric analysis of purified MpaA suggested that 
it co-purifies with a zinc ion and exists as a dimer in solution. The first crystal 
structure of an MpaA protein from Vibrio harveyi was solved to 2.17Å. The 
structural fold of V. harveyi MpaA was similar to eukaryotic carboxypeptidases. 
Analysis of the structure showed an obvious dimer interface between two monomers 
of MpaA and presence of a zinc ion in the active centre of each monomer consistent 
with the mass spectrometric data. The structure provides the basis for future 
modelling and mutational studies for extensive functional characterization of MpaA.  
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The chapter begins by explaining the need for transporters in living cells and a brief 
overview on the major types of transporters present in living organisms. A detailed 
description is given on the ATP binding cassette (ABC) transporters using the E. coli 
maltose transporter as a model. There is a separate section on substrate-binding proteins 
mainly discussing their classification into different groups based upon their structural 
similarity. Transport of peptides in bacteria is described with the main focus on ABC 
transporters of peptides in E. coli. In the later part of this chapter I introduce the 
peptidoglycan, including its structure, synthesis and turnover. The section also explains 
the existing pathway for recycling of cell wall derived murein tripeptide in E. coli. 
Finally, an overview of protein crystallography as a technique to obtain three 
dimensional structures of proteins is given. 
1.1 The need for transporters  
Living cells are surrounded by a membrane composed of phospholipids, separating the 
inside from the outside. In Gram-positive bacteria, this membrane is surrounded by a 
thick layer of protective peptidoglycan, together making up the cell envelope (Figure 
1.1). Gram-negative bacteria possess a second membrane above a much thinner 
peptidoglycan layer, producing another distinct compartment for the cell called the 
periplasm (Figure 1.1).  
The phospholipids are arranged in a bilayer, with their polar, hydrophilic phosphate 
heads facing outwards, and their non-polar, hydrophobic fatty acid tails facing inwards 
towards the middle of the bilayer (Wilkins et al., 1971). Cell membranes are a barrier to 
most substances, and this property allows materials to be concentrated inside cells, 
excluded from cells, or simply separated from the outside environment. This is 
compartmentalisation and is essential for life, as it enables metabolic reactions to take 
place that would otherwise be impossible. Obviously materials need to be able to enter 
and leave the cells, and thus transporters have evolved to move exogenous and 
endogenous substrates across this barrier (Saier Jr, 1994, Saier Jr, 2000b). These act as 
gateways controlling what compounds are allowed to enter and leave the cell. 
Various types of membrane transporters have evolved to suit environment and function. 
They can be divided into two superfamilies. First, the transporters that function 
independent of an energy source and allow the unimpeded movement of substrates 
18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Components of a typical bacterial cell envelope  
Cell envelope of Gram-positive bacteria (A) and Gram-negative bacteria (B) indicating the 
relative locations of the cytoplasmic (inner) membrane, periplasm, peptidoglycan, outer 
membrane and lipopolycassharide (LPS). IMP represents inner membrane protein and OMP 
stands for outer membrane protein. 
 
A) 
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19 
across the membrane down a concentration gradient, which are traditionally known as 
“channels”. The second superfamily consists of the transporters that utilize energy to 
enable active transport, often against a concentration gradient. This energy comes either 
from an „energy currency‟ such as ATP (primary transporters) or via the proton 
gradient, in which case the transporters are classed as secondary transporters. These 
superfamilies, and all substrate uptake or export systems more generally, have been 
defined by Milton Saier, and can be divided up into five accepted classes of the 
Transport Classification (TC) system based on similar mechanisms of function and 
sequence (Busch and Saier, Jr., 2002). All transport systems are included in the 
Transport Classification Database, TCDB available at http://www.tcdb.org/ (Saier et al., 
2009). 
1.2 Major types of transporters 
Diffusion of a substrate on either side of a membrane via a channel is the least complex 
method of transport. This process does not involve any energy and is called passive 
transport. The channels constitute the first class of the transport classification system. 
An example of this phenomenon is glycerol facilitator, GlpF (TC1.A.8.1.1) of 
Escherichia coli (Figure 1.2) (Sweet et al., 1990, Fu et al., 2000). 
The second class of TC system are ion gradient driven transporters, called secondary 
active transporters where transport of the solute is driven by its coupling with ion flow 
down an electrochemical gradient, such as H
+
 or Na
+
 (Saier Jr, 2000b) (Figure 1.2). 
These ion driven transporters can be subdivided into three classes; uniporters, 
antiporters and symporters. Uniporters transport one substrate in one direction and the 
latter two are involved in the transport of two different substrates simultaneously. 
Symporters transport two substrates in the same direction whereas antiporters transport 
two substrates in the opposite directions. The classical example of this class of 
transporter is the E. coli lactose permease (TC2.A.1.5.1). This is a lactose:H
+
 symporter 
where the translocation of extracellular protons into the low proton environment of the 
cytoplasm drives the accumulation of intracellular lactose (Wong et al., 1970).  
The third class of transporters are primary active transporters that use a primary source 
of energy to drive active transport of a solute against a concentration gradient. Primary
20 
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sources known to be coupled to transport are chemical or solar energy. A well studied 
example of a primary transporter that uses chemical energy are the P-type ATPases. 
These adenosine triphosphate (ATP) driven ion pumps are multisubunit complexes 
found ubiquitously from bacteria to animal cells (Kühlbrandt, 2004). P-type ATPase 
complexes pump a number of different substrates including H
+
, K
+
, Na
+
 and Ca
2+
 
forming electrochemical gradients. The formation of these electrochemical gradients 
can power transport (Doeven et al., 2004). The primary transporters most appropriate to 
the current project are the ATP-binding cassette trasnporters that use ATP hydrolysis to 
drive substrate translocation across the membrane. In the case of importers, the substrate 
is often delivered to the permease by a substrate-binding protein, which binds the 
substrate with high specificity and affinity (Figure 1.2) (Ames and Nikaido, 1978). ATP 
is hydrolysed by ATP-binding cassettes, hence the superfamily name of ABC 
transporters. The classical example of this family is the E. coli maltose transporter 
(TC3.A.1.1.1) (Oldham et al., 2007).  
Class four transporters are called group translocators and they alter the substrate during 
translocation as in the bacterial phosphotransferase system (PTS) (Figure 1.2) (Saier Jr 
et al., 2005). The range of substrates for these transporters is limited to sugars including 
glucose, ascorbate, glucosides, maltose and N-acetylglucosamine (Saier Jr et al., 2005). 
The substrate is transported into the cell by an integral membrane protein (Cao et al., 
2011) in the complex and then phosphorylated by a complex of cytoplasmic enzymes 
using phosphoenol pyruvate (PEP) as a substrate (Saier Jr et al., 2005). 
It is also worth mentioning that different classes of transporters exist for the inward 
translocation of substrates through the outer membrane of Gram-negative bacteria. 
These include porins (non specific channels), specific channels and TonB-dependent 
receptors, which are powered transporters and are capable of active transport, 
accumulating their substrate against a concentration gradient (Nikaido, 2003). 
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1.3 ATP binding cassette (ABC) transporters  
The ATP-binding cassette (ABC) transporters are widespread transport system among 
living organisms with representatives in all three domains of life from bacteria to higher 
eukaryotes, including humans (Holland, 2003). ABC transporters constitute one of the 
largest superfamilies of paralogous sequences. A lot of ABC transporters have been 
implicated in various human diseases, including cystic fibrosis (Gadsby et al., 2006) 
and multidrug resistance in chemotherapeutic treatment (van de Water et al., 2007).  
The ABC transporters were first discovered and characterized in prokaryotes in the 
early 1970 (Davidson et al., 2008). The most extensively analyzed systems are the high 
affinity maltose and histidine uptake systems of Escherichia coli and Salmonella 
enterica serovar Typhimurium, respectively. The first nucleotide sequence of all the 
components of an ABC transporter was determined in 1982 for histidine transporter 
from S. Typhimurium (Higgins et al., 1982). The term ABC transporter was coined as a 
common name for transporters of this superfamily in 1990 (Hyde et al., 1990). 
ABC transporters are called primary active transporters because it has been found that 
they couple the hydolysis of ATP forming ADP and Pi to the transport of the substrate 
across the membrane. They perform active transport on a number of diverse substrates 
resulting in the formation of a high substrate gradient up to (10
6
:1) (Dippel and Boos, 
2005). 
Although the composition of ABC transporter components is quite variable, they can be 
generally divided into two categories; ABC importers and ABC exporters. ABC 
importers catalyze the unidirectional uptake of a wide range of substrates including 
sugars (Dean et al., 1989), a number of amino acids (Higgins et al., 1982), peptides 
(Tame et al., 1994), vitamins (Borths et al., 2002) and metal chelate complexes (Pinkett 
et al., 2007). ABC exporters catalyze the extrusion of virulence factors, for example 
haemolysin (Dinh et al., 1994) and hydrophobic compounds, the majority of which have 
anti-microbial action.  
The core structure of an ABC transporter contains two components; a hydrophobic 
integral membrane domain that forms the translocation channel also known as 
transmembrane domain (TMD) and a soluble, cytoplasmic nucleotide binding domain 
(NBD), also known as ATPase domain that binds and hydrolyses ATP. In the functional 
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ABC transporter, the TMD and NBD are both dimeric and have been found in a number 
of configurations. Often the four domains are independent polypeptide chains that come 
together to make a multimeric complex. However, they have also been found to have 
one TMD and one ATPase domain fused into one polypeptide and the functional 
transporter composed of two of these so-called “half transporter”(Dawson et al., 2007). 
A third structural component of ABC importers is an extracytoplasmic solute receptor 
also known as substrate-binding protein (SBP). This component is found in the 
periplasm of Gram-negative bacteria and attached to the cytoplasmic membrane by a 
lipid moiety in Gram-positive bacteria (Sutcliffe and Russell, 1995). The SBP binds the 
substrate of the transporter with high affinity (sub micromolar) and delivers it to the 
membrane components of the transporter for translocation. The SBP is thought to confer 
specificity, high affinity and also unidirectionality to the transporter (Holland, 2003). 
1.4 The E. coli ABC transporter for maltose as a model system  
The E. coli genome contains 65 predicted ABC transporters, taking up over 5% of the 
total genome (Moussatova et al., 2008). Fifteen of these transporters lack SBP and are 
presumed to be ATP-driven exporters, leaving the remaining 50 as importers. The 
maltose ABC transporter in E. coli is the most comprehensively studied ABC 
transporter in nature. It belongs to the carbohydrate uptake transporter family (CUT) as 
defined by Saier (Saier Jr, 2000a) and has been shown to transport di and 
oligosaccharides. The maltose uptake system in E. coli is composed of a periplasmic 
SBP (maltose binding protein; MBP, MalE), two integral membrane domains (MalF and 
MalG) and a homodimer of the ATPase domain (MalK2). These components are 
discussed in detail in the following sections. 
1.4.1 Maltose binding protein MalE  
MalE is a soluble protein that is found in the periplasm of Gram-negative bacteria or 
anchored to the cytoplasmic membrane as a lipoprotein in Gram-positive bacteria. Like 
other SBPs, MalE, is synthesized in the cytoplasm and then translocated to the 
periplasm by the Sec translocon that recognizes an N-terminal signal peptide. The signal 
peptide is cleaved off during the translocation process producing the mature protein. 
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In vitro studies using purified MalE has shown that it binds maltose and maltodextrin 
with a high affinity and dissociation constant (KD) of 1 µM (Kellermann and 
Szmelcman, 1974). MalE is also known to have been recruited for a use as a chemotaxis 
receptor. The high resolution structure of MalE has been determined in both the 
liganded and unliganded states (Sharff et al., 1992, Spurlino et al., 1991). These 
structures revealed that MalE is composed of two globular domains connected by a 
flexible hinge region (Figure 1.3). The ligand binding site is in the middle of the 
globular domains which is freely accessible to the solvent prior to binding the ligand. 
Upon binding ligand, the protein undergoes a large conformational change which results 
in complete occlusion of the ligand from the bulk solvent (Figure 1.3). Residues from 
both globular domains contribute to the formation of the binding site and make a 
number of van der Waals interactions and hydrogen bonding interactions. 
1.4.2 ATPase domain (MalK) 
MalK is the NBD subunit of the maltose ABC transporter and is the most 
comprehensively studied of all the ABC transporter subunits. MalK was experimentally 
confirmed to be the ATPase subunit because when expressed and purified alone, MalK 
spontaneously hydrolyses ATP (Morbach et al., 1993), whereas, in the full transporter 
ATP hydrolysis is tightly coupled to the presence of the substrate-binding protein MalE 
(Davidson et al., 1992). 
The first structure of a MalK homologue was from the archaeon Thermococcus litoralis. 
This structure was determined to be non-physiological due to the small dimer interface 
and peculiar arrangement of sub-domains (Diederichs et al., 2000). More recent 
structures of MalK in isolation (Chen et al., 2003, Lu et al., 2005) and in complex with 
the rest of the complex (MalEFGK2) from E. coli have been solved that are consistent 
with the biochemical data for MalK (Oldham and Chen, 2011, Oldham et al., 2007). 
The structure of MalK subunit has revealed that it is composed of two domains, an N-
terminus nucleotide binding domain (NBD) and a C-terminus regulatory domain (RD) 
(Figure 1.4). NBD can be further divided into two subdomains: RecA like subdomain 
present in many ATPases (Story and Steitz, 1992), containing the Walker A and Walker 
B motifs (Walker et al., 1982) and a helical subdomain that is specific to ABC 
transporters and contains the ABC family signature motif, LSGGQ (Hyde et al., 1990).  
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Figure 1.3 Crytal structures of MalE 
High resolution structure of MalE in open, unliganded form (PDB accession code 1OMP) and 
closed maltose bound from (PDB accession 1ANF). The figures were prepared using the 
program PyMOL (DeLano Scientific).  
 
Open 
Closed 
Maltose 
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Figure 1.4 The structure of MalK homodimer with bound ATP 
A) Crystal structure of a MalK monomer showing the nucleotide binding domain (NBD), the 
regulatory domain (RD), LSGGQ motif, Q loop and Walker A/B motifs. B) Crystal structure of 
a dimer of MalK with two molecules of ATP bound at the dimeric interface. The ATP is 
represented in ball-and-stick model (O atom, red; N atom, blue; and P atom, yellow). Both N 
and C termini of each monomer are labelled. Figure taken from (Chen et al., 2003). 
B) 
A) 
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MalK from E. coli is not a typical ABC transporter NBD/subunit for two reasons. 
Firstly, it contains an additional C-terminal domain present in MalK homologues, but 
not in other NBDs/subunits (Oldham et al., 2007, Diederichs et al., 2000) and secondly, 
MalK can be purified as a dimer in the presence and absence of nucleotide. This feature 
of MalK is not shared with other NBDs (Diederichs et al., 2000, Kennedy and Traxler, 
1999). The structure reveals that MalK is a homodimer and two ATP molecules are 
bound along the dimeric interface of the nucleotide binding domains and the ATP 
binding sites are buried(Chen et al., 2003) . There are a number of contacts between the 
two protomers and also a number of contacts between both subunits of the dimer with 
each ATP molecule. Each ATP molecule interacts with the Walker A motif from one 
protomers and the LSGGQ motif from the other promoter, explaining the requirement 
for a dimer.  
Mutational and phylogenetic analysis has revealed that MalK, and indeed all NBDs, 
contain several conserved motifs, some of which are characteristic of all ATPases and 
some are specific to ABC proteins. The Walker A and Walker B motifs are found in a 
number of different nucleotide-binding proteins. The Walker B motif is preceded by 
LSGGQ (“ABC signature sequence”) motif (Hyde et al., 1990). This motif is found in 
all NBD subunits in ABC transporters. There is also a conserved glutamine, called the 
Q loop between Walker A and LSGGQ motifs. 
The proposed functions of these motifs and folds have been deduced from the observed 
phenotypes produced upon mutation of residues within the motifs. This mutational 
analysis has shown that any variants of the Walker A or Walker B motifs prevent ATP 
binding and/or hydrolysis and therefore also inhibit transport.  
The Q loop has been implicated in signalling between the NBD and the TMDs because 
mutations in this motif abolished transport, but left nucleotide binding unaffected. The 
postulate that the Q loop facilitates the interaction of the NBD with the TMD is further 
strengthened by the production of suppressor mutations in MalK that restore transport 
activity in response to mutation of a conserved region of the TMD (Hunke et al., 2000, 
Mourez et al., 1997). Mutations in the LSGGQ motif have been found to abolish 
transport, but leave nucleotide binding unaffected indicating that this motif is also 
involved in signalling between the NBD and TMD. 
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1.4.3 Transmembrane domains: MalFG 
The transmembrane component of the maltose ABC transporter is composed of two 
integral membrane proteins, MalF and MalG. These proteins make a transmembrane 
channel for the translocation of substrate delivered by the SBP. MalF and MalG are 
made up of 8 and 6 transmembrane helices, respectively. 
MalF is unusual in that it has an extended periplasmic loop (MalF P2) that reaches 
around MalE in the protein crystal structure. This interaction with MalE is apparently 
stable, since this loop, when expressed alone, can associate with MalE in solution (Jacso 
et al., 2009).  
Phylogenetic analysis of the amino acid sequence of MalG revealed a conserved motif 
in a cytoplasmic loop that was present in MalF and other ABC transporter TMDs 
(Dassa and Hofnung, 1985). The consensus sequence of this motif is EAAX3GX9IXLP 
(where X is any amino acid) and is referred to as the EAA motif. Due to the conserved 
nature of the EAA motif it was thought essential for functional transport and, because of 
its cytoplasmic location, was infered to interact with the NBD of MalK. This was later 
confirmed using site-specific chemical crosslinking (Hunke et al., 2000) and by 
mutating the most highly conserved residues in the EAA motif in MalF and/or MalG 
(Mourez et al., 1997). This latter study revealed that mutation of the highly conserved 
residues leads to decreased or complete abolition of transport activity. In the mutants 
where transport was abolished, MalK was no longer membrane associated and was 
localized in the cytoplasm indicating that the EAA motif forms an interaction with 
MalK.  
1.4.4 The structure of complete MalEFGK2 complex 
Following the determination of the crystal structure of E. coli vitamin B12 transporter 
BtuCD (Locher et al., 2002) a large number of crystal structures of intact ABC 
transporter complexes have been solved (Rees et al., 2009).  
The first structure of MalEFGK2 was solved to a resolution of 2.8Å in 2007 (Oldham 
2007) (Figure 1.5). In order to obtain the structure of the intact complex, a single 
mutation was introduced into MalK (E159Q). This mutation permitted binding of ATP 
to NBD but prevented its hydrolysis. 
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Figure 1.5 Crystal structure of the intact MalEFGK2 complex 
Each polypeptide is coloured and labelled accordingly on the left hand side. The structure is of a 
catalytic intermediate able to bind, but not hydrolyze ATP. In the structure the NBDs are closed 
and bound to ATP. MalE (MBP) is open and maltose is bound in the translocation channel of 
MalF and MalG. A loop from MalG “scoop loop” is inserted into the binding pocket of MalE. 
Figure taken from (Oldham et al., 2007) 
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An overview of the structure reveals that the MalK dimer is essentially identical to the 
crystal structure of isolated MalK previously obtained (Chen et al., 2003). It is a closed 
dimer with two ATP molecules bound. The only difference between this structure and 
the structure of MalK2 crystallized on its own is that the Q loops are ordered into ß–
strand structures. In the structure of MalK2 alone, this region was disordered, but in the 
structure of the complete transporter the Q loops interact with the TMDs and form an 
ordered structure. MalF and MalG form the translocation channel. The SBP, MalE is 
unliganded with both globular domains forming interactions with both MalF and MalG. 
As predicted from previous work, the EAA motif of the TMDs is prominent in the 
interaction face between the MalFG dimer and the MalK dimer.  The EAA motifs from 
both MalF and MalG form 2 small helices and each of these helices is docked into a 
cleft of corresponding MalK (Figure 1.6A). This MalK cleft consists of the helical 
subdomain, the Q loop and the helix after the Walker A motif.   
The substrate binding pathway is the second region forming important interactions in 
this structure. This pathway is composed of MalF, MalG and MalE and at the 
intersection of these three proteins there is a large solvent-filled cavity that extends from 
the periplasmic side to the mid-point of the lipid bilayer (Figure 1.6B). This cavity is 
sufficiently large to accommodate the longest MalEFGK2 substrate, maltoheptaose. At 
the bottom of this cavity, which is at the mid-point of the lipid bilayer, a maltose 
molecule is observed making a number of contacts with several residues from MalF, but 
none from MalG. The specific interactions made between protein and substrate, and 
previous biochemical evidence, suggests that this is a genuine interaction and not an 
artefact of purification or crystallization (Figure 1.6B). This is the first structural 
evidence of a binding site in the TMD of an ABC transporter. 
At the other end of this cavity, MalE is in its open conformation, covering the top of the 
translocation channel. There is no maltose in the binding cleft of MalE, therefore 
binding to MalFG presumably stabilizes the open conformation allowing release of 
maltose into the MalFG binding pocket. One of the most striking features from this 
structure is the presence of a periplasmic loop (P3) from MalG in the binding cleft of 
MalE (Figure 1.5). This so-called “scoop loop” either dislodges maltose from MalE 
and/or sterically hinders its re-entry therefore facilitating unidirectional transport. 
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Figure 1.6 Domain interactions in the MalEFGK2 complex 
A) The conserved EAA loop of MalF and MalG docking with a surface cleft in MalK. Positions 
of the EAA motif from MalF (blue) and MalG (yellow) are compared by superposing the MalK 
monomers (red and green). The Q loop, Walker A (W/A) and Walker B (W/B) are shown. B) 
Cross-section of a space-filling model showing the open conformation of MalE, the solvent 
filled cavity and the positioning of maltose at the bottom. The maltose binding site within the 
TMD is enlarged showing interactions between maltose and amino acids.  
A) 
B) 
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The structure of MalEFGK2 described above is a catalytic intermediate of the maltose 
transporter in the outward-facing conformation with a TM maltose binding site exposed 
to the periplasm. Later on, another structure of the complex was obtained in the absence 
of maltose binding protein (Khare et al., 2009). Analysis of this structure shows that in 
the absence of MalE, MalFGK2 forms an inward-facing conformation with the TM 
maltose-binding site exposed to the cytoplasm. Comparison of this structure to that of 
outward-facing conformation reveals that there is a rigid body rotation of the TMDs 
which is coupled to the opening of NBD dimer interface in the inward-facing 
conformation of MalFGK2.  
The inward-facing conformation represents the resting state where the transporter has a 
very low ATPase activity and the outward-facing conformation represents a catalytic 
intermediate where ATP is ready for hydrolysis. More recently, another structure of 
MalEFGK2 has been solved where MalE interacts with the resting state conformation to 
give a pre-translocation complex (Oldham and Chen, 2011). This complex represents an 
intermediate state between inward and outward-facing conformations (Figure 1.7A). 
Analysis of this structure reveals that MalE is present in the closed liganded 
conformation and two lobes of MalE interact with MalF and MalG. The interface 
between MalE and MalFG is smaller than observed in the open outward-facing 
complex. A maltose molecule was also identified in the TM site of this structure which 
is likely nonphysiological and an artefact of crystallization. Access to the TM binding 
site was restricted from both sides of the membrane. The MalK dimer is semi-open as 
the distance between the two NBDs is between those of open and closed forms (Figure 
1.7B).  
A key feature of this structure is that the conserved D-loops are present at the MalK 
dimer interface making contacts to the residues of Walker A of the opposite subunit. 
Walker A residues interact with the gamma phosphate of ATP in the closed dimer form 
of outward-facing state. Thus the binding of ATP to MalK of the pre-translocation state 
causes local conformational changes of Walker A and the D loop and initiates 
progression towards the outward-facing conformation. In contrast, in the inward-facing 
resting state, where MalE is absent, the Walker A and D loops are distant from the 
dimer interface (Figure 1.7B); thus, ATP binding would not induce such a global 
structural rearrangement necessary for dimerization of MalK and ATP hydrolysis. In 
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Figure 1.7 Pre-translocation state is an intermediate conformation between inward and 
outward facing states  
A) Surface slab view of three different states of the transport cycle. Each component of the 
complex is colour coded and labelled accordingly on the left hand side. B) Surface 
representations of the nucleotide-binding domains (NBDs) in the three states. The RecA-like 
and the helical subdomains are differentiated by color shade. The D loop and theWalker A 
(WA) motifs are labeled. The rotation of the helical subdomain with respect to the RecA-like 
domain during transition from the pretranslocation state to the outward-facing conformation is 
indicated. Figure adapted from (Khare et al., 2009, Oldham and Chen, 2011). 
 
A) 
B) 
Inward-facing Pre-translocation Outward-facing 
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 pre-T state MalE induces rotation of TMDs and partial closure of the MalK dimer and 
lowers the energy barrier for closure of the MalK dimer necessary for ATP hydrolysis. 
1.4.5 Proposed mechanism of transport of maltose 
The wealth of information available from previous biochemical and genetic data and 
recent biophysical data has allowed proposing a model for the transport of maltose by 
MalEFGK2 (Figure 1.8).  
Once maltose diffuses into the periplasm through the outer membrane channel, it binds 
MalE and stabilizes it. The ligand bound MalE interacts with the inward-open state of 
MalFGK2, in which the TM channel is closed to periplasm and the NBD is in the open 
form. Binding of MalE to MalFGK2 induces conformational changes in the TMD which 
in turn brings the NBDs closer and the complex is now in a pre-translocation state. 
Binding of ATP to MalK promotes a concerted motion of MalK closure, reorientation 
of the TM subunits and opening of MalE. This results in the formation of the outward-
facing conformation and transfers maltose from MalE to the TM binding site. This is the 
time for ATP hydrolysis to occur. Although the crystal structure of the post hydrolysis 
state of the complete transporter is lacking, analysis of the isolated NBD structures 
suggest that ADP is not sufficient to stabilize the closed dimer conformation (Lu et al., 
2005). Thus once ATP is hydrolyzed, the TMDs will likely reorient towards the 
cytoplasm and the substrate will be released into the cytoplasm. MalE is released, 
MalFGK2 reverts to the resting state and the transport cycle is ready to begin again. 
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Figure 1.8 Proposed mechanism for transport of maltose by MalEFGK2 
Maltose binds to the SBP and interacts with TMD and NBD complex at inward-facing state 
(resting state). Interaction of liganded SBP triggers the conformational changes within the TMD 
and NBD bringing NBDs closer (pre-translocation). Binding of ATP to NBDs causes 
dimerization of NBDs and reorientation of TMDs resulting the opening of the periplasmic side 
of TMDs and release of substrate from SBP. The hydrolysis of ATP occurs leading to opening 
of NBDs and subsequent opening of the cytoplasmic side of the TMD releasing substrate into 
the cytoplasm. Figure adapted from (Oldham and Chen, 2011).  
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1.5 Substrate-binding Proteins 
Substrate-binding proteins (SBPs) are a group of proteins that are often associated with 
membrane protein complexes for transport of substrate. They have also been shown to 
perform a receptor function in chemoreception and signal transduction (Tam and Saier, 
1993, Neiditch et al., 2006). The SBPs were originally found to be associated with ABC 
transporters (Holland, 2003), but recently they have been shown to be associated with 
other membrane protein complexes, such as tripartite ATP independent periplasmic 
(TRAP)-transporters (Mulligan et al., 2009).  
The SBP is the most variable of the subunits of ABC transporters and this is due to the 
fact that this subunit binds the ligand directly and therefore confers specificity on the 
system. As stated ABC transporters that contain an SBP normally function as substrate 
importers while those systems that lack the SBP tend to function in substrate export and 
this fact can almost be used as a rule in defining the two major classes of ABC systems 
(Higgins and Linton, 2001). 
The SBPs are found within the periplasm of Gram-negative bacteria, often in large 
excess over the TMD and NBD subunits, with the SBPs found at around 0.1-1 mM 
concentration within the periplasm (Holland, 2003). In Gram-positive bacteria and 
Archaea, organisms without a periplasm, the SBPs are anchored to the outer surface of 
cell membrane via an N-terminal lipid moiety (Sutcliffe and Russell, 1995) or an N-
terminal TM segment in Archaea (Albers et al., 1999).  
In addition to the SBP dependent ABC transporters, a new family of prokaryotic ABC 
transporters has been identified that does not depend upon SBP for the uptake of ligand. 
This is called energy coupling factor transporter (Rodionov et al., 2006, Rodionov et 
al., 2009). Here, an integral membrane protein binds the substrate with high affinity 
(nM) and translocates it into the cytoplasm (Zhang et al., 2010). 
In the last decade new membrane protein complexes were discovered that contained a 
SBP. This family of transporters was called tripartite ATP-independent periplasmic 
(TRAP)-transporters (Kelly and Thomas, 2001). They are secondary transporters but 
rely on SBPs to import their ligands. The membrane component of these proteins 
usually consists of one larger and one smaller subunit. The transport of substrate is 
driven by an electrochemical ion gradient (H
+
 or Na
+
 gradient) (Mulligan et al., 2009).  
Many SBPs have been characterized in the last fifty years and shown to bind a diverse 
variety of ligands including amino acids, sugars, peptides, vitamins and metal ion or 
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their chelates (Magnusson et al., 2004, Tame et al., 1995, Borths et al., 2002, Clarke et 
al., 2000, Heddle et al., 2003). The size of the ligands accommodated by SBPs range 
from a single ion such as Zn
2+
 (Bound by TroA) with a volume of 1.5 Å
3
 to large 
peptides of up to 26 amino acids long with the volume up to 4900 Å
3
 (Bound in OppA) 
(Lee et al., 1999, Levdikov et al., 2005, Berntsson et al., 2009). 
In bacteria, ABC transporters are generally encoded in operons containing all the 
components needed for the transport of substrates. These components include a single 
gene encoding the SBP, genes encoding TM domains and NBDs which bind and 
hydrolyze ATP. The maltose ABC transporter from E. coli is an example of this type of 
transporter. However, there are examples of SBPs which are encoded by genes which 
are not part of an operon and are present at remote locations on the genome. They are 
called orphan SBPs (Thomas, 2010). An example of orphan SBP from the model 
bacterium E. coli K-12 is MppA that is homologous to the oligopeptide SBP OppA 
which recognizes the murein tripeptide and functions with TMD/NBD proteins 
(OppBCDF) of the oligopeptide transport system (Park et al., 1998). The orphan SBPs 
are widespread among different groups of bacteria: for example, a quick look in 
TransportDB (Ren et al., 2006) shows that Enterococcus faecalis V583 has 10 genes 
encoding orphan SBPs suggesting that bacteria use SBP dependent transporters to 
increase substrate range at minimal cost  of energy. 
1.5.1 Overall structures of SBPs and their classification 
The first SBP crystal structure was solved in 1974 for L-arabinose binding protein 
(Quiocho et al., 1974). Since then, many more have been solved revealing a wealth of 
information about this family of proteins. The core of all SBPs consists of two 
structurally conserved domains (Quiocho and Ledvina, 1996), although some members 
contain an extra domain as an exception from the common rule (Tame et al., 1994). The 
two domains are connected by a hinge region, with the ligand binding site buried in 
between two domains usually in a manner that sequesters them completely from the 
solvent (Holland, 2003). In the absence of ligand, the protein is normally flexible, with 
the two domains rotating around the hinge and exists largely in the open conformation. 
Upon substrate binding, the closed conformation is stabilized and the ligand is trapped 
between the domains. This process is called the “Venus Fly-Trap” mechanism (Mao et 
al., 1982).  
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Based upon the available structural information, SBPs have been observed in four 
distinct structural states (Figure 1.9); open unliganded, open liganded, closed 
unliganded and closed liganded (Berntsson et al., 2010). As stated above, SBPs mainly 
exist in the open-unliganded state in the absence of substrate, with possibly a small 
fraction in a closed-unliganded state (Bermejo et al., 2010). In the presence of a 
substrate, the equilibrium between open and closed conformation shifts towards the 
closed-liganded state. 
Crystal structures of SBPs have shown that they generally act as monomers ranging in 
size from 25 to 60 kDa (Holland, 2003). However, recently it was shown that TakP, a 
SBP from a tripartite ATP-independent transporter, is a dimer (Gonin et al., 2007). 
Another example of dimeric SBP is of the iron-binding protein FitE (Shi et al., 2009). It 
is clear that these proteins dimerize in solution, but whether these dimers are of 
physiological relevance remains unclear. 
In the past 20 years several groups have performed phylogenetic analysis of the SBPs 
from specific organisms or more widely with the aim of creating subgroups or classes 
that bind to specific ligand or types of ligand (Saurin and Dassa, 1994, Tam and Saier, 
1993). In 1999 Fukami-Kobayashi classified SBPs into two different classes based on 
the connectivity of secondary structure elements and especially the topology of the beta-
sheets core in the domains (Fukami-Kobayashi et al., 1999). Examples of proteins 
belonging to Class I are the leucine/isoleucine/valine-binding protein (LIVBP) and of 
class II are the histidine-binding protein (HisJ) and the oligopeptide-binding protein 
(OppA). Later on, a third class of SBPs was defined, with proteins containing B12 
binding protein and Zinc binding protein. The size of SBPs does not correlate with the 
class to which it belongs, e.g., both OppA (65 kDa) and HisJ (27 kDa) fall in Class II.  
For the purposes of this thesis the classification of Ronnie Berntsson was chosen 
(Berntsson et al., 2010). In this classification scheme, SBPs were grouped into six 
clusters on the basis of their structural similarity. 
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Figure 1.9 Different structural states of the monomeric SBPs 
A) Open-unliganded B) Closed-unliganded C) Open-liganded and D) Closed-liganded. SBPs 
are represented by blue circles and ligand is represented by red star. In the absence of a 
substrate, the equilibrium is towards the open-unliganded conformation. Upon binding of 
substrate, the open-liganded conformation is formed and the equilibrium is shifted to closed 
liganded. 
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Cluster A consists of SBPs that play a role in metal binding. The distinguishing 
characteristic of Cluster A is an α-helix serving as the hinge between the two domains 
(Figure 1.10A). This helix ensures a rigid overall structure. An example of this group is 
BtuF, the SBP of vitamin B12 ABC importer from Escherichia coli. This cluster is 
further divided into into two sub clusters (A-I and A-II) based on their cognate ligands. 
In A-I the SBPs bind metal ions (iron, zinc, or manganese) via direct interactions with 
the metal ion and in A-II they bind chelated metals by siderophores like enterobactin, 
catecholate and hydroxamate. 
Cluster B consists of SBPs that bind mainly carbohydrates such as ribose, glucose and 
arabinose but also amino acids. The SBPs of this cluster interact with ABC-transporters 
and the receptors involved in signal transduction. The SBPs of this cluster contain three 
hinges between the two domains (Figure 1.10B) as shown in the structure of ribose 
binding protein (RBP) (Figure 1.10B). 
The SBPs belonging to cluster C bind very different ligands, such as di- and 
oligopeptides, arginine, nickel ions and cellobiose. A characteristic feature of SBPs in 
this cluster is their large size ranging from 55 to 70 kDa. This large size is due to 
presence of an extra domain in these proteins (Figure 1.10C). 
Cluster D contains SBPs which are characterized by a unique hinge region consisting of 
two short strands, 4-5 amino acids long (Figure 1.10D). This group of proteins binds to 
a large variety of substrates; carbohydrates, thiamine, tetrahedral oxyanion and iron etc. 
Cluster E consists of SBPs which are part of TRAP transporters. The unique feature of 
this class of SBPs is a long helix that spans both domains and an additional β-strand 
connecting both domains (Müller et al., 2006) (Figure 1.10E). 
Cluster F contain SBPs, with a distinguishing feature in the form of a hinge containing 
domains I and II. However, the hinges of the cluster F proteins are significantly longer, 
8–10 amino acids (Figure 1.10F) than the hinges of 4–5 amino acids typically observed 
in SBPs of cluster D. Cluster F SBPs bind a large variety of substrates ranging from 
trigonal planar anions (nitrate and bicarbonate) to amino acids and compatible solutes 
such as glycine and betaine.  
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Figure 1.10 The different clusters of SBPs are shown with their distinct structural feature 
colored in orange. 
(A) Cluster A contains proteins having a single connection between the two domains in the form 
of a rigid helix. (B) Cluster B contains SBPs with three interconnecting segments between the 
two domains. (C) Cluster C contains SBPs that have an extra domain and are significantly 
larger in size when compared with the others. (D) Cluster D contains SBPs with two relative 
short hinges. (E) Cluster E contains SBPs associated with TRAP-transporters which all contain 
a large helix functioning as hinge region. (F) Cluster F contains SBPs with two hinges similar 
like cluster D, however, these hinges have almost double the length creating more flexibility 
inside the SBP. The proteins used to illustrate the features in clusters A–F are BtuF (PDB code: 
1N2Z), RBP (PDB code: 1DRJ), OppA (PDB code: 3DRF), ModA (PDB code: 1ONR), UehA 
(PDB code: 3FXB) and HisJ (PDB code: 1HSL), respectively (Taken from Berntsson et al 
2010) 
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1.6 Peptide transport 
Peptides transport refers to the uptake of peptides of a chain length of two or more 
amino acids. Peptide transporters are integral membrane components that mediate 
cellular uptake of peptides. They are found in bacteria, yeast, plants, invertebrates and 
vertebrates (Wilkinson, 1996). Peptides are widespread in nature and serve a variety of 
functions, for example they serve as a source of nutrients for a cell and in 
microorganisms they are also involved in various cellular signaling processes like 
sporulation, DNA transfer by conjugation and competence development (Lazazzera, 
2001) 
Free-living bacteria have evolved multiple routes for the uptake of peptides from 
environment (Detmers et al., 2001). High-affinity bacterial transporters for di-, tri-, 
tetra-, and oligopeptides are well studied in bacteria and allow them to take up any 
peptide of a particular length (Detmers et al., 2001, Doeven et al., 2005). The high-
affinity peptide transporters are all members of the ATP-binding cassette (ABC) 
transporter family and utilize a substrate-binding protein, (Guyer et al., 1986) which 
defines the substrate specificity of the transporter.  
Escherichia coli has two well characterized high-affinity peptide transporters with broad 
specificity for substrates: the oligopeptide system (Opp) that recognizes peptides 
between 2 and 5 amino acid residues in length, irrespective of their amino acid 
sequence, with highest affinity for tripeptides (Guyer et al., 1986) and the Dpp system, 
which has a preference for dipeptides (Smith et al., 1999) (Figure 1.11).  
The sequencing and annotation of the E. coli genome revealed the presence of a number 
of orthologues of the oppA and dppA genes on the chromosome including a number of 
orphan SBP coding sequences. Genetic data suggest that the orphan SBP, MppA, which 
is 46% identical to OppA, functions with the OppBCDF ABC transporter (Figure 1.11) 
(Park et al., 1998). The mppA gene was identified in 1998 as an additional locus in E. 
coli that was required for growth on the cell wall-derived murein tripeptide (L-Ala-γ-d-
Glu-meso-Dap, where meso-Dap is meso-diaminopimelate) as a source of Dap for 
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peptidoglycan biosynthesis (Park et al., 1998). This MppA/OppBCDF transporter 
presumably allows E. coli to recycle murein tripeptide (Mtp) from either exogenous 
sources or Mtp that is released by the AmiD outer membrane amidase into the 
periplasm during cell growth (Park and Uehara, 2008). YgiS is another putative peptide-
binding orphan SBP of unknown specificity (Figure 1.11) which has 44% amino acid 
sequence identity to OppA. 
E. coli also contains a third characterized peptide ABC transporter, the Ddp system, 
which is thought to have evolved from the general dipeptide (Dpp) transporter system to 
specifically recognize D-Ala-D-Ala, another component of the peptidoglycan that can 
be recycled by the cell (Figure 1.11) (Lessard et al., 1998). 
Finally, a glutathione-specific transporter of the oligopeptide permease family has been 
characterized genetically in E. coli, the GsiABCD system (Suzuki et al., 2005) (Figure 
1.11). Glutathione is a tripeptide (γ-glutamylcysteinylglycine) which is taken up by 
bacteria as part of the cysteine salvage pathway. Genetic studies show that transport of 
glutathione was not observed when the gene encoding the glutathione binding protein 
(GsiB) was deleted. 
Therefore it is clear that the cluster C oligopeptide SBP family includes proteins that 
recognize general peptides, as well as others that have evolved to recognize specific 
peptides. The SBPs recognizing specific peptides are not restricted to Gram-negative 
bacteria. There is genetic evidence in the literature about specific peptide-binding 
proteins from Gram-positive bacteria too. It is worth mentioning that in a Gram-
negative bacterium like E. coli there exists an outer membrane that limits the size of 
peptides that can be taken up. Peptides up to five or six amino acids long can freely 
diffuse across the outer membrane (Nikaido, 2003) of Gram-negative bacteria. In Gram-
positive bacteria there is no such restriction and peptides up to 35 amino acids long are 
transported (Doeven et al., 2004). 
Conjugation is the transfer of certain plasmids from donor cells to recipient cells. 
Pheromone dependent conjugation is an interesting phenomenon studied in 
Enterococcus faecalis (Leonard et al., 1996). Pheromones are small hydrophobic 
peptides of seven or eight amino acids secreted by plasmid free recipient cells. Each of 
these pheromones triggers the transfer of a specific plasmid from a donor cell to a 
recipient cell. The pheromones cPD1, cAD1, and cCF10 are specific for plasmids 
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pPD1, pAD1 and pCF10 respectively and are recognised by a cell surface binding 
protein (designated TraC for pPD1 and pAD1, and PrgZ for pCF10) (Chandler and 
Dunny, 2004). Studies conducted on pCF10 show that import of peptide into donor cells 
depends upon the concerted action of the membrane components of the Opp system and 
PrgZ (Leonard et al., 1996). Mutation of PrgZ decreased the sensitivity of donor cells to 
pheromone. In mutants without PrgZ, but with a functional Opp system, signalling still 
occurs but higher concentration of the pheromone is necessary. This indicates that 
OppA is able to bind the pheromone but with lower affinity than PrgZ. Both PrgZ and 
TraC are orphan SBPs and likely use membrane components of E. faecalis Opp system. 
Both PrgZ and TraC proteins exhibit a very high binding affinity, the dissociation 
constants for peptides are in the nanomolar range. PrgZ and TraC are highly similar but 
they seem to be dedicated to specific hydrophobic peptides. On the other hand, the 
general binding protein (OppA) of the Opp systems have dissociation constants in the 
micromolar range for a wide variety of peptides, differing in length and amino acid 
composition. This correlates with the function of these peptide-binding proteins. OppA 
plays a role in nutrition and should be able to accept peptides irrespective of their 
sequence and composition, whereas the binding proteins involved in conjugation should 
only respond to a specific signal (Detmers et al., 2001). 
1.6.1 The structural basis of sequence independent peptide binding  
The peptide-binding SBPs of ABC transporters determine the substrate specificity of the 
system. A wealth of structural data is now available for these peptide-binding SBPs. 
The first structure of a peptide-binding SBP (OppA of S. Typhimurium) was solved by 
Prof. Tony Wilkinson and colleagues in 1994 (Tame et al., 1994). The structures of two 
liganded forms of OppA were determined, the first containing trilysine (KKK) and the 
second containing a co-purified (presumably heterogenous) peptide ligand. OppA has 
high affinity for its ligands and as a result co-purifies with bound peptides, a 
phenomenon referred as the retention effect (Guyer et al., 1986, Silhavy et al., 1975). 
A unique feature of the overall structure of liganded forms of OppA was the 
organization of the polypeptide chain into three domains instead of two (Figure 1.12). 
Two of the domains (I and II) are structurally analogous to those present in other SBPs 
(Figure 1.10). Domain III has no counterpart among other SBPs and its function is not 
clear.  
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Figure 1.12 Crystal structure of OppA in complex with peptide ligands 
A) Crystal structure of OppA in complex with trilysine (KKK). Domain I, II and III are labeled. 
The electron density of the ligand (2Fo-Fc map) is displayed as blue mesh (right) and contoured 
at 1 . Image is drawn in PyMol using the coordinates from PDB (2OLB). B) Crystal structure 
of OppA in complex with an undefined mixture of co-purified peptides. The electron density of 
the ligand (2Fo-Fc map) is displayed as blue mesh (right) and contoured at 1 . A tetrapeptide 
(VKPG) is modeled into the density.  
 
A) 
B) 
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The structure of OppA in complex with a tripeptide (KKK) shows a very clear electron 
density for the tripeptide in the binding pocket (Figure 1.12A). The peptide adopts an 
extended conformation. Tight peptide binding is mainly due to main-chain to main-
chain contacts. The main-chain interactions between the protein and a tripeptide are 
shown in Figure 1.13. The charges at the N and C termini of the peptide are countered 
in the complex by oppositely charged side chains, Asp419 and Arg413.  
The structure of OppA in complex with endogenously co-purified ligand also shows 
extra electron density in the binding pocket of OppA, which could not be accounted for 
by protein atoms (Figure 1.12B). However the additional electron density was not well 
defined and it was not possible to model a peptide that fits well into the electron density. 
The true sequence of the peptide ligand remains unidentified in the structure and it was 
attempted to model the tetrapeptide (VKPG) into the electron density (Figure 1.12). The 
ambiguity in defining the electron density was perhaps due to heterogeneous population 
of peptides that were co-purified with OppA. This feature is consistent with the 
structures of all peptide-binding SBPs that are thought to bind a large variety of 
peptides (Berntsson et al., 2009, Levdikov et al., 2005, Klepsch et al., 2011). 
Later on, structure of OppA was solved in complex with tripeptides of varying amino 
acid sequences (Sleigh et al., 1999) proving the versatility of OppA in terms of 
accommodating various peptides irrespective of their amino acid sequence. 
Crystallographic analysis of the structures showed that the side chains of the amino 
acids are accommodated in large hydrated pockets. These pockets can accept any side 
chain, which is the basis of lack of specificity for the ligand‟s amino acid sequence. The 
hydrogen bonds and salt bridges formed by the peptide backbone alone can drive 
binding and there is only a small contribution of the amino acid side chains to the 
binding affinity. 
Specificity for peptides of a particular length is determined by salt bridges that constrain 
the positions of their N and C termini in the binding site. This is consistent with the 
architecture of Gram-negative bacteria where an outer membrane restricts the size of 
peptides that can diffuse into the periplasm. 
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Figure 1.13 Schematic diagram illustrating the interactions made by the main chain of the 
tri-lysine ligand with OppA 
Protein residues are labelled. Hydrogen bonding and electrostatic interactions are 
indicated by the dotted lines. R1, R2 and R3 indicate the ligand side chains. Figure 
taken from Tame et al 1995.  
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In Gram-positive bacteria there is no outer membrane and thus large peptides are 
accessible to peptide-binding SBPs. A crystal structure of a peptide-binding SBP 
(AppA) from Bacillus subtilis has shown that it can accommodate a nonapeptide 
(Levdikov et al., 2005). Similarly the Opp system of Lactococcus lactis has been shown 
to bind and transport peptides as long as 35 residues of any composition though it has a 
clear preference for nonapeptide (Doeven et al., 2004). The basis of binding larger 
peptides has recently been shown by solving the crystal structure of OppA from L. 
lactis. A salient feature of the structure is the enormous volume (4900Å3) of its ligand 
binding cavity (Berntsson et al., 2009). The volume of cavity is bigger than those of 
AppA (2600Å3) and OppA (1000Å3) from B. subtilis and S. Typhimurium, respectively. 
This greatly expanded cavity is created due to structural rearrangements of the loops 
and thus responsible for accommodating larger peptides. 
1.7 Peptidoglycan 
Peptidoglycan (or murein) is the major structural component of bacterial cell walls, 
which conserves the turgor pressure and shape of the cells. Peptidoglycan (PG) is a 
macromolecular structure that forms a mesh like layer outside the cytoplasmic 
membrane (van Heijenoort, 2001). It consists of glycan strands cross-linked by short 
peptides referred to as stem peptides. The glycan strands are made up of alternating 
units of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc), which 
are linked together by - 1,4 linkage (Vollmer et al., 2008, Park and Uehara, 2008) 
(Figure 1.14). The glycan moiety of the PG is remarkably uniform among bacteria 
(Schleifer and Kandler, 1972). Short peptides are attached to MurNAc sugars and 
expand in all directions. In E. coli, a pentapeptide (L-Ala-γ-D-Glu-m-Dap-D-Ala- D-
Ala) is attached at the carboxyl group of MurNAc in nascent peptidoglycan (Figure 
1.14). Mature peptidoglycan subsequently loses one or both D-Ala residues (van 
Heijenoort, 2001). About one half of the stem peptides are involved in cross linking 
between neighbouring glycan strands. This-cross linking occurs between amino group 
of m-Dap residue at position 3 of one peptide and carboxy terminus of the D-Ala 
residue at position 4 of adjacent peptide (Navarre and Schneewind, 1999). 
In contrast to the uniform structure of the glycan, the peptide moiety shows 
considerable variation. The peptide subunits are attached at the carboxyl group of 
muramic acid by their N-terminal amino acid. The amino acid linked to muramic acid is 
50 
usually L-Ala, but in some cases it can be replaced by L-Ser  (Schleifer and Kandler, 
1972). The second amino acid is usually D-Glu.  The -carboxyl group of D-Glu is 
linked to the next amino acid in the peptide subunit. The -carboxyl group is either free 
or substituted. In many organisms it is amidated for example in S. aureus, S. pneumonia 
and Mycobacteria (Waldmer review and 1972 review). In some bacteria like 
Micrococus leuteus it is substituted by Gly (Schleifer and Kandler, 1972). The greatest 
variation occurs at position 3, where usually a diamino acid is present. The most widely 
present diamino acid is meso-diaminopimelic acid (m-Dap). It is present in most Gram-
negative bacteria, Mycobacteria and Bacilli. In most Gram-positive bacteria L-Lys is 
present instead. Less frequently L-Orn and LL-Dap are present. Since all these amino 
acids possess an additional amino group, they are excellent anchoring point for the cross 
linking of peptides. L-homoserine may be present in rare cases (Schleifer and Kandler, 
1972, Patin et al., 2010) but as it lacks additional amino group, cross linking occurs in a 
different way. Since all the amino acids at position 3 possess an additional amino group, 
they are an excellent anchoring point for the crosslinking of the peptide subunits. 
Indeed, almost all peptide subunits containing one of these diamino acids in position 3 
are crosslinked by means of these diamino acids. Positions 4 and 5 are almost always 
occupied by D-Ala, with very little variation (Schleifer and Kandler, 1972). 
 
 
 
 
 
 
 
 
 
Figure 1.14 Basic structure of peptidoglycan of E. coli 
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1.7.1 Synthesis of peptidoglycan 
The biosynthesis of peptidoglycan is a complex process and takes place in three 
compartments of the cell: cytoplasm, cytoplasmic membrane and periplasm. The first 
step involves the assembly of its monomer unit by the enzymes located in the cytoplasm 
or at the inner side of cytoplasmic membrane (van Heijenoort, 2001). The subunits of 
the PG polymer are synthesized in the cytoplasm as UDP-activated precursors (UDP-
MurNAc-pentapeptide). These precursors are then translocated as lipid-linked 
compounds across the cytoplasmic membrane and finally inserted into the preexisiting 
PG by murein synthases (Holtje, 1998).  
1.7.2 Turnover of PG and recycling of Mtp 
The cell wall of bacteria is not a static structure since permanent remodelling occurs 
during cell growth and division; for example, in E. coli 40-50% of peptidoglycan is 
broken down and reused each generation for the synthesis of new murein (Park, 1995). 
In this process, murein is degraded by the murein hydrolases which include lytic 
transglycosylases, amidases and endopeptidases. The main turnover products, which 
have been identified as GlcNAc-MurNAc(anhydro)-tetra- and tripeptides, are imported 
into the cytoplasm by a specific permease (AmpG) and are reused in a process that has 
been termed the recycling pathway (Park and Uehara, 2008) (Figure 1.15). This process 
involves a large set of enzymes including the amidase (AmpD), the LD-
carboxypeptidase (LdcA) and the -N-acetylglucosaminidase (NagZ), that catalyze the 
stepwise breakdown of anhydro-muropeptides, yielding GlcNAc, anhydro- MurNAc, D-
Ala, and the tripeptide L-Ala- -D-Glu-meso-Dap. The murein tripeptide L-Ala- -D-Glu-
meso-Dap is then directly ligated to UDP-MurNAc by a dedicated murein peptide ligase 
(Mpl) and thus re-enters the biosynthesis pathway for de novo peptidoglycan synthesis 
(Herve et al., 2007, Park and Uehara, 2008). 
1.7.3 Peptidoglycan amidases 
Amidases are one of the most numerous peptidoglycan degrading enzymes in bacteria. 
Almost all peptidoglycan amidases are peptidases. In most species there exists a specific 
amidase for almost every peptide linkage present in the peptidoglycan. Often the 
number of amidases actually exceeds the number of peptide bonds. For example in E. 
coli 3 different proteins have D-Ala-D-Ala amidase activity (Firczuk and Bochtler, 
2007). This multiplicity can be understood as functional redundancy. 
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Figure 1.15 Turnover of peptidoglycan and pathway for recycling of murein tripeptide 
The figure is adapted from Park et al., 2008 
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Another explanation is that they are involved in different cellular processes at different 
stages of bacterial life cycle. Peptidoglycan amidases represent a very diverse group of 
enzymes in terms of their sequence similarities and structural criteria. They can be 
grouped into three main families; metallopeptidases, cysteine peptidases and serine 
peptidases and into nine different fold groups (Firczuk and Bochtler, 2007). MpaA is a 
putative D-Glu-meso-Dap amidase of E. coli and has been grouped into 
metallopeptidase family and carboxypeptidase T fold group on the basis of its sequence 
similarity to characterized amidases (Firczuk and Bochtler, 2007). Chapter 6 describes 
biochemical and structural characterization of MpaA. 
1.8 Protein crystallography 
Protein crystallography is a technique used to determine three dimensional structures of 
proteins and their complexes to atomic resolution level. During this process a crystalline 
form of a single protein or protein complexes is produced which is then exposed to an 
X-ray beam resulting in a diffraction pattern on the X-ray detector. Using a combination 
of mathematical functions, the diffraction pattern is translated into an electron density 
map. A three dimensional model of the protein structure is then produced by 
interpreting the electron density map (Blow, 2002, Glusker and Trueblood, 1985) . 
The method is similar to light microscopy in many ways. In case of light microscopy 
light is transmitted through an object. In both cases scattered light is focused by a series 
of lenses to form an image of object. Similarly X-rays are scattered by the atoms of 
macromolecule. However X-rays cannot be focused by lenses to form an image of a 
molecule. Instead X-rays are scattered from a single crystal to give a pattern that 
represents macromolecular order and structure. The structure is constructed using 
mathematics as a lens to transform the pattern back into the original structure (Van 
Holde et al., 1998). Since the crystals are imperfect and some information is lost during 
the transformation, the structure we get is not a true image, as from microscopy, but a 
model of the structure. Although a number of higher resolution microscopes have been 
developed, the only method that provides structure of macromolecule at atomic 
resolution is X-ray diffraction. The closest distance between two atoms in space is the 
length of a covalent bond. Since the typical covalent bond is approximately 0.12 nm, we 
need to see two atoms separated by this distance as distinct particles. There are some 
practical limitations to get a molecular structure solved to atomic resolution. First, the 
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system must have the atoms of its molecules held rigidly and secondly each molecule 
must have identical conformations. Any fluctuation in the positions of the atoms in the 
molecule or any deviation of molecules from a single conformation would result in an 
averaging of the structure, which would reduce the resolution of the technique. 
1.8.1 Protein crystallization 
Proteins solidify to form crystals under certain conditions. In the process of 
crystallization individual molecules adopt identical orientations. The resulting crystal is 
an ordered three dimensional array of molecules held together by noncovalent 
interactions. Crystals of protein are grown by slow, controlled precipitation from 
aqueous solution under conditions that do not denature the protein. A number of 
substances cause proteins to precipitate. Ionic compounds (salts) precipitate proteins by 
a process called "salting out." Organic solvents also cause precipitation, but they often 
interact with hydrophobic portions of proteins and thereby denature them. The water-
soluble polymer polyethylene glycol (PEG) is widely used because it is a powerful 
precipitant and a weak denaturant. One simple means of causing slow precipitation is to 
add denaturant to an aqueous solution of protein until the denaturant concentration is 
just below that required to precipitate the protein. Then water is allowed to evaporate 
slowly, which gently raises the concentration of both protein and denaturant until 
precipitation occurs. Whether the protein forms crystals or instead forms a useless 
amorphous solid depends on many properties of the solution, including protein 
concentration, temperature, pH, and ionic strength. Finding the exact conditions to 
produce good crystals of a specific protein often requires many careful trials and is 
perhaps more art than science (Rhodes, 2000).  
1.8.2 X-ray diffraction 
When an X-ray beam is directed towards a crystal, the X-rays are scattered from a 
regular repeating array of molecules in a single crystal. As a result a diffraction pattern 
is obtained on the X-ray detector. Each reflection can be assigned three coordinates or 
indices (named as h, k and l) in imaginary 3D space of the diffraction pattern. The 
position of spots from the diffraction experiment gives information about the unit cell 
dimensions and the intensities of spots give information on the arrangement of atoms in 
that unit cell. Each diffracted X-ray that arrives at the film to produce a recorded 
reflection can also be described as the sum of the contributions of all scatterers in the 
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unit cell. The sum that describes a diffracted ray is called a structure-factor equation. 
The computed sum for the reflection hkl is called the structure factor Fhkl. The structure 
factor is a wave created by the superposition of many individual waves, each resulting 
from diffraction by an individual atom (Rhodes, 2000). 
1.8.3 Phase problem  
In the diffraction experiment we measure the intensities of waves scattered from planes 
(denoted by hkl) in the crystal. The amplitude of the wave |Fhkl| is proportional to the 
square root of the intensity Ihkl measured on the detector. To calculate the electron 
density at a position (xyz) in the unit cell of a crystal requires us to perform the 
following summation over all the hkl planes, which in words we can express as: electron 
density at (xyz) which is equal to the sum of contributions to the point (xyz) of waves 
scattered from plane (hkl) whose amplitude depends on the number of electrons in the 
plane, added with the correct relative phase relationship. Mathematically this can be 
expressed as in equation 1.1, where V is the volume of the unit cell and alpha hkl is the 
phase associated with the structure-factor amplitude |Fhkl| (Taylor, 2003). We can 
measure the amplitudes, but the phases are lost in the diffraction experiment. This is 
called the phase problem. 
 
   (1.1) 
 
There are different ways to determine the phases. One of the methods to solve the phase 
problem is molecular replacement (MR). This method was first described by Michael 
Rossmann and David Blow (Blow, 2002). MR utilizes the solved structure of a 
homologous protein as a model source of the initial phases for the new structure. Only 
structures showing high similarilty can be considered as a suitable model. As a rule of 
thumb, a sequence identity >25% is normally required between the model and new 
structure (Taylor, 2003). The phases are obtained from the model structure to produce 
an initial electron density map. MR is a fast and relatively straight forward approach 
provided a suitable homology model is available. In the absence of any homology 
model, experimental phasing is the only way to solve the phase problem (Taylor, 2003). 
Since the detectors can only detect the intensity of the reflection, the phase information 
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has to be measured through variations in the intensities. This is achieved through 
interference between a diffracted wave of unknown phase and a reference wave of 
known phase. There are two possible sources of such a reference wave that can be 
introduced into the structure, a heavy atom (isomorphous replacement method) or 
anomalous atoms such as selenium, which resonate with incoming X-ray radiation 
(anomalous scattering method) (Blow, 2002). 
1.9 Aims of this study 
This thesis focuses on the biochemical characterization of peptide specific substrate-
binding proteins (SBPs) which are thought to recognize specific peptides. The project 
uses three peptide-binding SBPs namely MppA, GsiB and YgiS from Escherichia coli 
and involves a combination of biophysical and biochemical methods to examine 
specific peptide binding and also a structural approach to investigate how specific 
peptides are coordinated by the SBPs. The study also investigates the catabolism of a 
peptidoglycan derived component, murein tripeptide, by an amidase enzyme MpaA in 
the context of conserved scavenging pathway for murein tripeptide in -proteobacteria. 
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Chapter 2 
 
 
2 Materials and Methods 
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2.1 Media and Antibiotics 
2.1.1 Luria-Bertani broth and agar 
Luria-Bertani (LB) broth was made in distilled water using 10 g/l tryptone, 5 g/l yeast 
extract (trace elements) and 10 g/l NaCl. LB agar was made in smaller volumes of 200 
ml using 4g tryptone, 2g yeast extract, 4g NaCl and 3g agar. Volume was made up with 
distilled water.  
2.1.2 M9 minimal medium  
20x M9 minimal medium (Neidhardt et al., 1974) was made up from 68g Na2HPO4 
(Fisher Scientific), 30g KH2PO4 (Fisher Scientific) and 10g NH4Cl (Melford) with 
distilled water to 500 ml, pH adjusted to 7.4 and autoclaved. 1 M MgSO4 (Fisher 
Scientific) and 12.5 mg/ml FeSO4.7H20 (AnalaR) were sterilized separately. The M9 
minimal medium salts were supplemented with 2 mM MgSO4, 25 μg/ml FeSO4.7H20 
and 0.4 % glucose as a carbon source.  
2.1.3 Enhanced M9 minimal medium  
Enhanced minimal medium was composed of same components as M9 minimal 
medium with the addition of following supplements in order to enhance bacterial 
growth. A mix of 19 amino acids (-Met) at 40 g/ml, seleno-L-methionine at 40 g/ml 
and mix of vitamins at 1 g/ml.  
2.1.4 Antibiotics  
Antibiotic selection, where appropriate, was used at 100 μg/ml ampicillin (Melford) and 
30 μg/ml kanamycin (Sigma-Aldrich), each from 1000-fold stock, 0.22 μm filter 
sterilized and stored at 4ºC.  
2.1.5 IPTG and Arabinose (Inducers) 
10 ml aliquots of 100 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) were 
routinely made. 238 mg IPTG was weighed and made up with sterile distilled water to 
10 ml. This was then filter sterilized using a 0.22 nm filter. All aliquots were stored in 
sterile universal, wrapped in aluminium foil to prevent photodegredation and stored at 
4ºC. Large scale protein expression cultures needed larger amounts of IPTG and thus 1 
M IPTG was prepared for that as described above. IPTG was added to cells such that its 
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final concentration was 0.5 mM.  Similarly 5 ml aliquots of 10% L-arabinose were 
made in sterile water, filter sterilized and stored at 4ºC. L-arabinose was added to cells 
such that its final concentration became 0.005%. 
2.1.6 Strains and plasmids 
The genotypes of bacterial strains that were used for this work are described in Table 
2.1 while Table 2.3 lists all the plasmids used and constructed during this work. 
2.2 Recombinant DNA techniques / Gene cloning 
2.2.1 Agarose gel electrophoresis  
Separation of DNA fragments by electrophoresis was performed using 1% (w/v) 
agarose gel in TBE buffer. TBE buffer was made up with 1.62 g/l Tris (Invitrogen), 
2.75 g/l boric acid (Fisher Scientific) and 0.95 g/l EDTA (Fisher Scientific). 1 % 
agarose gels were made by pouring molten agarose directly into a horizontal 
electrophoresis tank, adding combs to produce appropriate sized wells and then 
allowing the gel to set. SYBR safe DNA stain (Invitrogen) was added at 10 l per 100 
ml of molten agarose before pouring into the tank. Upon setting of agarose gel the comb 
and plastic blockers were removed and the gel was submerged in TBE buffer. Samples 
were prepared by mixing 15 l DNA with 5x stock of sample loading buffer (Bioline) 
and loading into a well. Each gel contained at least one DNA ladder (Bioline 
Hyperladder ) to act as a marker (Figure 2.3).  DNA separation was performed by 
applying a potential difference of 80 Volts for 40 minutes. SYBR safe stained DNA was 
visualised on a transilluminator (Syngene Imaging System). 
2.2.2 Table of primers  
The primers used in this work are shown in Table 2.2. All primers were ordered from a 
biotech company (Eurofins MWG Operon). 
2.2.3 Polymerase Chain Reaction (PCR)    
PCR was used for the amplification of genes for cloning. High fidelity DNA 
polymerase (KOD from Novagen) was used throughout. A standard PCR reaction of 50 
l consisted of KOD PCR buffer (1x), 0.2 mM each dNTPs, 1 mM MgSO4, 25 pmoles  
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Table 2.1 Bacterial strains 
 
Strains Genotype Source 
DH5α K-12 F 80dlacZΔM15 recA1 endA1 gyrA26 thi-1 
supE44 relA1 deoR Δ(lacZYA-argF)U169 
Invitrogen 
BL21 (DE3) F
-
 ompT hsdSB (rB
-
, mB
-
) gal dcm (DE3) Novagen 
MC1061 araD139 Δ(ara-leu)7696 ΔlacX74 galU- galK- 
hsdR2 (r k
-
 m k
+
) mcrB1 rpsL (F
-
) 
(Casadaban 
and Cohen, 
1980) 
CH212 hsdS2 (rB
-
 mB
-
) recA13 ara-14 proA2 lacY1 galK2 
rpsL20 (Sm
r
) xyl-5 mtl-1 supE44 oppA462 
(Higgins and 
Hardie, 1983) 
B834 (DE3) F– ompT hsdSB (rB 
-
 mB
-
) gal dcm met (DE3) Novagen 
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Table 2.2 Details of nucleotide primers used for amplification of DNA fragments 
 
Name of 
Primer 
Sequence of primer (5 -3 ) 
mppAF CCAGGGACCAGCAATGGCAGAAGTTCCGAGCGGCACAGTACTGG 
mppAR GAGGAGAAGGCGCGTTATCAATGCTTCACAATATACATAGTCCGACTGTACG 
gsiBF CCAGGGACCAGCAATGGCCAAAGATGTGGTGGTGGCGGTAGG 
gsiBR GAGGAGAAGGCGCGTTATTGCAAATCCGCGTCTTCAAAGCTG 
ygiSF CCAGGGACCAGCAATGGCTGACGTTCCCGCCAACAC 
ygiSR GAGGAGAAGGCGCGTTATCAATGTGCCTTGATATACAACTCT 
mppA-NF ATGGTGAGAATTTATATTTTCAAGGTGCAGAAGTTCCGAGCGGCA 
mppA-NR TGGGAGGGTGGGATTTTCATCAATGCTTCACAATATACATA 
mppA-CF ATGGGTGGTGGATTTGCTATGTCGGTTAGAGGGAAACT 
mppA-CR TTGGAAGTATAAATTTTCATGCTTCACAATATACATAG 
gsiB-NF ATGGTGAGAATTTATATTTTCAAGGTGCCAAAGATGTGGTGGTGG 
gsiB-NR TGGGAGGGTGGGATTTTCATTATTGCAAATCCGCGTCTTC 
gsiB-CF ATGGGTGGTGGATTTGCTATGGCAAGAGCTGTACACCGT 
gsiB-CR TTGGAAGTATAAATTTTCTTGCAAATCCGCGTCTTCAA 
mppAA274EF TATTATGAATTTAACACGCAAAAGGGCCCGACG 
mppAA274ER GTTAAATTCATAATAATAGGTCCCGAGCTGCGG 
mppAR402AF GATAGCGCGAACACCGGCAATTTTGATGTTATC 
mppAR402AR GGTGTTCGCGCTATCGATATAGGTCTTCCATTCCTG 
Ec_mpaAF CCAGGGACCAGCAATGACCGTAACCCGCCCACG 
Ec_mpaAR GAGGAGAAGGCGCGTTATCACGACGGGCGAATTGCATCT 
Vh_mpaAF CCAGGGACCAGCAATGAGTCTAATTCCAAGAACG 
Vh_mpaAR TAACGCGCCTTCTCCTCCAGCACGATCCAGATCTTTAA 
Vh_mppAF CCAGGGACCAGCAATGGATTCTTTGCCTGATGGTGT 
Vh_mppAR TAACGCGCCTTCTCCTCAGACCTCTACATCAAGAAGTAG 
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Table 2.3 Plasmids used for vector construction and expression studies 
 
Plasmid Description Resistance Source 
pET-YSBLIC3C High copy number expression 
plasmid based on pET28a 
Kan YSBL 
pBADnLIC2005 pBAD vector modified with LIC 
cassette 
Amp Dr. Eric  
Geertsma 
pBADcLIC2005 pBAD vector modified with LIC 
cassette 
Amp This study 
pAM6091 mppA in pET-YSBLIC3C with N-
terminal H6 
Kan This study 
pAM6092 gsiB in pETY-SBLIC3C with N-
terminal H6 
Kan This study 
pAM6093 ygiS in pET-YSBLIC3C with N-
terminal H6 
Kan This study 
pBAD6094 mppA in pBADnLIC2005 with N-
terminal H10 
Amp This study 
pBAD6095 gsiB in pBADnLIC2005 with N-
terminal H10 
Amp This study 
pBAD6096 mppA in pBADcLIC2005 with C-
terminal H10 
Amp This study 
pBAD6097 gsiB in pBADcLIC2005 with C-
terminal H10 
Amp This study 
pAM6091A274E mppA in pET-YSBLIC3C with N-
terminal H6 mppA (A274E) mutant 
Kan This study 
pAM6091R402A mppA in pET-YSBLIC3C with N-
terminal H6 mppA (R402A) mutant 
Kan This study 
pEC6091 Ec_mpaA in pET-YSBLIC3C with 
N-terminal hexahistidine 
Kan This study 
pVH6092 Vh_mpaA in pET-YSBLIC3C with 
N-terminal hexahistidine 
Kan This study 
pVH6093 Vh_mppA in pET-YSBLIC3C with 
N-terminal H6 
Kan This study 
pCH19 St_oppA in pCH19 Amp (Hiles and 
Higgins, 
1986) 
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of forward and reverse oligonucleotide primers, 1 unit KOD polymerase of Novagen 
and either genomic or plasmid DNA template. The standard reaction volume was 50 l 
and the final volume was made up with sterile distilled deionised water. The whole 
process was performed on ice in 0.5 ml PCR tubes. Following a 2 minute, 95 °C 
denaturation step, the target DNA was amplified by 40 cycles of 94 °C for 1 minute, 55 
°C for 1 minute and 72 °C for 1 minute per kilobase of target. Following a final 
extension step of 10 minutes at 72 °C, the PCR product was removed from the thermal 
cycler (Techne) and frozen. 
2.2.4 Site-directed mutagenesis  
2.2.4.1 Mutagenic primer design 
Oligonucleotide primers for site-directed mutagenesis were designed according to the 
published protocol (Zheng et al., 2004). This used 30-50 base primers with a 5  overlap 
to reduce the primer-primer annealing temperature. The overlap covered a fifteen base 
region centred on the target codon and each primer was extended in the 3  direction for 
at least 15 bases or until the expected melting temperature reached 70 °C. Using 
Webcutter 2.0 (http://users.unimi.it/~camelot/tools/cut2.html), a silent restriction site 
was introduced into one of the overhanging regions that would produce a unique 
restriction digestion pattern.  
2.2.4.2 Mutagenic PCR conditions  
The 50 l PCR reaction mixture was made up as in Section 2.2.3. Following a 5 minute, 
95 °C denaturation step, the whole target plasmid was amplified by 16 cycles of 94 °C 
for 1 minute, 55 °C for 1 minute and 68 °C for 3 minute per kilobase of target. 
Following a final extension step of 1 hour at 68 °C, the PCR product was held at 10 °C 
until it was removed from the thermal cycler and frozen. Before transformation in to 
competent E. coli DH5α, the PCR product was subjected to DpnI restriction enzyme 
digestion to destroy the template DNA.  
2.2.5 Preparation of plasmid DNA 
Plasmid DNA was isolated from overnight grown bacterial cultures using a miniprep kit  
(Machery-Nagel) that employs the alkaline lysis method for plasmid recovery. The 
manufacturers recommended protocol was used. 
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2.2.6 Gel extraction 
DNA components were purified by 1% agarose gel electrophoresis and extracted from 
the gel using a Qiagen kit, before switching to one provided by Machery-Nagel.  
2.2.7 Ligation independent cloning (LIC) 
Ligation independent cloning was used to ligate PCR products of the target genes with a 
pET-YSBLIC3C (Fogg and Wilkinson, 2008) vector or with pBAD vectors; 
pBADnLIC2005 and pBADcLIC2005. pET-YSBLIC3C is a cleavable N-terminal His 
tagged vector that leaves 3 additional N-terminal amino acids after cleavage of His tag 
by HRV3C protease. It is based on pET28a (Figure 2.1) such that all the restriction sites 
in the MCS of pET28a are intact. pBADnLIC2005 and pBADcLIC2005 (Figure 2.2) are 
modified versions of the commercially available pBAD vectors with the inclusion of a 
LIC cassette at the site of cloning (modified by Dr. Eric Geertsma). 
Primers were designed such that a dedicated LIC tail was added to the PCR product, 
which was designed to be complementary to the LIC cassette in vectors. The gene of 
interest was amplified using PCR and purified using gel extraction. The vectors were 
linearised by digesting with the appropriate enzyme, BseRI for pET-YSBLIC3C and 
SwaI for pBAD vectors. The linearised vectors were purified by gel extraction. Both the 
insert and vector DNA were treated with T4 DNA polymerase (Novagen). The 3 5  
exonuclease activity of T4 DNA polymerase produces long, complementary overhangs 
on the vector and the insert. To do this, 200 ng of linearised vector was made up to 10 l 
with sterile water and treated with T4 DNA polymerase in the presence of dTTP for 
pET-YSBLIC3C and dCTP for pBAD vectors (1.5 μl 25 mM dCTP / dTTP, 3 μl 5x 
buffer and 0.5 μl T4 DNA polymerase). The reaction was incubated at room 
temperature for 30 minutes, after which T4 DNA polymerase was deactivated by 
incubation at 75 °C for 20 minutes. A volume of insert DNA corresponding to a 1:1 
molar ratio with vector was treated with T4 DNA polymerase but this time in the 
presence of dGTP (for cloning into pBAD vectors) or dATP (for cloning into pET-
YSBLIC3C). Both the LIC ready insert and vectors can be stored at -20 °C for several 
months.   
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Figure 2.1 Map of pET28a vector  
The kanamycin resistance protein is used as a selectable marker. The map is taken from 
Novagen. 
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Figure 2.2 Physical maps of pBADnLIC2005 and pBADcLIC2005 
Maps were kindly provided by Dr. Christoph Mulligan 
pBADnLIC2005 
4139 bp 
pBADcLIC2005 
4139 bp 
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The LIC-ready components were mixed in a 1:2 ratio of vector to insert and incubated 
at room temperature for 20 min. 1.5 µl of 25 mM EDTA was added and the reaction 
was incubated at room temperature for another 15 min. 2 µl of the reaction was used to 
transform into competent cells using the heat shock method. Transformation of pBAD 
based constructs was done into competent cells of MC1061 strain of E. coli while 
transformation of pET based vectors was made into DH5α strain of E. coli. 
2.2.8 Preparation of competent E. coli 
To chemically induce competence in E. coli, a 10 ml LB culture of the desired strain 
was incubated overnight. 1 ml of this culture was diluted 10-fold and allowed to grow to 
an optical density (OD 650) of 0.4-0.5 at which point the cells were kept on ice. The cells 
were separated into 1 ml aliquots in sterile 1.5 ml tubes. The cells were harvested by 
centrifugation at 4430 x g for 10 minutes and then resuspended in 1 ml ice-cold 100 
mM CaCl2. The cells were incubated on ice for 1 hour and then harvested by 
centrifugation at 4430 x g for 10 min. The aliquots of cells were resuspended in 200 μl 
ice-cold 100 mM CaCl2 each and incubated on ice for 20 minutes. The chemically 
competent cells could be used immediately or, by addition of 20 % glycerol in the final 
resuspension, could be snap frozen with liquid nitrogen and stored at -80°C.  
2.2.9 Transformation of competent cells: heat shock method 
This method of transformation can be used to transform the desired E. coli strain with 
plasmid DNA or ligation mixtures. This method requires a stock of ready-made 
competent cells as described above. An aliquot of chemically competent cells was 
allowed to thaw on ice. 1-5 ng of plasmid DNA or a volume of ligation mixture was 
added to the cells. The mixtures was mixed by tapping and incubated on ice for further 
30 minutes. The mixture was incubated for 30 seconds at 42 °C, and then 1 ml of LB 
was added and the mixture was incubated at 37 °C for 90 minutes. After that 100 μl of 
the cell suspension was spread on selective LB agar plate, the remaining cell suspension 
was harvested by centrifugation and resuspended in 100 μl LB and spread on a second 
selective LB agar plate. All plates were incubated at 37 °C overnight. 
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2.2.10 Restriction digestion of plasmid DNA 
Restriction endonuclease digestions were used to ensure the insert was correctly cloned 
into vectors. Restriction digests are normally done using two enzymes, which are 
normally chosen based on sequence they cut at and intercompatibility. For example 
NdeI and NcoI are compatible with each other and can be used in NEB buffer 4. 
Typically a 10 μl reaction of restriction digestion reaction consists of 0.5 μl of each 
restriction enzyme, 1 μl of appropriate buffer, 1 μl of mini preprating DNA and 7 μl of 
sterile distilled water. The reaction was incubated at 37°C for a minimum of two hours. 
After incubation 2 μl of loading dye was added into reaction tube and analysed on a 1% 
agarose gel. 
2.2.11 Automated DNA sequencing 
Where necessary, the sequence of specific target region (gene of interest) in 
recombinant plasmid was confirmed by DNA sequencing done at Technology Facility, 
University of York. The sequence data were verified on the basis of corresponding 
fluorescence electropherogram.  
2.3 Expression of recombinant proteins 
2.3.1 Whole cell small scale expression trials  
For expression of recombinant genes, 1-2 ng of purified plasmid was introduced into the 
expression strain given in Table 2.1. A single colony was used to inoculate 5 ml LB 
medium and the culture was grown aerobically at 37°C overnight. This was used to 
inoculate 25 ml of fresh LB medium (supplemented with antibiotic) to OD650 of 0.05. 
Cultures were grown aerobically at 37°C with shaking (180 rpm) to mid-log phase 
(OD650 of 0.5) and induced (IPTG / L-arabinose). 1 ml of culture samples were taken 
every hour after induction for four hours. A sample was also taken from the culture after 
overnight growth.  It was done for each of four constructs. Cells were sedimented by 
centrifugation at 38000 x g for 5 min. Cells were resuspended in 25  b l of 4x sample 
buffer (where b l is the OD650 of the cells when harvested), boiled for 5 minutes at 97.5 
°C on the heating block and centrifuged at 38000 x g for 5 minutes to get the 
supernatant. Accumulation of protein was checked by loading the supernatant on 
sodium dodecyl sulphate-polyacrylamide gel and running the gel at 200 Volts for 50 
minutes.  
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2.3.2 Solubilization trials 
Multiple samples (1 ml) were taken from small scale expression trials, cells were 
pelleted by centrifugation and the supernatant was discarded. The cells were 
resuspended in a particular buffer (for example, 50 mM potassium phosphate pH 7.8 or 
50 mM Tris pH 8) and lysed using a microtip sonicator (3×3 sec). A small portion of 
total cell lysate was taken out and the rest was centrifuged at 38000 x g for 5 min to get 
a clear/soluble lysate. Total and soluble fractions were run on SDS-PAGE to check the 
solubility of over produced protein in that buffer.  
2.3.3 Large scale expression 
625 ml LB medium (supplemented with antibiotic) was inoculated to OD650 of 0.05 
with overnight cultures of the particular E. coli strain. Cultures were grown to mid log 
phase (OD650 of 0.5) at 37 ºC with shaking (180 rpm), at which point expression was 
induced. After induction, cells were grown overnight and were harvested by 
centrifugation at 4430 x g for 15 min and resuspended  in appropriate buffer (For 
example, 50 mM KPi, pH 7.8 supplemented with 20% glycerol). Cells were lysed by 
sonication and cell debris was removed by centrifugation at 4430 x g. Soluble fraction, 
containing the over produced protein was stored at -20ºC.  
2.4 Selenomethionine labeling of recombinant proteins 
To produce selenomethionyl protein, the plasmid containing the cloned gene was 
transformed to BL 834 (DE3) strain of E. coli. This strain is a derivative of the 
commonly used BL21 (DE3) strain, and is methionine-requiring auxotroph containing 
the T7 RNA polymerase gene under lac control on the host chromosome. The T7 RNA 
polymerase is turned on by the addition of IPTG to 0.5 mM. Growth of these cells in 
selenomethionine ensures that all the methionine in the protein is in the form of 
selenomethionine.  Growth in selenomethionine is slow in minimal media (M9) and 
yield can be low. This problem can be addressed by using a synthetic medium 
(enhanced M9 minimal medium) containing a cocktail of the other 19 amino acids and 
L-selenomethionine. 
2.4.1 Small scale expression trials 
10 ml of enhanced minimal M9 medium (supplemented with kanamycin) was 
inoculated to OD650 of 0.1 with overnight grown culture in LB. Cultures were grown 
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aerobically at two temperature (37°C and 16°C) at 180 rpm. All cultures were grown to 
mid-log phase (OD650 of 0.5) and induced with 0.5 mM IPTG. 1 ml of culture samples 
were taken every hour after induction for three hours. Cells were sedimented by 
centrifugation at 38000 x g for 5 min. Cells were resuspended in 100 l of resuspension 
buffer (50 mM Tris pH 8) and were lysed by using microtip sonicator for 3 3sec. A 
portion (10 l) of total lysate was taken out and rest was spun in microcentrifuge at 
38000 x g for 5 min in order to get clear lysate containing soluble protein. Total and 
soluble fractions were run on SDS-PAGE to check accumulation and solubility of over 
produced protein.  
2.4.2 Large scale expression  
500 ml enhanced minimal M9 medium (supplemented with kanamycin) was inoculated 
to OD650 of 0.1 with overnight culture (inoculum) of the particular E. coli strain in LB 
that had been washed twice with M9 media. Cultures were grown to mid-log phase 
(OD650 of 0.5) at 37 ºC with shaking (180 rpm), at which point expression was induced 
by the addition of 0.5 mM IPTG. After induction, cells were grown for four hours and 
were harvested by centrifugation at 4430 x g for 15 min and resuspended in 50 mM Tris 
buffer of pH 8. Cells were lysed by sonication and cell debris was removed by 
centrifugation. The soluble fraction, containing the over produced protein was stored at 
-20 ºC and later on used for purification of over produced protein. 
2.5 Preparation of bacterial extracts  
2.5.1 Periplasmic fraction preparation  
The cells were harvested by centrifugation at 4430 x g for 15 minutes at 4 ºC (SLC 
6000 rotor in Sorvall Evolution centrifuge). The subsequent cell pellet was resuspended 
in ice-cold SET buffer (5 mM EDTA, 0.5 M sucrose and 50 mM KPi pH 7.8) in a ratio 
of 10 ml per litre of original culture. Chicken egg white lysozyme (Sigma) was added to 
cell resuspension at 600 μg/ml and incubated at 30 ºC for 2 hours. The subsequent 
sphaeroplasts were harvested by centrifugation at 38000 x g for 30 minutes at 4 ºC 
(SS34 rotor in Sorvall Evolution centrifuge); the supernatant from this centrifugation 
was the periplasmic fraction.  
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2.5.2 Cytoplasmic protein recovery  
Induced cells were harvested by centrifugation at 4430 x g for 15 minutes at 4 ºC (SLC 
6000 rotor in Sorvall Evolution centrifuge). The cells were resuspended in 35 ml of 
resuspension buffer (for 1250 ml of culture) and sonicated on ice for a total of 10 
minutes to rupture the cells. Insoluble protein and cell debris were removed by 
centrifugation at 38000 x g for 10 minutes at 4 ºC and the supernatant collected. 
2.6 Protein purification techniques  
2.6.1 Nickel-affinity chromatography using gravity flow columns 
The soluble fraction containing the protein of interest was mixed with Ni
2+
-NTA resin 
(Qiagen) equilibrated with buffer A (50 mM KPi, pH 7.8, 200 mM NaCl, 20% glycerol) 
supplemented with 10 mM imidazole. The mixture was incubated for 1 h at room 
temperature in a disposable polystyrene column (Pierce). Subsequently, the resin was 
washed with buffer A containing 50 mM imidazole, for 20 column volumes (CV) to 
remove weakly binding contaminants. Bound His-tagged protein was eluted with 
elution buffer A containing 500 mM imidazole. 
2.6.2 Nickel-affinity chromatography using HisTrap HP columns 
The soluble fraction containing recombinant protein was filtered through a 0.2 µm filter. 
A 5 ml HisTrap column (GE Healthcare) was equilibrated with buffer A (50 mM Tris 
pH 8, 200 mM NaCl and 10 mM imidazole) and connected to an AKTA Purifier P-900. 
Filtered supernatant was then injected into a pre-equilibrated column. The column was 
washed with 7 CV of wash buffer (50 mM Tris, pH 8, 200 mm NaCl and 10 mM 
imidazole) to remove weakly bound contaminants. A gradient was applied over 20 CV 
from 10 to 500 mM imidazole to elute His-tagged bound protein. Purification was 
monitored by detecting the absorbance of the column eluent at 280 nm (A280). Fractions 
were collected with an automated F-950 Fraction Collector (GE Healthcare) and were 
run on SDS-PAGE gel for analysis. 
2.6.3 Ion exchange chromatography 
The soluble fraction containing over produced protein was dialysed into 50 mM Tris 
buffer of pH 8 and filtered through a 0.2 µm filter. A 5 ml MonoQ column (GE 
Healthcare) was equilibrated with buffer A (50 mM Tris pH 8) and connected to an 
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AKTA Purifier P-900. The protein was injected on the column using a flow rate of 2 
ml/min. The column was then washed with 10 CV of buffer A. A linear gradient was 
applied over 20 CV from 0 to 500 mM NaCl with a flow rate of 2 ml/min. Purification 
was monitored by detecting the absorbance of the column eluent at 280 nm. Fractions 
were collected with an automated F-950 Fraction Collector (GE Healthcare) and were 
run on SDS-PAGE gel for analysis. 
2.7 Purification of ligand free protein 
2.7.1 Guanidine hydrochloride (GnHCl) denaturation  
2.7.1.1 Buffers  
The wash buffer was made up to 50 mM KPi buffer pH 7.8, 200 mM NaCl, 20% 
glycerol, 10 mM imidazole from higher concentration stocks. Guanidine hydrochloride 
(GnHCl) was added to 50 mM KPi buffer, 200 mM NaCl, 20% glycerol, 20 mM 
imidazole to give wash buffers containing 2 M, 1.5 M, 1 M and 0.5 M GnHCl. The 
elution buffer was made up of 50 mM KPi buffer, 200 mM NaCl, 20% glycerol, 500 
mM imidazole.  
2.7.1.2 In-column denaturation and refolding  
The soluble fraction containing protein was mixed with pre-equilibrated Ni-NTA resin 
and incubated for 1 hour at room temperature in gravity flow columns. After the resin 
was sedimented in a disposable column, the bound protein was denatured with 30 CV of 
buffer containing 2 M GnHCl, followed by 4 CV of each of the wash buffer containing 
decreasing GnHCl concentrations. Finally, the column was washed with 50 mM KPi 
buffer, 200 mM NaCl, 20% glycerol, 20 mM imidazole pH 7.8 and then the protein was 
eluted with 50 mM KPi buffer, 200 mM NaCl, 20% glycerol, 500 mM imidazole pH 
7.8.  
2.7.2 Cation exchange chromatography 
The soluble fraction containing protein was dialysed into buffer A (50 mM sodium 
acetate pH 5) and filtered through a 0.2 µm filter. A 5 ml MonoS column (GE 
Healthcare) was equilibrated with buffer A and connected to an AKTA Purifier P-900. 
The protein was injected into the column using a flow rate of 2 ml/min. The column was 
then washed with 25 CV of buffer A. A linear gradient was applied over 20 CV from 0 
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to 500 mM NaCl with a flow rate of 2 ml/min. Purification was monitored by detecting 
the absorbance of the column eluent at 280 nm. Fractions were collected with an 
automated F-950 Fraction Collector (GE Healthcare) and were run on SDS-PAGE gel 
for analysis. 
2.8 SDS- Polyacrylamide gel electrophoresis (SDS-PAGE)   
2.8.1 Buffers and gel   
The resolving polyacrylamide gel was cast from 12% acrylamide, 375 mM Tris-HCl pH 
8.8, 0.1% sodium dodecyl sulphate (SDS; Melford), 0.1% APS, 0.01% TEMED, while 
the stacking gel was cast from 4% acrylamide, 125 mM Tris/HCl pH 6.8, 0.1% SDS, 
0.1% APS, 0.01% TEMED. The running buffer in the tank was made up of 3 g/l Tris, 
14 g/l glycine and 1 g/l SDS and pH was adjusted to 8.8 with HCl.  
2.8.2 Sample preparation  
The desired amount of protein was mixed with sterile water and 4x sample buffer 
consisting of 100 mM Tris pH 6.8, 5 % SDS, 0.4 % bromophenol blue, 20% glycerol 
and 30 μl/ml β-mercaptoethanol. This mixture was then heated to 97.5 °C for 5 minutes 
and spun at 38000 x g for 5 minutes. NEB prestained protein marker (Figure 2.3B) was 
used to allow the molecular weight of proteins to be estimated. 
2.8.3 Electrophoresis conditions  
SDS-PAGE gels were run using a Mini-PROTEAN 3 Cell system (Bio-Rad). The 
manufacturer‟s guidelines were used for the assembly of the SDS-PAGE apparatus. 
Once the gel was submerged in running buffer, the samples were loaded and a 200 volt 
potential difference was applied for 50 minutes. When finished, the gels were rinsed 
with distilled water. 
2.8.4 Staining/destaining of SDS-PAGE gels  
Coomassie Brilliant Blue (CBB) dye was used to detect proteins on SDS-PAGE gels. 
The stain was prepared by mixing 2.5 g CBB, 450 ml methanol, 450 ml sterile water 
and 100 ml acetic acid. Gels were removed from apparatus, rinsed with water and 
submerged in stain for 5 minutes with gentle agitation. The excess stain was poured off  
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Figure 2.3 Markers for DNA and protein gels 
A) DNA hyperladder I from Bioline B) NEB prestained protein marker  
 
 
 
 
 
A) B) 
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and the gel was briefly rinsed with water to remove the residual dye. Approximately 
100 ml of destain containing 10% acetic acid and 10% ethanol was added and heated at 
full power in a microwave for 90 seconds. The gel was left on a rocker with gentle 
agitation for 30 minutes before an image was captured using the Syngene Imaging 
System.  
2.9 Protein concentration determination 
2.9.1 Bradford assay 
A set of protein standards were produced by serially diluting a stock solution of bovine 
serum albumin (BSA) from 400 µg/ml to 6.25 µg/ml. The protein of unknown 
concentration was serially diluted by at least 6 times. 50 µl of each of dilutions of BSA 
and unknown sample was added to 1 ml of Bradford reagent (Bio-Rad) in a cuvette. The 
absorbance was measured at 595 nm wavelength. A graph of protein concentration 
versus absorbance (A595) was plotted and the concentrations of the unknown samples 
were calculated using the standard curve. 
2.9.2 Using A280/extinction coefficient  
A NanoDrop ND-1000 spectrometer was used to confirm the results from the Bradford 
assay by measuring the absorbance at a wavelength of 280nm. The molecular weight 
and the extinction coefficient of purified proteins were calculated using the peptide 
property calculator tool available on Northwestern University website 
(http://www.basic.northwestern.edu/biotools/proteincalc.html). Protein concentration 
was determined using the Beer-Lambert law. 
2.10 Dialysis, concentrating and storage of protein 
Dialysis was used to change the buffer solution of both proteins and cell fractions. 
Dialysis was performed using 0.33 or 3.33 ml/cm dialysis tubing that is activated by 
“moisturising” using distilled water. Mediclips were used to seal the end of the tubing 
and then the sample pipetted into the dialysis tubing which was placed in a beaker of the 
new buffer at least 100x the volume to be dialysed. A minimum of three changes of 
buffer was used and each dialysis step left for a minimum three hours and at least one 
dialysis step was done overnight, with all dialysis performed at 4ºC. Protein 
concentration was increased using a MWCO 5000 Vivaspin columns. These columns 
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use centrifugation to reduce the amount of solvent while preventing the protein from 
passing through the membrane. Concentrated protein was stored at –80ºC for long 
periods, or at 4ºC for routine use. 
2.11 General biochemical and biophysical techniques 
2.11.1 Mass spectrometry 
A Micromass LCT Premier XE mass spectrometer using a nanospray source was used 
for electrospray mass spectrometry (ES-MS). For analysis of protein under denaturing 
conditions, purified protein (after removal of the His-tag) was dialysed into 50 mM KPi 
buffer pH 7.8 or 10 mM Tris pH 7.5 and concentrated to 100 μM. Concentrated protein 
was diluted to 1 μM in 1:1 acetonitrile-water containing 0.1% formic acid. The sample 
was passed into the ES-MS and the data were collected in positive mode over 3 minutes 
within an m/z range of 500-2000. To investigate the mass of any endogenous ligand 
bound to protein, a spectrum was obtained under native conditions. For analysis under 
native conditions purified MppA was dialysed into sterile water or 200 mM ammonium 
acetate and then concentrated to 100 μM. Data were collected over 5 minutes within an 
m/z range of 500-10000.
 
The raw m/z data were deconvoluted to mass spectra using the 
MaxEnt1 routine in the MassLynx software provided by the manufacturer (Waters). 
2.11.2 Fourier-transform ion cyclotron resonance mass spectrometry (FT-ICR-
MS / FT-MS) 
A CoEMS‟s Burker apex ultra 9.4 Tesla spectrometer was used for Fourier transform 
ion cyclotron resonace mass spectrometry of protein complexes. Purified protein after 
removal of the His-tag was dialysed into water and concentrated to 200 μM and given to 
Adam Dowle in the Technology Facilty, University of York, for analysis using the 
CoEMS‟s mass spectrometry equipment. Samples were diluted to between 10 and 100 
μM to give a final concentration of 50 % (v;v) aqueous methanol, 1% (v;v) formic acid, 
before introduction into the mass spectrometer. 
FT-ICR-MS was performed using an Apex ultra Fourier Transform Ion Cyclotron 
Resonance mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with a 
9.4 T superconducting magnet, interfaced to a Triversa NanoMate nanoESI source 
(Advion BioSciences, Ithaca, NY).   
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Instrument control and data acquisition were performed using Compass 1.3 for Apex 
software (Bruker Daltonics).  Nitrogen served as both the nebulizer gas and the dry gas 
for nanoESI.  Observed precursors were manually selected for sustained off-resonance 
irradiation (SORI) fragmentation in the infinity ICR cell, with argon used as both the 
cooling and collision gas.  
Bruker dataAnalysis software (version 4.0) was used to perform the spectral processing 
and peak picking for both MS and SORI fragmentation spectra.  Monoisotopic masses 
of proteins were calculated using the SNAP 2.0 algorithm in dataAnalysis (repetitive 
building block: C 4.9384, N 1.3577, O 1.4773, S 0.0417, H 7.7583). 
2.11.3 Circular Dichroism (CD) spectroscopy 
CD spectra of MppA mutants were obtained using a J-810 spectropolarimeter (Jasco) 
controlled by the supplied software SpectraManager version 1.53.00 (Jasco). Protein 
was dialysed into 10 mM KPi buffer pH 7.8 and diluted to a concentration of 5 μM. The 
spectrum was recorded at 20 °C in a 1 mm pathlength quartz cuvette (Starna) between 
180 – 240 nm at 100 nm/minute with 1 nm pitch. 
2.11.4 Tryptophan fluorescence spectroscopy  
Tryptophan fluorescence spectroscopy was performed using a FluoroMax 4 
fluorescence spectrometer (Horiba Jobin-Yvon) with connecting water bath to maintain 
temperature. Fluorescence experiments were performed in 3 ml quartz cuvettes (Starna) 
and purified protein was used at a concentration of 0.05 μM in 50 mM KPi, pH 7.8. The 
sample was excited at the 297 nm with slit widths of 3.5 nm and emission was 
monitored at 330 nm with slit widths of 3.5 nm.  Increasing concentrations of ligand 
was added to protein solution in 3 ml cuvette and the fluorescence change was 
measured. The cumulative fluorescence change was plotted against the cumulative 
concentration of ligand in SigmaPlot 11. The data were fitted to a single rectangular 
hyperbola, using the equation 2.1 and non-linear regression was used to solve the 
equation and produce values for dissociation constant (KD). 
 
 (2.1) 
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Here, y represents the change in fluorescence, x represents concentration of ligand, b 
represents dissociation constant (KD) and a represents fluorescence when curve flattens 
at high concentration of x.  
The change in fluorescence for addition of ligand was rescaled before plotting in 
SigmaPlot. A fluorescence change of 10,000 counts per second was scaled to 1. The 
data used to calculate dissociation constant (KD) of Mtp to MppA is given below in 
Table 2.4 as an example. 
 
 
Table 2.4 Fluorescence data for binding of Mtp to MppA 
 
Concentration of 
ligand (Mtp) 
added (μM)  
Cumulative 
concentration of 
Mtp added  (μM) 
Change in 
fluorescence upon 
addition of Mtp 
(cps) 
Change in 
fluorescence upon 
addition of Mtp 
(10,000 cps = 1) 
Cumulative change 
in fluorescence 
upon addition of 
Mtp 
0 0 14,88,000 0 0 
0.0676 0.0676 15,00,000 1.2 1.2 
0.0879 0.1555 15,35,000 3.5 4.7 
0.1488 0.3043 15,55,000 2 6.7 
0.2706 0.5749 15,70,000 1.5 8.2 
0.676 1.2509 15,85,000 1.5 9.7 
1.3491 2.6 15,85,000 0 9.7 
 
 
2.11.5 Isothermal Titration Calorimetry (ITC)  
Isothermal titration calorimetry (ITC) is a solution based technique to determine the 
thermodynamic parameters of molecular interactions. In the simplest case, a ligand (L) 
is introduced into a solution of protein (P) that can bind to form a simple complex (PL). 
The binding parameters; enthalpy change ( H), entropy change ( S), change in Gibb‟s 
free energy ( G), association constant (Ka) and stoichiometry (n) can be determined 
from a single ITC experiment by measuring the heat evolved or absorbed during an 
interaction. The heat change is a direct result of the protein-protein interactions. 
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Calorimetry experiments were carried out using a VP-ITC instrument (MicroCal Inc., 
GE Health Sciences). In a typical experiment, the calorimeter cell contained 1.4 ml of 
protein, and the syringe contained 300 μl of peptide ligand. The concentration of ligand 
in the syringe was typically 10 times that in the cell, whereas the cell concentration was 
chosen according to c value of greater than 10, where c = [macromolecule]/ (predicted) 
KD. Experiments were carried out in 50mM KPi buffer, pH 7.8 at 25°C. Both cell and 
syringe solutions were degassed at 20 °C for 10 min before use. The titrations were 
performed as follows. A single preliminary injection of 5 μl of ligand solution was 
followed by 28 injections (10 μl), delivered at an injection speed of 10 μl s-1. Injections 
were made at 3 min intervals with a stirring speed of 307 rpm. For titrations involving 
peptide PFK a heat of dilution control experiment was performed, where equivalent 
volumes of peptide were injected into buffer. This ruled out the possibility of heat of 
dilution masking weak binding. Raw titration data were integrated and binding 
isotherms fitted by an iteration process based on the „one-set of sites‟ model using 
MicroCal Origin version 7.0. The goodness of the fit was determined by an algorithm in 
the software (least square method). Values for Ka can and H can be determined by 
fitting the data obtained from the ITC experiment with the equation (2.2), where qi is 
heat absorbed or released at time interval i for the amount of ligand added at that 
interval, T is temperature and V is volume of the sample. 
 
 
 
 
Once Ka and H are determined, G can be calculated as G = -RT ln Ka and S from 
the standard equation G = H - T S. 
2.11.6 Size Exclusion Chromatography Multi-Angle Laser Light Scattering (SEC-
MALLS) 
Size exclusion chromatography (SEC) coupled with multi angle laser light scattering is 
a technique, which allows to determine the molecular weight of proteins and their 
complexes in solution (Folta-Stogniew and Williams, 1999). In a typical measurement 
the fractionation device, a light scattering (LS) detector and a concentration detector are 
(2.2) 
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connected in series. The concentration detector is usually a refractive index (RI) or 
ultraviolet (UV) absorption detector. When light passes through a solution containing 
the macromolecule (protein), interaction with the macromolecule leads to scattering of 
light beam. The scattering of light can directly determine the molecular mass, molecular 
root mean square (rms) radius size and aggregation state of macromolecule and is 
measured by LS detector. Because accurate concentration determination is vital for 
estimation of molar masses, the system also includes a refractive index detector. The 
molecular mass is determined for each eluting fraction separately. 
For SEC-MALLS experiments, sample of protein (100 µl of 1 mg/ml in 20 mM MES 
buffer pH 6.5, 200 mM NaCl) was injected and separated on a Superdex 200 10/300 GL 
SEC column (GE Healthcare) at 0.5 ml/min with an HPLC system (Shimadzu). Light 
scattering data were recorded on an in-line Wyatt Dawn Heleos LS detector with an in-
line Wyatt Optilab rEX refractive index detector and SPD-20A UV detector. Molecular 
weights were calculated by analysing the LS and RI data with the Wyatt program 
ASTRA version 5.3.4.14. A value of 0.19 ml/g was used for protein refractive index 
increment (dn/dc). 
2.12 Crystallization of protein 
Purified proteins were maintained at a concentration of 7-30 mg/ml in different buffers. 
Preliminary crystallization screening was performed by the Mosquito Nanolitre 
Pipetting robot (TTP Labtech) to set up 96-well plates at room temperature, using the 
sitting-drop vapour diffusion method in which 150 nl of protein were mixed with 150 nl 
of reservoir solutions. Various commercially available screens were used: Index, 
Hampton I and II, JCSG (Hampton Research, Molecular Dimensions), PACT (Newman 
et al., 2005), CSS I and II (Brzozowski and Walton, 2001). The plates were sealed to 
avoid evaporation and then incubated at 20 ºC and examined regularly for the 
appearance of crystals. Conditions where small crystals grew were further optimized 
either using the same robotic procedure or done manually in 24 well plate using 
hanging-drop vapour diffusion and a 1:1 mixture of protein solution with the reservoir 
solution (1 l each). 
Crystals were harvested by nylon loops of various sizes, transferred to a precipitant 
solution containing glycerol for cryoprotection and flash cooled in liquid nitrogen. The 
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crystals were then checked for diffraction at the YSBL X-ray source and test images 
were collected using a Rigaku RU-H3R X-ray generator with rotating anode equipped 
with Osmic multilayer optics and a MAR Research mar345 imaging plate detector. Test 
data was collected in-house at 0° and 90° in the two crystal dimensions orthogonal to 
the incident X-ray beam to check for anisotropic diffraction and to get an indication of 
crystal quality, exclude salt crystals and determine unit cell dimensions. In case the 
sample changer was used, data was collected on an R-Axis IV++ detector. This 
significantly reduced the time invested on screening of dozens of crystals. The best 
crystal was frozen in liquid nitrogen and was shipped to European Synchrotron 
Radiation Facility (ESRF), Grenoble, or the DIAMOND light source, Didcot, for X-ray 
data collection 
 
. 
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3.1 Cloning of mppA, gsiB and ygiS genes  
A common approach for expression and purification of substrate-binding proteins is to 
clone the protein encoding genes in-frame with short tags like hexahistidine, into a 
plasmid vector suited for over pruction of the proteins. In the present study three genes 
encoding putative peptide-binding proteins were cloned into two different expression 
vectors, an IPTG inducible pET-YSBLIC3C vector and an arabinose inducible pBAD 
vector. 
The pET-YSBLIC3C expression vector is based on pET28a (Figure 2.1 in methods 
section) and has an N-terminal hexahistidine tag which can be cleaved by HRV 3C 
protease (Fogg and Wilkinson, 2008). Regions of the E. coli K-12 genome were 
amplified by PCR using primers mppAF and mppAR for mppA, gsiBF and gsiBR for 
gsiB, and ygiSF and ygiSR for ygiS amplification. These were cloned into pET-
YSBLIC3C using ligation independent cloning (LIC) so that the coding sequence was 
in-frame with a 5  nucleotide sequence encoding a hexahistidine tag (Methods section 
2.2.7). This resulted in three different expression vectors; pAM6091, pAM6092 and 
pAM6093 expressing an N-terminally hexahistidine tagged MppA, GsiB and YgiS, 
respectively.  The vectors were made such that they encode a version of protein lacking 
its native signal peptide and resulting in cytoplasmic accumulation of protein.  
The pBAD system has been used successfully in the Thomas lab to obtain high yield of 
soluble SBPs (Mulligan et al., 2009). It allows addition of the decahistidine tag to either 
the N or C-terminus of the protein. Regions of the E. coli K-12 genome were amplified 
by PCR using primers mppA-NF with mppA-NR  and mppA-CF with mppA-CR for  
mppA and gsiB-NF with gsiB-NR and gsiB-CF with gsiB-CR for gsiB and cloned into 
pBAD using LIC so that the gene sequence was in-frame with a 5 - or 3 - nucleotide 
sequence encoding a decahistidine tag (Methods section 2.2.7). This resulted in four 
different expression vectors; pBAD6094, pBAD6095, pBAD6096 and pBAD6097 
expressing an N- or C- terminally decahistidine tagged MppA and GsiB. pBAD6094 
and pBAD6095 resulted in cytoplasmic accumulation of MppA and GsiB whereas 
pBAD6096 and pBAD6097 encode a version of protein with its native signal peptide 
and resulting in periplasmic accumulation of MppA and GsiB, respectively. 
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Construction of the desired recombinant plasmid was confirmed by restriction analysis 
with the appropriate restriction endonuclease (Figure 3.1). Recombinant plasmids that 
showed the correct insert size, 1.5 Kb for mppA, gsiB and ygiS, were sequenced in the 
Technology Facility (University of York) and the sequence analysis confirmed in frame 
cloning of genes with no mutation.  
3.2 Expression trials of selected binding proteins 
If the putative peptide-binding SBP genes appear to be correctly inserted into the 
expression vectors, a series of small-scale expression trials were performed to determine 
whether the recombinant gene is expressed and is of the correct molecular weight.  
3.2.1 Expression trials of mppA, gsiB and ygiS genes cloned in pET-YSBLIC3C  
The recombinant plasmids (pAM6091, pAM6092 and pAM6093) were transformed into 
the expression strain BL21 of E. coli and used in small scale expression trials. The 
expression trials were performed using 25 ml LB media in 100 ml flask and cultures of 
E. coli BL21 strains were grown at two temperatures, 25°C and 37°C. Cultures were 
induced using 0.5 mM IPTG at an OD650 of 0.4-0.6. Growth was monitored by 
measuring OD650 after each hour starting from the time of induction and was continued 
for four hours post induction with a final reading taken after 24 hours. At each time 
point 1 ml of culture was pelleted for later analysis by SDS-PAGE. The rate of growth 
for each target grown at 25°C and 37°C can be seen in (Figure 3.2). None of the strains 
failed to grow or showed an obvious reduction in growth after induction so this shows 
that the recombinant proteins are not toxic to the cell, assuming they were induced. The 
strains carrying recombinant plasmids grew better than the control strain (BL21 
transformed with empty vector). 
Accumulation of protein was checked by re-suspending the cell pellets in sample buffer 
and separating the proteins using SDS-PAGE as described in methods section 2.8. The 
gel from Figure 3.3A shows the protein accumulation profile of the strain carrying the 
mppA construct, an IPTG inducible band is seen at around 54 kDa (whereas the 
expected size of MppA is 60 kDa) with almost same expression at all stages when 
grown at 25°C and 37°C . However the culture reaches a higher OD650 after 24 hours
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Figure 3.1 Agarose gel to verify recombinant plasmids 
A) Agarose gel (1 %) stained with SYBR safe showing products of a restriction digestion of 
pET vector constructs after gel electrophoresis. Plasmids were doubly digested with NdeI and 
NcoI. M is Hyperladder I.  Lanes 1, 2 and 3 show the products of restriction digestion of the 
vectors; pAM6091, pAM6092 and pAM6093 respectively and arrow represent the excised 
fragment of DNA resulting from double digestion of vectors. B) Agarose gel (1 %) stained with 
SYBR safe showing products of a restriction digestion of pBAD vector constructs after gel 
electrophoresis. Plasmids were doubly digested with BamHI and EcoRI.  M is Hyperladder I. 
Lanes 1, 2, 3 and 4 show the products of a restriction digestion of the vectors; pBAD6094, 
pBAD6095, pBAD6096 and pBAD6097 respectively and arrow represent the excised fragment 
of DNA resulting from double digestion of vectors. 
A) 
B) 
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Figure 3.2 Growth curves of E. coli BL21 (DE3) strains used in expression trials 
BL21 (DE3) containing plasmid was grown in a single growth experiment at 25°C (A) and 37°C 
(B)   pAM6091 (MppA),   pAM6092 (GsiB),    pAM6093 (YgiS) and  
vector only (pET-YSBLIC3C) 
 
A) 
B) 
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Figure 3.3 Expression of MppA, GsiB and YgiS from pET based constructs 
Coomassie stained SDS-PAGE gels from expression trials conducted at 25°C (left) and 37°C 
(right). M is Pre-stained protein ladder, time (t) is equal to number of hours post induction and 
arrow indicates the position of an over produced protein on the gel. 
A) Expression of MppA from BL21 (DE3) pAM6091 B) Expression of GsiB from BL21 (DE3) 
pAM6092 C) Expression of YgiS from BL21 (DE3) pAM6093 
 
A) 
B) 
C) 
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when grown at 37°C (Figure 3.2), so these conditions were chosen for future over 
expression of MppA to maximise yield. The SDS polyacrylamide gel of the strain 
carrying GsiB construct (Figure 3.3B) shows induced synthesis of a 50 kDa protein 
(whereas the expected size of GsiB is 56 kDa) with maximum accumulation of protein 
at 4 hours post-induction when grown at 37°C. The expression of GsiB was lower at 
each stage when grown at 25°C. YgiS shows an intense band around 54 kDa (whereas 
the expected size of YgiS is 60 kDa) in Figure 3.3C, after induction with IPTG. 
Maximum accumulation of YgiS occurs at 25°C with the overnight time point. 
3.2.2 Expression trials of mppA and gsiB genes cloned in pBAD vectors 
The recombinant plasmids (pBAD6094, pBAD6095, pBAD6096 and pBAD6097) were 
transformed into the expression strain MC1061 of E. coli and used in small scale 
expression trials. The expression trials were performed at two growth temperatures, 
25°C and 37°C. Cultures were induced using 0.005% L-arabinose at an OD650 of 0.4-
0.6. Growth was monitored by measuring OD650 after each hour starting from the time 
of induction and was continued for four hours post-induction with a final reading taken 
after 24 hours. At each time point 1 ml of culture was pelleted for later analysis by 
SDS-PAGE. The rate of growth for each target grown at 25°C and 37°C can be seen in 
Figure 3.4. It is evident that cultures of E.coli carrying constructs based on pBAD 
vector grow better and reach a higher OD650 than those carrying pET based constructs. 
Accumulation of protein was checked by re-suspending the cell pellets in sample buffer 
and separating the proteins using SDS-PAGE as described in the methods section 2.8. 
The gel from Figure 3.5A shows the protein accumulation profile of the strain carrying 
the MppA construct (pAM6094) for its cytoplasmic expression, an arabinose inducible 
band is seen at around 54 kDa (where as the expected size of MppA is 60 kDa) with 
almost the same expression at all stages. Periplasmic accumulation of MppA was 
checked from the SDS-PAGE gel of the strain carrying the construct pBAD6096 
(Figure 3.5B). Maximum level of protein accumulation can be seen in the culture grown 
for overnight post-induction. However the level of MppA synthesis resulting from the 
construct pAM6094 was lower than resulting from the construct pAM6096. The gel 
from Figure 3.5C shows cytoplasmic accumulation of GsiB in an E. coli strain carrying 
the 
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Figure 3.4 Growth curves of E. coli MC1061 strains used in expression trials 
MC1061 containing plasmid was grown in a single growth experiment at 25°C (A) and 37°C 
(B)   pAM6094 (Cytoplasmic MppA),   pAM6096 (Periplasmic MppA),    
pAM6095 (Cytoplasmic GsiB), pAM6097 (Periplasmic GsiB) and  vector only 
(pBADnLIC) 
A) 
B) 
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Figure 3.5 Expression of MppA and GsiB from pBAD vectors 
Coomassie stained SDS-PAGE gels from expression trials conducted at 37°C. M is pre-stained 
protein ladder, time (t) is equal to number of hours post induction and arrow indicates the 
position of an over produced protein on the gel. 
A) Cytoplasmic expression of MppA from MC10601 (pAM96094) B) Periplasmic expression 
of MppA from MC10601 (pAM96096) C) Cytoplasmic expression of GsiB from MC10601 
(pAM96095) D) Periplasmic expression of GsiB from MC10601 (pAM96097) 
A) B) 
C) D) 
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construct (pAM6094). The band of over produced protein can be seen at around 50 kDa 
(whereas the expected size of GsiB is 56 kDa) with maximum accumulation from 
overnight grown culture at 37°C. Similar expression was also observed for GsiB 
targeted to the periplasm with a His tag on its C-terminus (Figure 3.5D).  
Analysis of MppA and GsiB accumulation at 25°C demonstrated less accumulation of 
MppA and GsiB than at 37°C (data not shown). 
The small scale expression trials show that strains of E. coli carrying pBAD vectors 
grow better and achieve higher OD650 than those carrying pET vectors. Among pBAD 
vectors, constructs producing cytoplasmic production of protein (pBAD6094 and 
pBAD6095) give higher level of accumulated protein than constructs producing 
periplasmic accumulation of protein (pBAD6096 and pBAD6097). Thus we decided to 
grow strains of E. coli carrying pBAD6094 and pBAD6095 on large scale for 
purification of recombinant protein. 
3.3 Large scale expression and purification of MppA and GsiB using pBAD 
based expression constructs 
Large scale expression was performed in 2 L flasks and cultures of E. coli MC1061 
strains were grown under the optimum conditions determined during the small scale 
expression trials for each target. After induction, cells were grown overnight and 
harvested by centrifugation at 4430 x g for 15 min and resuspended in 50 mM KPi, pH 
7.8. Cells were lysed by sonication and cell debris was removed by centrifugation at 
38000 x g for 30 min at 4°C. The whole cell lysate containing over produced protein 
was collected. Nickel affinity chromatography was used for the purification of 
recombinant protein (MppA and GsiB) using gravity-flow columns (Methods section 
2.6.1). The whole cell lysate containing the recombinant protein was incubated with 
equilibrated Ni
2+
-NTA resin for 1 hour and weakly binding contaminants were eluted by 
washing the resin with a wash buffer containing 50 mM imidazole. Bound His-tagged 
protein was eluted with elution buffer containing 500 mM imidazole. 
Analysis of the fractions taken during purification of protein using Coomassie-stained 
SDS-PAGE revealed an intense band in elution fraction 2 that corresponded to purified 
protein (Figure 3.6). An intense band was present in the whole cell lysate fraction, 
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Figure 3.6 Purification of MppA and GsiB from cultures of E. coli MC1061 
Coomassie stained SDS-PAGE of purification of MppA (A) and GsiB (B) by Ni-affinity 
chromatography showing clarified whole cell lysate (WCL), the flowthrough (UB), the 50 mM 
imidazole washing step (W) and the elution fractions containing purified proteins indicated by 
arrows. M is pre-stained protein ladder. 
A) 
B) 
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which was less intense in the flow through from the column, indicating that this band 
was over produced protein and was abundant enough to be visible in the whole cell 
lysate (Figure 3.6). The entire elution fractions containing purified protein were pooled 
together and the concentration of protein was determined using a NanoDrop ND-1000 
spectrometer as described in methods section 2.9.2. The total yield obtained after Ni
2+
-
affinity chromatography was 35 mg/l and 20 mg/l for MppA and GsiB, respectively.  
The ultimate objective of the project was to solve the crystal structure of the selected 
binding proteins using X-ray crystallography which requires production of protein 
crystals. It was advised by Prof. Tony Wilkinson (YSBL) that the His tag should be 
removed from purified protein. The recombinant proteins produced in pBAD vectors 
have a cleavage site of TEV protease to remove decahistidine tag. Purified proteins 
were incubated with increasing concentration of TEV protease for different time 
intervals and at different temperatures. His tag cleaved protein being smaller in size 
migrate faster than uncleaved protein on SDS-PAGE gels and can be distinguished from 
protein with decahistidine tag. Thus cleavage of decahistidine tag was checked by 
running SDS-PAGE gels (data not shown). The gels showed no cleavage of His tag. A 
possible reason could be that the proteins expressed in pBAD vectors are not good 
substrates for TEV protease. 
Therefore, it was decided to purify proteins from strains of E. coli carrying pET based 
expression vectors. Recombinant proteins expressed in pET-YSBLIC3C vector have a 
cleavage site of HRV 3C protease to remove His tag. HRV 3C was routinely used in 
YSBL to cleave His tag from protein.  
3.4 Large scale expression and purification of MppA, GsiB and YgiS using pET 
based expression constructs 
Large scale expression was performed by growing E. coli cultures in 625 ml LB using 
two litre flasks under the optimum conditions determined during the small scale 
expression trials. N-terminal hexahistidine tagged proteins (MppA, GsiB and YgiS) 
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were purified using nickel affinity chromatography (Figure 3.7) as described previously 
in the section 3.3. 
Analysis of the fractions taken during protein purification using Coomassie-stained 
SDS-PAGE revealed an intense band in elution fraction 2 that corresponded to purified 
protein (Figure 3.7A, B and C). An intense band was present in the whole cell lysate 
fraction, which was absent in the flow-through from the column, indicating that this 
band was recombinant protein and was abundant enough to be visible in the whole cell 
lysate (Figure 3.7).  
The entire elution fractions containing purified protein were pooled together and the 
concentration of protein was determined using a NanoDrop ND-1000 spectrometer or 
by performing Bradford assay as described in methods section 2.9. The total yield 
obtained after Ni
2+
-affinity chromatography was 26 mg/l, 15 mg/l and 23 mg/l for 
MppA, GsiB and YgiS, respectively. 
3.5 Cleavage of hexahistidine tag by HRV 3C protease and purification of 
cleaved protein 
Fractions containing purified protein were mixed with HRV 3C protease in a ratio of 1 
to 100 while dialysing into 50 mM KPi overnight. Cleavage of the His tag was checked 
by running SDS-PAGE of cleaved and uncleaved protein. Cleaved protein being smaller 
migrated faster than un-cleaved protein on SDS-PAGE. An example of this 
phenomenon is shown for MppA in Figure 3.8 where cleaved protein can be 
distinguished from uncleaved sample. HRV 3C protease has His-tag on N-terminal and 
it binds with Ni
2+
-NTA resin. This property of protease was exploited to separate it 
from cleaved protein using 5 ml His Trap column (GE Healthcare). At this stage 
proteins were approximately 99 % pure as judged by SDS-PAGE (Figure 3.9A, inset for 
MppA). Four residues from the affinity tag (GPAM) remain attached to the protein 
following HRV 3C cleavage. Fractions containing purified protein were pooled together 
and dialysed in an appropriate buffer for mass spectrometry.  
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Figure 3.7 Purification of MppA, GsiB and YgiS from cultures of E. coli BL21 (DE3) 
Coomassie stained SDS-PAGE of purification of MppA (A), GsiB (B) and YgiS (C) by Ni-
affinity chromatography showing clarified whole cell lysate (WCL), the flowthrough (UB), the 
50 mM imidazole washing step (W) and the elution fractions containing purified proteins 
indicated by arrows. M is pre-stained protein ladder. 
A) 
B) 
C) 
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Figure 3.8 Cleavage of His tag from MppA 
Coomassie-stained SDS-PAGE showing migration of cleaved and uncleaved MppA. M is pre-
stained protein ladder. Lanes 1 and 3 represent MppA after cleavage of the His tag and lane 2 
represent MppA with hexahistidine tag. Arrows on right show the position of cleaved and 
uncleaved MppA on gel. 
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3.6  Mass spectrometry of purified SBPs 
Mass spectrometry is used to ensure that the recombinant protein produced and purified 
is the one expected and that it is not modified in any way during synthesis. As purified 
MppA, GsiB and YgiS migrated faster on SDS-PAGE gels than their expected sizes 
(Figure 3.3) suggesting they had been modified, electrospray mass spectrometry (ES-
MS) was therefore used to ensure that these proteins expressed and purified are of the 
correct size and there is no proteolysis occuring. A Micromass LCT Premier XE mass 
spectrometer using a nanospray source was used for ES-MS of the proteins as described 
in the methods. Apart from determining the molecular weight of proteins, mass 
spectrometry was also used to check the presence of any co-purified ligand. These 
experiments used native electrospray mass spectrometry analysis, that is under 
conditions in which SBPs often retain endogenously bound ligands (Severi et al., 2005, 
Thomas et al., 2006).  
3.6.1 Analysis of MppA by mass spectrometry 
The spectrum recorded under denaturing conditions show a peak at 57979 ± 6 Da 
(Figure 3.9A). This is very close to the predicted molecular weight of MppA after 
removal of hexahistidine tag (57972 Da). The result shows that the recombinant protein 
was MppA and is of correct molecular weight. Previous genetic studies had suggested 
indirectly that MppA binds the murein tripeptide (Mtp, L-Ala-γ-D-Glu-meso-Dap). A 
mutant strain of E. coli was isolated which failed to grow in minimal media when Dap 
was replaced by Mtp, and this phenotype could be rescued by complementation with a 
plasmid carrying the mppA gene (Park et al., 1998). We used ES-MS under native 
conditions to identify if MppA purifies with an endogenous prebound ligand from E. 
coli. A native spectrum for MppA shows a clear peak in the mass spectrum that was not 
present in the denaturing spectrum (Figure 3.9B). This additional peak accounts for 
nearly half of the total protein signal. This species has a mass of 58361 Da, being 389 
mass units larger than that of the ligand-free protein (57972 mass units in this sample). 
Given that the mass of Mtp is 389.38 Da, this is strong biophysical evidence that the 
protein binds a single molecule of Mtp selectively over other peptides present in the 
cytoplasm. 
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Figure 3.9 ES-MS spectrum of MppA 
A) ES-MS spectrum of 5 μM MppA under denaturing conditions. The molecular mass of the 
unbound protein (U) is indicated at 57978.9 atomic mass units (amu). Inset: Coomassie stained 
SDS-PAGE gel containing 3 µg of purified MppA (lane 1) and molecular weight markers (M). 
B) ES-MS spectrum of MppA under native conditions in water. Peak (U) gives the molecular 
weight of ligand free MppA and peak (L) gives the molecular weight of MppA bound to a 
ligand (Mtp) of 390 Da. Other peaks are adducts of phosphates. 
 
A) 
B) 
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3.6.2 Analysis of GsiB by mass spectrometry 
Using denaturing electrospray mass spectrometry the molecular weight of GsiB was 
determined to be 54261 ± 6 Da (Figure 3.10A) which is consistent with the predicted 
mass of the protein after removal of the hexahistidine tag (54255 Da). This clearly 
shows that purified protein is full length GsiB.  
Genetic studies suggest that GsiB facilitates transport of glutathione, a tripeptide (γ-
glutamylcysteinylglycine; GSH) (Suzuki et al., 2005). We again used mass 
spectrometry under native conditions to check the presence of any endogenously bound 
ligand to GsiB. A native spectrum of purified GsiB shows an additional peak that was 
not present in the denaturing spectrum (Figure 3.10B). The peak has a mass of 54564 
Da, being 309 Da larger than that of ligand free protein. This result shows that GsiB has 
co purified with ligand of 309 Da. Given that the mass of GSH is 307.3 Da, this is 
biophysical evidence that supports the hypothesis that GsiB binds GSH selectively in a 
myriad of peptides in the cytoplasm.  
3.6.3 Analysis of YgiS by mass spectrometry 
The molecular weight of YgiS was determined to be 58782  6 Da using denaturing ES-
MS (Figure 3.11A) which is in agreement with the theoretical mass of YgiS after 
removal of the hexa histidine tag (58784 Da). Unlike MppA and GsiB, YgiS did not 
show any additional peak in the spectrum recorded under native conditions (Figure 
3.11B). This means that either YgiS does not bind a peptide or it binds to a specific non-
endogenous peptide not seen in the growth medium.  
3.7 Detection of protein ligand complexes using FT-ICR-MS 
Although results from ES-MS gave an indication of the ligands bound to SBPs, these 
were further confirmed using the high mass accuracy of FT-ICR-MS. The accuracy of 
this technique results from the extremely high resolution achievable (> 100,000 at full 
width half maximum). At these resolutions it is possible to measure the monoisotopic 
masses of proteins to well within half a Dalton, whereas conventional ES-MS will 
typically give the average mass of proteins, also called apex mass, with precisions of 
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Figure 3.10 ES-MS spectrum of GsiB 
A) ES-MS spectrum of 5 μM GsiB under denaturing conditions. The molecular mass of the 
unbound protein (U) is indicated at 54261 atomic mass units (amu). Inset: Coomassie stained 
SDS-PAGE gel containing 3 µg of purified GsiB (lane 1) and molecular weight markers (M). B) 
ES-MS spectrum of GsiB under native conditions in water. Peak (U) gives the molecular weight 
of ligand free GsiB and peak (L) gives the molecular weight of GsiB bound to a ligand (GSH) 
of 307 Da. Other peaks are adducts of phosphates. 
 
B) 
A) 
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Figure 3.11 ES-MS spectrum of YgiS 
A) ES-MS spectrum of 5 μM YgiS under denaturing conditions. The molecular mass of the 
unbound protein (U) is indicated at 58782 atomic mass units (amu). Inset: Coomassie stained 
SDS-PAGE gel containing 3 µg of purified YgiS (lane 1) and molecular weight markers (M). B) 
ES-MS spectrum of YgiS under native conditions in water. Peak (U) gives the molecular weight 
of ligand free YgiS.  
 
A) 
B) 
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less than one Dalton being difficult to achieve. FT-ICR-MS affords even greater 
precision with lower mass analytes such as peptides, where a mass accuracy of sub milli 
Dalton is routinely achievable.  
We first used FT-ICR-MS to study MppA and obtained an accurate mass for the protein 
([M+H]
+
 = 57940.10 m/z, mass error = 0.2 Da). A clear signal for the released ligand 
was also observed (Figure 3.12A). The accurately measured mass of the ligand ([M+H]
+
 
= 391.1827 m/z) is consistent with only one possible empirical formula (considering: 
carbon, hydrogen, nitrogen and oxygen atoms) within a mass tolerance of 3 ppm, that of 
Mtp (Figure 3.12B) (mass error = 0.4 mDa). Fragmentation of this peptide using 
sustained off-resonance irradiation (SORI) enabled detection of the C-terminal 
diaminopimelate (Dap) residue (observed at 191.1027 m/z, mass error = 0.1 mDa), 
further confirming the identification of Mtp (Figure 3.12B).  
We also demonstrated that GsiB is able to bind to GSH using the same method. In a 
typical FT-ICR-MS experiment the molecular weight of GsiB was accurately measured 
at [M+H]
+
 = 54222.532 m/z, mass error = 0.03 Da. We saw two clear peaks for the 
released ligands; (Figure 3.13B) a peak at 308.09129 m/z is in agreement with the 
predicted monoisotopic mass of GSH ([M+H]
+
 = 308.09108 m/z, mass error = 0.21 
mDa). This is consistent with ES-MS, which shows a ligand of mass 309 Da bound to 
GsiB. A second peak represents another species at 613.15918 m/z, which was not seen 
by conventional ES-MS. This species was identified as glutathione sulphide (GSSG) on 
the basis of its accurately measured mass (mass error = 0.14 mDa). GSSG is an oxidized 
form of glutathione derived from two glutathione molecules. GSSG may either result 
from oxidation of two glutathione molecules during the FT-ICR-MS experiment, or 
alternatively be prebound with GsiB. The later possibility suggests that GsiB may also 
bind to GSSG. 
For these peptide-binding SBPs the use of FT-ICR-MS has been shown to be a much 
more powerful technique than conventional ES-MS.  This is primarily because we were 
able to measure the masses of ligands with a sub milli Dalton level of accuracy.  
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Figure 3.12 FT-ICR-MS of MppA-Mtp complex 
A) FT-MS spectrum of 10 μM MppA. The peaks on right side represent multiple charge species 
of MppA. A small peak on left side represents the released peptide ligand (Mtp). B) Quad 
isolation and sustained off-resonance irradiation of Mtp to establish the presence of Dap upon 
fragmentation. 
B) 
A) 
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Figure 3.13 FT-ICR-MS of GsiB 
A) FT-MS spectrum of 10 μM GsiB. The peaks represent multiple charge species of GsiB. B) 
FT-MS spectrum of GsiB optimized for low mass showing the released peptide ligands (GSG 
and GSSG). 
 
A) 
B) 
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3.8 Conclusion 
The genes encoding SBPs MppA, GsiB and YgiS were successfully cloned into 
expression vectors. Growth conditions were optimized for achieving stable and higher 
production of proteins and all the targets were successfully purified using Ni-affinity 
chromatography. Histidine tags were cleaved off from purified proteins and tag free 
proteins were purified to almost 99% purity. Mass spectrometric analysis showed that 
MppA and GsiB were purified with their cognate ligands and thus selected for 
crystallization experiments. However we could not identify the ligand for YgiS and the 
protein was not taken forward for crystallization studies. 
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Chapter 4 
 
 
4 Crystallization of SBPs and solving the 
X-ray structure of MppA 
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4.1 Protein crystallography 
As the ultimate aim of my project was to understand the structural basis of ligand 
binding in peptide-binding proteins, I used protein crystallography to solve the 
structures of peptide-binding proteins in the presence of their cognate ligands. Mass 
spectrometric analysis of purified protein from chapter 3 suggested that MppA and 
GsiB were co-purified with their cognate peptide ligands. These proteins were dialysed 
into appropriate buffers and concentrated to between 10-60 mg/ml for crystallization.  
4.1.1 Growing MppA crystals 
For crystallization, MppA was concentrated to 16 mg/ml in 20 mM MES, pH 6.5. 
Preliminary crystallization trials were performed using a range of commercially 
available screens; PACT, Hampton I, II, Index and Clear Strategy Screens CSSI and 
CSSII, by hanging-drop vapour diffusion procedures in 96-well plates setup with a 
Mosquito nanolitre pipetting robot as described in methods. The plates were sealed to 
avoid evaporation and then incubated at 20 ºC and examined regularly for the 
appearance of crystals. Initial crystallization trials resulted in crystals obtained under 
three different conditions. Two of these conditions where the crystals were very small in 
size (Figure 4.1A) were further optimized. Crystals grown with 0.1 M Tris pH 8, 10 
mM zinc chloride (PACT condition 48) did not reproduce while optimization of crystals 
grown with 0.1 M bis-Tris pH 6.5, 2M ammonium sulphate (Index Condition 4) led to 
crystals with poor diffraction quality of 4.5 Å resolution. Optimisation experiments 
involved varying the pH, precipitant concentrations, volume ratio of protein and 
crystallization conditions, as well as the MppA concentration which was increased from 
16 mg/ml to 27 mg/ml. One condition produced single crystals that were big enough for 
X-ray data collection. These crystals grew with 50 mM zinc acetate and 20% w/v 
PEG3350 (Index condition 93) and had dimensions of 0.1 x 0.1 x 0.1 mm
3
 (Figure 
4.2A). One of the crystals was transferred to a precipitant solution containing 25% 
glycerol for cryoprotection, flash cooled in liquid nitrogen and checked for diffraction 
(Figure 4.2). The crystal diffracted to 2.6 Å when tested for X-ray diffraction at the 
YSBL home source (Rigaku MicroMax 007HF generator) and was stored in liquid 
nitrogen in order to collect X-ray data on a beamline at a synchrotron facility.  
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Figure 4.1 Crystallization trials of MppA and GsiB 
Images of crystals for target proteins MppA (A) and GsiB (B) taken while crystals growing in 
96 well plates 
A1 = Crystals of MppA in PACT condition 48 
A2 = Crystals of MppA in Index condition 93 
B1 = Crystals of GsiB in PACT condition 7 
B2 = Crystals of GsiB in HCS II condition 25 
2 
2 1 
1 A) 
B) 
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4.1.2 Growing GsiB crystals 
GsiB was concentrated to 60 mg/ml in 20 mM MES, pH 6.5 and subjected to 
crystallization trials using Mosquito nanolitre pipetting robort. Commercial screens 
(PACT, Hampton, CSS, and Index) were employed initially and crystallization trials 
were conducted using two concentrations of protein, i.e. 30 mg/ml and 60 mg/ml. This 
resulted in needle like crystals of GsiB under two different conditions; 0.1 M sodium 
acetate, pH 5 and  20% w/v PEG6000 (PACT condition 7) and 1.8 M ammonium 
sulphate, 0.1 M MES, pH 6.5 and 0.01 M cobaltous chloride hexahydrate (Hampton 
Crystal Screen II condition 25). These crystals were too small to be used for diffraction 
experiment (Figure 4.1B). Much subsequent effort was made to improve the crystals by 
trying various modifications like seeding, varying the concentration of the protein, 
varying buffer composition and buffer pH, etc. None of these strategies produced good 
enough crystals to be used for diffraction.  Some crystallization experiments were also 
conducted at 4 °C but with no success.  
4.2 Solving the X-ray structure of MppA 
The crystal of MppA that diffracted to 2.6 Å at YSBL home source was sent to 
European Synchrotron Radiation Facility (ESRF), Grenoble for data collection. For 
MppA X-ray data were collected at ESRF station on beam line ID14-4 from a single 
crystal. Data collection was performed at 100 K using an oscillation range of 0.5° per 
image with a total crystal rotation of 180°. The diffraction images were indexed and 
integrated with DENZO and scaled with SCALEPACK (Otwinowski and Minor, 1997). 
Indexing permitted the determination of the crystal system, the unit cell dimensions and 
assignment to each spot on the image an index, quoted as three integers: h, k, and l. Data 
collection and processing statistics are summarised in Table 4.1.  
A homology model was available for MppA in the form of oligopeptide binding protein 
(OppA) from Yersinia pestis, thus the structure of MppA was determined by the 
molecular replacement method using these coordinates (PDB code 2Z23) as a search 
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Table 4.1 X-ray data statistics for the crystal of MppA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
The outer shell corresponds to 2.10 – 2.06 Å. 
b
Rmerge = ∑hkl∑i|Ii - <I> | / ∑hkl∑i <I> where Ii is the intensity of the ith measurement of a 
reflection with indexes hkl and <I> is the statistically weighted average reflection intensity. 
 
Data collection and processing statistics 
X-ray source ID14-4, ESRF 
Wavelength (Å) 0.9335 
Temperature (K) 100 
Space group P6 
Unit cell parameters (Å) 
a=b=165.1 Å, c=38.2 Å         
α=β=90, γ=120 
Resolution range (Å) 47.65-2.07 
Number of unique reflections, 
overall/outer shell
a
 
34597 (633) 
Rmerge
b
 (%), overall/outer shell
a
 10.7 (55.3) 
Completeness (%),  overall/outer shell
a
 92 (53.5) 
Redundancy , overall/outer shell
a
 9.7 (4.3) 
I/ (I), overall/outer shell
a
 20.6 (1.6) 
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model. Molecular replacement was carried out using the MOLREP program (Vagin and 
Teplyakov, 2000). The first peak of rotation function (RF) had a sigma value of 6.67 
which was distinctive from other RF peaks (for example second peak was at 4.3 and all 
others were below 4). Similarly, the first peak of the translation function had a sigma 
value of 38.52 with all other sigma values less than 5. The correctness of the solution 
was also reflected in the high contrast factor of 12.77. Manual model building was 
carried out in the program COOT (Emsley and Cowtan, 2004) and the structure was 
refined using REFMAC5 (Murshudov et al., 1997) to give final Rfactor and Rfree values of 
16.7% and 21.9% respectively. The prefinement statistics are given in the Table 4.2. 
The quality of our model was checked by PROCHECK analysis from PDBSum page. 
The Ramachandran plot thus generated put more than 90% of amino acid residues of 
protein in the most favoured regions. The statistics of Ramachandran plot are given in 
Table 4.2. The final set of coordinates and structure factors were deposited in the RCSB 
Protein Data Bank under the accession code 309P.  
4.3 Overall structure of MppA 
The open reading frame coding for E. coli MppA encodes a 537 residue protein that 
contains a 22 residue N-terminal signal peptide that is cleaved off after export through 
the cytoplasmic membrane. Thus mature protein contains 515 amino acids starting from 
Ala 1 to the C-terminal residue His 515. As we crystallized the mature form of MppA, 
the model of MppA structure was built from Ala 1 to His 515. The structure of MppA 
shows a continuous polypeptide chain from Thr-7 to His-515 (Figure 4.3). The first 6 
residues (AEVPSG) are not represented in the electron density maps and are assumed to 
be disordered. The protein is organized into three structural domains, with domain 1 
encompassing residues 7-46, 165-263 and 487-515, domain 2  encompassing residues 
264-486 and domain 3 encompassing residues from 47-164 (Figure 4.3). The overall 
fold of MppA is similar to that of the oligopeptide binding protein as discussed below. 
A DALI search (Holm et al., 2008) of the protein data bank (PDB) revealed that MppA 
has highest structural similarity to the oligopeptide binding proteins (OppAs) of 
Yersinia pestis (PDB code 2Z23; Z-score = 55.3, with 508 equivalent Cα atoms 
superimposing with an rms  of 1.1 Å) and Salmonella Typhimurium (PDB code 2OLB; 
Z-score = 55.2, with 509 equivalent Cα atoms superimposing with an rms  of 1.0 Å). 
This structural similarity spans the full length of the protein (Figure 4.4). 
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Table 4.2 MppA structure refinement statistics  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
Rfactor = Σ‖Fo|−|Fc‖ / Σ|Fo|, where Fo and Fc are the observed and calculated structure factor 
amplitudes, respectively. 
b
Rfree is the Rfactor calculated with 5% of the reflections chosen at random and omitted from 
refinement. 
c
Outer shell for refinement corresponds to 2.073–2.126 Å. 
d
Root mean square deviation of bond lenths and bond angles from ideal geometry 
e
Percentage of residues in most favored/additionally allowed/generously allowed/disallowed 
regions of the Ramachandran plot, according to PROCHECK. 
Refinement statistics 
Rfactor
a
 (Rfree
b
) 16.7 (21.9) 
Reflections (working / free) 32581 / 1743 
Outer shell
c
 Rfactor
a
 (Rfree
b
) 24.2 / (30.4) 
Outer shell
c
 reflections (working / free) 1697 / 74 
Molecules / asymmetric unit 1 
Number of protein nonhydrogen atoms 4046 
Number of ligand atoms 50 
Number of water molecules 366 
rmsd bond lengths(Å)
d
 0.02 
rmsd bond angles(Å)
d
 1.84 
Average B-factor (Å
2
) 25 
Ramachandran plot
e
 91.3/8.5/0.2/0.0 
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Figure 4.3 Structure of MppA in the closed ligand bound state 
Ribbon representation of the MppA structure. The three-domain organisation; domains I, II and 
III are coloured in cyan, magenta and gold, respectively. The amino [N] and carboxyl [C] 
termini are indicated. The Mtp ligand is displayed in space-filling format. 
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Figure 4.4 Structural superposition of MppA with OppAs 
The proteins were superposed in PyMol and are shown in cartoon representation with MppA in 
green, OppA Salmonella Typhimurium (OppA_St) in cyan and OppA Yersinia pestis 
(OppA_Yp) in magenta. The ligands, KEK for OppA_St, KKK for OppA_Yp or Mtp for MppA 
are shown in stick representation. 
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Four other high scoring matches are DppA from E. coli (PDB code 1DPP, Z-score = 
41.2, with 471 equivalent Cα atoms superimposing with an rms  2.1 Å), AppA from B. 
subtilis (PDB code 1XOC, Z-score = 39.4, with 471 equivalent Cα atoms 
superimposing with an rms  2.3 Å), GsiB from E. coli (PDB code 1UQW, Z-score = 
35.2, with 472 equivalent Cα atoms superimposing with an rms  4.8 Å) and NikA from 
E. coli (PDB code 3DP8, Z-score = 34.6, with 469 equivalent Cα atoms superimposing 
with an rms  2.8 Å). A sequence alignment of MppA with OppA, DppA, AppA, GsiB 
and NikA is shown in Figure 4.5. The peptide and nickel-binding proteins are larger 
than other ABC transporter receptors because the latter lack domain II (Figure 4.3). 
4.4 The structure of MppA contains bound Mtp 
Examination of the interdomain region in MppA revealed electron density that could 
not be accounted for by protein atoms. Usually the electron density for bound peptides 
in peptide-binding proteins is ambiguous because a heterogeneous mixture of the 
peptides is present (Tame et al., 1994, Berntsson et al., 2009, Levdikov et al., 2005), 
but here we were able to unambiguously model and refine Mtp into the electron density 
(Figure 4.6), This showed that MppA co-crystallized with its cognate ligand (Mtp) 
consistent with the idea that MppA binds Mtp selectively.  
4.5 The Mtp binding site in MppA 
The crystal structure reveals MppA in a „closed‟ conformation with a single molecule of 
Mtp completely buried within the protein, as seen with other peptides in oligopeptide 
binding protein structures (Levdikov et al., 2005, Berntsson et al., 2009, Tame et al., 
1994, Dunten and Mowbray, 1995). The Mtp sits in a clear binding pocket, forming 
multiple interactions with the protein (Figure 4.7). The N-terminal amino group of the 
peptide forms a salt bridge with the side chain carboxylate of Asp-417 and a hydrogen 
bond to the main chain carbonyl of Val-415 in MppA. A prominent interaction is a 
bivalent salt bridge that is formed between the free α-carboxylate from the γ-linked D-
Glu component of Mtp and Arg-402 in MppA. Additional charge-charge and charge-
dipole interactions are made to the first carboxylate group in the meso-Dap component 
via Lys-20, Arg-411 and Ser-413 in the protein. At the C-terminus of the tripeptide, the 
second carboxylate of the Dap is coordinated by two water molecules. Meanwhile the  
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Figure 4.5 Multiple sequence alignment of selected binding proteins 
Sequence alignment of MppA of E. coli (MppA_Ec), OppA of Y. pestis (OppA_Yp), OppA of 
S. Typhimurium (OppA_St), DppA of E. coli (DppA_Ec), GsiB of E.coli (GsiB_Ec), DdpA of 
E. coli (DdpA_Ec), AppA of B. subtilis (AppA-Bs) and NikA of E.coli (NikA_Ec) based on an 
alignment of the 3D structures of the proteins generated using ESPript. 
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Figure 4.6 The structure of Mtp modelled into its associated electron density  
Stereo image of OMIT maps calculated with coefficients Fobs – Fcalc (green) contoured at 
the 3  level and with coefficients  2Fobs – Fcalc (light blue) contoured at 1  
displayed in the vicinity of the Mtp ligand. The Mtp peptide was left out from the refined 
coordinate set and several cycles of refinement in REFMAC were performed prior to the 
calculation of an OMIT map. The component amino acids of Mtp are labeled. 
Temperature factors for Mtp atoms in the final model were refined with full occupancies 
and are in the range of 19 - 33 Å
2
, similar to that of surrounding protein atoms. 
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Figure 4.7 Binding pocket of MppA with the ligand Mtp 
The amino acids involved in coordinating the ligand Mtp are represented in ball and stick 
format and are labeled, and the Mtp is represented in cylinder format. Hydrogen bonding 
interactions are indicated with dashed lines. Water molecules interacting with ligand are 
represented as black spheres. 
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C-terminal amino group interacts with two water molecules and the side chain carbonyl 
of Gln-267 (Figure 4.7). 
4.6 Comparison of the binding sites in MppA to OppA 
To compare the binding site of a general oligopeptide binding protein with that of 
MppA, we superposed the backbones of OppA and MppA and analysed the binding of 
the two ligands, KEK for OppA and Mtp for MppA (Figure 4.8 and Figure 4.5 for a 
structure based sequence alignment). The proteins are 85% similar overall at the 
sequence level and hence certain parts of the binding site are very well conserved 
between these proteins, the first being the Asp-417 residue in OppA (Asp-419) which 
forms a salt bridge to the α-ammonium group of the peptide. This „anchors‟ the N-
terminus of the peptide and in OppA it is known that a protonated N-terminal amino 
group on the ligand is essential for transport, suggesting that this is also likely to be a 
key interaction in MppA (Payne, 1971). It is apparent that the overall shape of Mtp in 
the binding pocket of MppA is surprisingly similar to that of KEK in OppA, such that 
the γ-linked D-Glu adopts a similar conformation to the more typical peptide linkage 
seen in the KEK tripeptide (Figure 4.8B).  
The Arg-402 residue that binds to the carboxylate group of the γ-linked D-Glu is also 
conserved in OppA (Arg-404). However in OppA, it is positioned differently as a result 
of its interaction with Glu-276 (Figure 4.8) so that it does not form a direct contact to 
the peptide. In OppA, Arg-404 coordinates H2O molecules that in turn form polar 
contacts to the ligand (Tame et al., 1994). Water molecules, that are abundant in the 
OppA binding pocket, allow the protein to accommodate variability in its ligand side 
chains. This is because the water network can be adapted/altered according to the 
particular ligand present. However, in MppA, where Glu-276 is replaced by alanine 
(Ala-274), the Arg-402 side chain is more prominent in the binding pocket so that its 
guanidine group forms what are expected to be strong ion-pairing interactions with the 
-carboxylate group of the D-Glu in Mtp (Figure 4.8). The substitution of Ala for Glu at 
this position is a clear distinguishing feature of the MppA and OppA proteins (Figure 
5.7).  
A second conserved residue Arg-411 (Arg-413 in OppA) also interacts strongly with the 
ligand. In OppA, Arg-413 either forms a salt bridge to the C-terminal carboxylate of the  
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Figure 4.8 Ligand binding in MppA and OppA 
A) Structural superposition of the ligand binding sites of MppA and OppA. The amino 
acid residues in the region of substrate binding sites of MppA (green) and OppA (cyan) 
are compared and labelled by their positions in the PDB files 3O9P and 1JEU 
respectively. Mtp and KEK are represented in cylinder format, and amino acid residues of 
MppA and OppA are represented in ball and stick format. B) Chemical structures of Mtp 
and the KEK tripeptide. The structures were provided by Dr. Christoph Baumann  
A) 
B) 
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tripeptide KEK or a hydrogen bond to the main chain carbonyl of residue 3 in the 
tetrapeptide KKKA (Tame et al., 1995). In MppA where there is not a typical amino 
acid at the third position in the peptide, it is the first carboxylate of the meso-Dap that 
now forms a salt bridge to the corresponding Arg residue. The side chain -NH3
+
 group 
of Lys-20 also forms electrostatic interactions with this carboxylate in MppA. The 
corresponding residue is a glycine in OppA so this particular contact to the ligand is 
unique to MppA (Figure 4.8).  
4.7 Size Exclusion Chromatography Multi-Angle Laser Light Scattering (SEC-
MALLS 
The MppA crystal had an unusual P6 space group, often seen in proteins that are 
hexamers (Tsai et al., 2007, Satyshur et al., 2007, Yu et al., 1998), which prompted us 
to determine the native molecular weight of MppA using SEC-MALLS (Figure 4.9). 
The molecular weight measured by light scattering was 60.6 ± 1.5 kDa which is close to 
the calculated molecular weight for the monomer of 58 kDa, based on the amino acid 
sequence and suggests that MppA, like other peptide-binding SBPs, is a monomer in 
solution.  
4.8 Conclusion 
The structure of MppA was solved in the presence of its cognate ligand. Analysis of the 
binding cavity of MppA has revealed that Mtp is bound in a relatively extended 
conformation with its three carboxylates projecting from one side of the molecule and 
its two amino groups projecting from the opposite face. Comparison of the structure of 
MppA-Mtp with structures of conventional tripeptides bound to OppA, reveals that the 
peptide ligands superimpose remarkably closely given the profound differences in their 
structures. Strikingly, the effect of the D-stereochemistry, which projects the side chain 
of the D-Glu residue at position 2 in the direction of the main chain in a conventional 
tripeptide, is compensated by the formation of a γ-linkage to the amino group of 
diaminopimelic acid, mimicking the peptide bond between residues 2 and 3 of a 
conventional tripeptide. 
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Figure 4.9 Molecular mass of MppA determined by SEC-MALLS  
A SEC-MALLS trace of MppA showing the relative absorbance at A280 trace normalized to 1 
(thin line) and the molar mass of the species present in the sample (thick line). 
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5 Investigation of the ligand binding 
properties of MppA 
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So far we have provided a biophysical evidence to show that MppA binds a unique 
peptide, Mtp and presented a crystal structure of MppA in complex with Mtp. As a next 
step we decided to determine the binding properties of MppA with related ligands. This 
necessitates the purification of ligand free protein. Co-purified ligand (Mtp) was 
removed from MppA using guanidinium HCl (GdmHCl) as described previously 
(Lanfermeijer et al., 1999) to enable the ligand-free protein (denoted MppA*) to be 
used for binding studies with peptide ligands. The protein was partially unfolded while 
bound to the nickel-nitrilotriacetic acid resin, by including additional wash steps with 
buffer containing GdmHCl as described in methods section 2.7.1. The protein (MppA*) 
was eluted with elution buffer as described previously in section 3.3 and the absence of 
ligand being confirmed using native electrospray mass spectrometry (data not shown). 
All the binding experiments used ligand free MppA. The ligand, Mtp was kindly 
prepared and supplied by Dr. Mireille Herve (University of Paris-Sud, France). 
5.1 MppA binds Mtp with high affinity 
We investigated Mtp binding to the protein using tryptophan fluorescence spectroscopy, 
a method that exploits the significant conformational change that accompanies ligand 
binding. Binding of Mtp to MppA causes ~ 7% enhancement in fluorescence upon 
binding. A signal increase can be seen on addition of Mtp to MppA in Figure 5.1A. The 
affinity of MppA was determined by florescence titration where MppA was titrated with 
increasing concentrations of Mtp and the corresponding fluorescence change was 
monitored in time-acquisition mode. The cumulative fluorescence change was plotted in 
SigmaPlot and the KD was calculated from the hyperbolic fit of the binding curve 
(Figure 5.1B) using equation 2.1. Titration experiments yielded a KD of 0.24 ± 0.02 μM. 
We also assessed the binding of Mtp to MppA using isothermal titration calorimetry 
(ITC). 50 μM MppA was titrated with 10 μl additions of 500 μM Mtp in 50 mM KPi pH 
7.8 at 37 °C (Figure 5.2 ). This gave a KD of 0.30 ± 0.06 µM, consistent with the value 
obtained from tryptophan fluorescence spectroscopy (Figure 5.1A). The ITC data also 
confirm the 1 : 1 Mtp : MppA binding stoichiometry (0.99 ± 0.01) and demonstrate a 
positive enthalpy change upon Mtp binding (ΔH° of 2092 ± 27 kJ mol-1 and ΔS° of 36.9 
J.K
-1
mol
-1
) (Figure 5.2), suggesting that binding is entropy driven as observed 
previously for OppA (Sleigh et al., 1999).  
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Figure 5.1 Mtp binding to MppA 
A) Fluorescence change upon addition of Mtp to MppA, cumulative concentration of Mtp 
shown. B) Cumulative changes in tryptophan fluorescence of MppA upon titration with Mtp. 
A) 
B) 
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Figure 5.2 Binding isotherms for the interaction of MppA with Mtp 
The top panels show heat differences upon injection of ligands and lower panels show 
integrated heats of injection (■) and the best fit (solid line) to a single site binding model using 
Microcal Origin software. 
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5.2 Specific recognition of Mtp by MppA 
To determine the specificity of the interaction between Mtp and MppA we assessed 
whether MppA was able to bind a number of closely related ligands (Table 5.1). We 
first examined the binding of the synthetic peptide, L-Ala-γ-D-Glu-L-Lys (AEK), in 
which the Dap in Mtp is replaced by the closely related amino acid lysine. As measured 
by tryptophan fluorescence spectroscopy (Figure 5.3),AEK binds to MppA with a KD of 
130 ± 10 μM, which is ~500-fold lower affinity than for Mtp. The binding affinity was 
also confirmed by ITC (Table 5.1). This points to an important role for the side chain 
carboxylate of Dap in high affinity binding to MppA. We also investigated a peptide L-
Ala-D-Glu-meso-Dap where the D-stereochemistry of residue 2 is not accompanied by a 
 peptide linkage. We were unable to detect binding of this ligand to MppA by 
tryptophan fluorescence spectroscopy (Table 5.1). 
It has been demonstrated previously, using genetic methods, that a peptide transporter 
using MppA as the SBP is able to support growth of an E. coli proline auxotroph on the 
tripeptide L-Pro-L-Phe-L-Lys (PFK) (Park et al., 1998).We examined direct binding of 
this tripeptide to MppA, but were unable to detect binding even using concentrations up 
to 1 mM using tryptophan fluorescence (data not shown). It is possible that PFK binding 
to MppA does not result in a net change in the tryptophan fluorescence of the protein, 
and so we measured PFK binding to MppA using isothermal titration calorimetry 
(Figure 5.4). We were able to detect an interaction between MppA and PFK, although 
the binding was weak with a KD greater than 300 µM and the binding isotherm was 
markedly different from that observed for Mtp binding (ΔH of -3100 ± 43 kJ mol-1 and 
ΔS of 5.72 J.K-1mol-1) (Figure 5.4), suggesting that the binding mechanism is different, 
perhaps indicative of non-specific binding to the protein. It is certainly not consistent 
with a previous report that suggested a KD of MppA for PFK less than 50 µM (Letoffe 
et al., 2006). Together these data suggest that high-affinity binding in the 
submicromolar range is seen only for Mtp itself and even small modifications of the 
ligand structure result in significant reductions in affinity. 
We next examined a range of conventional tripeptides that have been used in studies on 
OppA including KEK, KKK, AAA, KKKA and AKK. For none of these peptides were 
we able to detect binding to MppA (Table 5.1). It has also been reported that MppA can 
bind heme and its precursor δ-aminolevulinic acid and its binding is competitive with  
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Table 5.1 Binding affinities of MppA with different ligands 
 
 
 
Ligand 
Binding affinity (KD) 
Tryptophan 
fluorescence 
ITC 
L-Ala-γ-D-Glu-mDap (Mtp) 0.24  0.02 μM 0.30  0.06 μM 
L-Ala-γ-D-Glu-Lys (AEK) 132  10 μM 240  40 μM 
L-Ala-D-Glu-mDap (AEDap) Binding not detected Not checked 
Pro-Phe-Lys (PFK) Binding not detected > 300 µM 
δ aminolevulinic acid Binding not detected Not checked 
KEK Binding not detected Not checked 
KKK Binding not detected Not checked 
AKK Binding not detected Not checked 
AAA Binding not detected Not checked 
KKKA Binding not detected Not checked 
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Figure 5.3 AEK binding to MppA 
A) Fluorescence change upon addition of AEK to MppA, cumulative concentration of AEK 
shown. B) Cumulative changes in tryptophan fluorescence of MppA upon titration with AEK. 
 
A) 
B) 
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Figure 5.4 Binding isotherms for the interaction of MppA with PFK 
The top panels show heat differences upon injection of ligands and lower panels show 
integrated heats of injection (■) and the best fit (solid line) to a single site binding model using 
Microcal Origin 
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PFK, which we have already demonstrated binds much more weakly to MppA than 
Mtp. Indeed we were unable to observe binding of δ-aminolevulinic acid to MppA via 
tryptophan fluorescence spectroscopy (Table 5.1). 
5.3 Binding of Mtp to OppA  
After establishing the specificity of MppA to Mtp, we assessed binding of the Mtp to 
OppA to investigate whether this unusual peptide ligand can be accommodated by a 
general peptide-binding protein. We purified Salmonella Typhimurium OppA from an 
E. coli strain CH212 (Hiles and Higgins, 1986) carrying a plasmid pCH19. pCH19 is a 
multicopy plasmid which expresses the S. Typhimurium OppA protein from its native 
promoter. A glycerol stock of the strain CH212 was previously received as a gift from 
Chris Higgin‟s lab and was maintained in YSBL. Culture of E. coli CH212 was grown 
in LB medium containing ampicillin 30 g/m at 37°C. Cells were harvested by 
centrifugation and the pellet was resuspended in ice-cold SET buffer (methods). 
Chicken egg white lysozyme (Sigma) was added to cell resuspension at 600 μg/ml and 
incubated at 30 ºC for 2 hours. The subsequent sphaeroplasts were harvested by 
centrifugation and the supernatant was stored. The supernatant constituted the 
periplasmic fraction and contained the over produced OppA. The periplasmic fraction 
was dialysed into 50 mM Tris buffer (pH 8) and then loaded onto a pre-equilibrated 5 
ml ion exchange column (MonoQ from GE Healthcare) on an AKTA Purifier P-900. 
The OppA protein remained bound to the column during washing with 50 mM Tris 
buffer (pH 8). Proteins were eluted using a continuous 20 CV gradient of 0 - 500 mM 
NaCl in buffer (50mM Tris pH 8, 0.5M NaCl) (Figure 5.5A). OppA protein eluted at 
about 150 mM NaCl. The fractions containing the OppA protein were analysed by 
separating the protein using SDS-PAGE gel (Figure 5.5B). 
As OppA is high affinity peptide-binding protein and co-purifies with bound peptides. 
Peptides were removed by extensive washing of protein with sodium acetate (pH 5) on 
a Mono S (GE Healthcare) cation exchange column. Ligand free protein (denoted 
OppA*) was eluted using a continuous 20CV gradient of 0 - 500 mM NaCl. Protein was 
99% pure at this stage as judged on SDS gel (Figure 5.5C) and was checked for the 
absence of peptides by native mass spectrometry.  
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Figure 5.5 Purification of Salmonella Typhimurium OppA 
A) Chromatogram of the purification of OppA from anion exchange column (Abs 280 nm in 
blue and % of buffer containing 0.5 M NaCl). B) Coomassie stained SDS-PAGE of the 
periplasmic extract (PE) loaded to the column and elution fractions (33-36) for peak 1 and (38-
41) for peak 2 in the chromatogram. Fractions 33-36 contain OppA where as fractions 38-41 
contain contaminant proteins. C) Coomassie stained SDS gel containing 5 µg (Lane 1) and 20 
µg Lane2) of ligand free purified OppA. M is prestained protein ladder. 
A) 
B) C) 
kDa 
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We used isothermal titration calorimetry to assess whether OppA can bind Mtp and 
similar peptides. The protein was able to bind a conventional tripeptide, KEK with 
submicromolar affinity but we could not detect binding of Mtp (Figure 5.6). 
5.4  Site directed mutagenesis of MppA  
5.4.1 Creation of A274E and R402A mutants 
As explained in section 4.5, that Arg-402 is a potentially important residue in MppA 
that binds to α carboxylate group of the γ-linked D-Glu of Mtp. However, In OppA, this 
residue (Arg-404) is interacting with water and positioned away from the ligand because 
of its interaction with Glu-276 (Figure 4.8A). In MppA, Glu-276 is replaced by Ala-274 
(Figure 5.7B) and thus allows Arg-402 to make a direct interaction with Mtp. In order to 
investigate the role of the Arg-402 residue in MppA, we mutated this residue to Ala and 
investigated the effects on ligand binding. We also mutated Ala-274 to Glu to assess 
whether an OppA-like residue at this position could sequester the Arg-402 side chain 
and prevent it from making a direct contact with Mtp. 
To construct A274E and R402A mutants of MppA, site-directed mutagenesis was 
carried out using the one-step site-directed and site-saturation mutagenesis protocol of 
Zheng et al., 2004. Briefly, this uses 30–50 base primers with a 5  overlap of about half 
their length to reduce the primer-primer annealing temperature and a silent mutation to 
add a restriction endonuclease cleavage site to allow for screening of potential mutants. 
The long overhang allows the primers to anneal across the opposite end of the plasmid 
PCR product, so introducing PCR-like properties to the reaction. This improves the 
yield by allowing amplification of the entire plasmid and the high melting temperature 
of the overhang region removes the need for a plasmid ligation step before 
transformation. The population of transformants bearing the template plasmid was 
reduced still further by digestion of the PCR product with DpnI restriction 
endonuclease. The expression vector pAM6091 was used as a template with the 
following primers: mppAA274EF and mppAA274ER for making A274E mutant and 
mppAR402AF and mppAR402AR for R402A mutant. The sequences of mutants were 
confirmed by DNA sequencing of the plasmids (pAM6091A274E and 
pAM6091R402A). The plasmids carrying the desired mutants were transformed into 
BL21 (DE3) strain of E. coli for over production of the mutants. 
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Figure 5.6 Binding isotherms for the interaction of OppA with Mtp (A) and KEK (B)  
The top panels show heat differences upon injection of ligands and lower panels show 
integrated heats of injection (■) and the best fit (solid line) to a single site binding 
model using Microcal Origin software. 
 
 
 
 
 
 
A) B) 
H  =     1300 kJmol-1 
S  =      31.1 J.mol-1.K-1 
  N  =     0.88  
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Figure 5.7 Conservation of Glu 276 and Ala 274 in MppA 
Sequence alignments of MppA and OppA in different -proteobacteria showing that Glu 276 is 
conserved in all OppAs (A) and is replaced by Ala 274 in all MppAs (B). 
 
 
 
A) 
B) 
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5.4.2 Expression and purification of A274E and R402A  
For each mutant, protein expression was tested in small scale expression trials. Both 
mutants accumulated to a similar level as the native protein (data not shown). For large 
scale production cultures of E. coli BL21 (DE3) strains were grown in LB medium at 37 
°C using 2L flasks. Expression was induced at OD650 0.4–0.6 with 0.5 mM IPTG and 
the cells were left growing overnight. The cells were harvested by centrifugation and 
resuspended in 50 mM KPi, pH 7.8. Cells were lysed by sonication and cell debris was 
removed by centrifugation at 38000 x g for 30 min at 4°C. The whole cell lysate 
containing over produced protein was collected. Nickel affinity chromatography was 
used for the purification of protein using gravity-flow columns. The whole cell lysate 
containing the over produced protein was incubated with equilibrated Ni
2+
-NTA resin 
for 1 hour and weakly binding contaminants were eluted by washing the resin with a 
wash buffer containing 50 mM imidazole. Bound His-tagged protein was eluted with 
elution buffer containing 500 mM imidazole. Analysis of the fractions taken during 
purification of protein using Coomassie-stained SDS-PAGE revealed an intense band in 
elution fraction 2 that corresponded to purified protein (Figure 5.8). An intense band 
was present in the whole cell lysate fraction, which was less intense in the flow through 
from the column, indicating that this band was over produced protein and was abundant 
enough to be visible in the whole cell lysate (Figure 5.8). The entire elution fractions 
containing purified protein were pooled together and dialysed into 50 mM KPi buffer 
pH 7.8 and stored.  
5.4.3 Analysis of A274E and R402A for ligand binding 
As native protein co-purifies with endogenously bound ligand, the mutant proteins were 
checked by ES-MS for the presence of a ligand. The mass spectrum of both the mutant 
proteins recorded under native conditions showed no peak for a ligand bound protein 
(Figure 5.9) suggesting that purified mutant proteins did not purify as complexes with 
Mtp. Purified mutant proteins were also examined using tryptophan fluorescence 
spectroscopy for their ability to bind Mtp. Neither of the mutant proteins showed any 
binding to Mtp suggesting that both residues are important for MppA recognition of 
Mtp. As we could not detect binding of Mtp to either mutant, we recorded the circular 
dichroism spectra of the mutant proteins. Both mutants give very similar spectra to the  
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Figure 5.8 Purification of A274E and R402A mutants of MppA 
Coomassie stained SDS-PAGE gels showing the purification of MppA: A274E (A) and 
MppAR402A (B) by Ni-affinity chromatography showing clarified whole cell lysate (WCL), 
the flowthrough (UB), the 50 mM imidazole washing step (W) and the elution fractions 
containing purified proteins indicated by arrows. M is pre-stained protein ladder. 
 
B) 
A) 
139 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9 ES-MS of MppA mutants 
(A) ES-MS spectrum of A274E under native conditions. The molecular mass of the unbound 
protein (U) is indicated at 58047 atomic mass units (amu). (B) ES-MS spectrum of R402A 
under native conditions. The molecular mass of the unbound protein (U) is indicated at 57903 
atomic mass units (amu). Other peaks are adducts of phosphates. 
 
A) 
B) 
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wild-type MppA (data not shown) indicating that failure to bind Mtp is probably not 
caused by protein misfolding or instability. The binding properties of the mutants were 
further investigated using tryptophan fluorescence spectroscopy for other peptide 
ligands. A274E mutant showed a slight quench in signal upon addition of PFK upto 10 
mM (Figure 5.10), however it was not possible to titrate this small change in 
fluorescence. This intrigued us to check binding of PFK by ITC and to check if binding 
affinity was improved for this ligand. We therefore used ITC to check whether the 
change in fluorescence represents true binding of A274E to PFK. Although we could 
detect an interaction between A274E and PFK but this was similar to that observed in 
case of wild type MppA (data not shown). This confirmed that the quench in 
fluorescence signal was an artefact and there is no or very weak binding (KD > 300 M) 
between A274E and PFK. We could not detect any binding of the mutant proteins with 
rest of the peptide ligands used in Table 5.1.  
5.5 A possible physiological function of MppA 
It has been suggested that MppA allows E. coli to scavange Mtp that is either released 
during turnover of its own cell wall or that is available in the environment. This 
suggestion is supported by the fact that E. coli is known to secrete Mtp during growth 
(Goodell and Schwarz, 1985). E. coli turns over one third of its cell wall each 
generation and efficiently reuses Mtp for the synthesis of new wall in a process termed 
cell wall recycling (Park, 1995). In this pathway cell wall is degraded to N-
acetylglucosaminyl-1,6-anhydro-N-acetylmuramyl-L-alanyl- -D-glutamyl-meso-
diaminopimelate (GlcNAc-anhMurNAc-tripeptide also called muropeptide) by the 
action of lytic enzymes which are present in the periplasm. The muropeptide is 
transported into the cytoplasm via the membrane-bound AmpG permease (Jacobs et al., 
1994). The tripeptide is released from the muropeptide by the cytoplasmic amidase 
AmpD (Jacobs et al., 1995) and thus reenters the cell wall biosynthetic pathway (Figure 
5.11A).We proposed a new route for the direct uptake of Mtp via MppA and OppBCDF 
(Figure 5.11B). This route may give the bacterium an extra advantage of scavenging all 
the Mtp present in the periplasm. An amidase enzyme (AmiD) present in the outer 
membrane liberates free Mtp, present in the peptidoglycan (Uehara and Park, 2007). 
However we realized that Mtp is only 7.41% of the total peptide content of cell wall and  
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Figure 5.10 PFK binding to A274E 
Fluorescence change upon addition of PFK to A274E, cumulative concentration of PFK is 
shown. 
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Figure 5.11 Schematic of peptidoglycan biosynthesis and recycling 
A) Existing pathway for recycling murein tripeptide (Park and Uehara, 2008) B) Proposed role 
of MppA in the uptake of Mtp as a part of cell wall recycling pathway. 
A) 
B) 
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the most abundant peptide in cell wall is tetrapeptide (35.9 % of the total peptide 
content) (Glauner et al., 1988). The tetrapeptide is an extension of D-Ala to the C-
terminus of Mtp. Considering the abundance of tetrapeptide in cell wall we proposed 
that bacterium must uptake this as well and reuse it too in the process of recycling. 
Considering that Mtp and tetrapeptides are not the substrates for AmpG (Cheng and 
Park, 2002), we speculated that transport of tetrapeptide might occur via the MppA-
OppBCDF pathway. We first analysed the structure of MppA to see any room in the 
binding pocket for accommodating a tetrapeptide. Modelling of a tetrapeptide into the 
binding cavity of MppA showed no steric clashes with MppA. Binding was confirmed 
in vitro where we showed binding of tetrapeptide to MppA using tryptophan 
fluorescence spectroscopy. Addition of tetrapeptide to MppA caused approximately 5.5 
% quench in the fluorescence. Titration of this change gave a KD of 0.140 μM ± 0.01311 
(Figure 5.12A). To our surprise tetrapeptide binds to MppA with 2 times higher affinity 
than Mtp. Other breakdown products of cell wall which are present in the periplasm 
were checked for their binding to MppA. This included a pentapeptide (Mtp-D-Ala-D-
Ala) and muropeptide. However we could not see any binding of MppA to these 
products (data not shown). Thus we propose that uptake of Mtp and tetrapeptide via 
MppA-OppBCDF is a part of cell wall recycling independent of the major recycling of 
muropeptide via AmpG (Figure 5.12B). 
5.6 Conclusion 
This chapter has focussed on the interactions between MppA and peptide ligands, 
particularly Mtp. MppA binds Mtp with high affinity (submicromolar) and specificity. 
The investigation of roles of A274 and R402 residues by site directed mutagenesis 
showed that they make key interactions with Mtp and are essential for MppA binding to 
Mtp. OppA did not show any binding to Mtp and thus disapproving the previous notion 
that OppA can accommodate Mtp (Goodell and Higgins, 1987). It was proposed that 
MppA plays role in cell wall recycling by uptake of Mtp from the periplasm. It was 
shown for a first time that MppA can also bind to a murein tetrapeptide.  
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Figure 5.12 Tetrapeptide binding to MppA 
A) Cumulative changes in tryptophan fluorescence of MppA upon titration with tetrapeptide. B) 
Proposed function of MppA for uptaking of Mtp and tetrapeptide in cell wall recycling pathway.  
 
 
A) 
B) 
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6.1 Genomic context of mppA and discovery of a conserved scavenging pathway 
for peptidoglycan derived peptides  
After proposing that MppA is involved in the uptake of murein tripeptide (Mtp) and 
tetrapeptide as a part of cell wall recycling, the next step was to test the hypothesis by 
performing growth experiments. The idea was to grow bacteria on cell wall derived 
peptides as a sole source of carbon and nitrogen and compare the growth of wild type 
and mppA mutant bacteria. This experiment needed large amounts of murein tri and 
tetrapeptides ( g) and we did not have enough peptides in the stock to do growth 
experiments.  
Meanwhile, an interesting observation was made concerning the genomic context of 
mppA in E. coli. mppA is situated near a gene called mpaA, which was suggested to 
cleave Mtp (Uehara and Park, 2003). Three uncharacterized genes (ycjZ, ycjY and ymjC) 
separate mppA and mpaA in E. coli. ycjZ is a putative DNA binding transcriptional 
regulator, ycjY is a predicted hydrolase and ymjC is a small stretch of DNA that codes 
for only 46 amino acid residues with no similarity to known proteins.  The genetic 
organization of mppA and mpaA was checked in other bacteria including Salmonella, 
Klebsiella, Yersinia, Erwinia and Vibrio. The comparative genomics analysis carried 
out with “The Seed” (Overbeek et al., 2005) revealed that the two genes are always 
present together and divergently transcribed (Figure 6.1). The clustering of mppA and 
mpaA genes suggests that they are co-regulated and may function together. In 
Salmonella, Klebsiella and Yersinia, the mpaA is adjacent to a gene (ycjG), encoding an 
epimerase enzyme (Figure 6.1) which epimerizes L-Ala-D-Glu to L-Ala-L-Glu 
(Schmidt et al., 2001). A myriad of murein hydrolases are known to degrade 
peptidoglycan to the product dipeptide L-Ala-D-Glu. No known bacterial peptidase can 
cleave this dipeptide. However, if L-Ala-D-Glu could be epimerized to L-Ala-D-Glu, 
hydrolysis could occur with known dipeptidases. The clustering of mppA, mpaA and 
epimerase genes led us to propose a peptide scavenging pathway that is conserved in -
proteobacteria. We propose that MpaA cleaves murein tripeptide and tetrapeptide that 
are taken up via MppA-OppBCDF thus enabling bacteria to scavange murein tripeptide 
and tetrapeptide present in the periplasm. The dipeptide L-Ala-D-Glu resulting from the 
action of MpaA is epimerized to L-Ala-L-Glu, further degraded by a peptidase (PepD) 
and utilized by bacteria as a nutrient (Figure 6.2). Thus MppA may be involved in a 
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Figure 6.1 Genetic organization of mppA and mpaA in different bacteria 
Putative mppA and mpaA genes are represented by dark blue and red boxes resepectively. The 
gene encoding the epimerase is coloured light blue. Genes with similar putative function are 
represented by boxes coloured appropriately. Ec, Escherichia coli K-12; St, Salmonella enterica 
serovar Typhimurium LT2; Kp, Klebsiella pneumoniae subsp. Pneumoniae MGH 78578; Yp, 
Yersinia pestis KIM; Eca, Erwinia carotowora subsp. Atroseptica SCRI1043; Vs, Vibrio sp. 
MED 222; Vp, Vibrio parahaemolyticus AQ3810; Vh, Vibrio harveyi ATCC BAA-1116. 
mppA* belongs to Vibrio and is different from other bacteria.  
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peptide catabolic pathway which is different from the recycling pathway proposed 
initially (Figure 6.1and Figure 5.12).  
A project was designed to biochemically characterize the enzyme MpaA in terms of its 
activity and substrate specificity for a range of peptides. As a first step, it was decided 
to clone the gene encoding MpaA from E. coli K-12 in an expression vector. 
During the analysis of mppA genome organization it was observed that MppA of Vibrio 
harveyi (Vh_MppA) is different from MppA of E. coli (Ec_MppA) as a simple BLAST 
search using amino acid sequence of Ec_MppA did not identify its orthologue from 
Vibrio harveyi. It rather pulled the OppA of V. harveyi. This was true also for Vibrio sp. 
MED 222 and Vibrio parahaemolyticus. This observation led us to hypothesize that 
mppA may have evolved twice. Thus we also decided to express Vh_mppA and 
Vh_mpaA in order to characterize them biochemically and to test if they are functional 
orthologues of Ec_mppA and Ec_mpaA. 
6.2 Cloning and expression trial of candidate mpaA and mppA homologues using 
the pET-YSBLIC3C vector 
To characterize the proteins, it was necessary to clone the genes Ec_mpaA, Vh_mpaA 
and Vh_mppA into a plasmid vector suitable for over production of the proteins. As for 
E. coli mppA, we used the pET-YSBLIC3C expression vector for the expression of 
recombinant proteins. Regions of the V. harveyi ATCC BAA-1116 genome were 
amplified by PCR using primers Vh_mpaAF and Vh_mpaAR for Vh_mpaA and 
Vh_mppAF and Vh_mppAR for Vh_mppA. Region of the E. coli K-12 genome encoding 
mpaA were PCR amplified using Ec_mpaAF and Ec_mpaAR primers. These were 
cloned into pET-YSBLIC3C using ligation independent cloning (LIC) so that the 
coding sequence was in-frame with a 5  nucleotide sequence encoding a hexa histidine 
tag. This resulted in three different expression vectors; pEC6091, pVH6092 and 
pVH6093, expressing an N-terminally hexa histidine tagged Ec_MpaA, Vh_MpaA and 
Vh_MppA, respectively. Construction of the desired recombinant plasmid was 
confirmed by the cleavage pattern analysis with the appropriate restriction endonuclease 
(data not shown). Recombinant plasmids were also sequenced in the Technology 
Facility (University of York) to confirm in frame cloning of genes with no mutation. 
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While the genes appear to be correctly inserted into the expression vector, the expressed 
protein is the actual target. To ensure that the target is expressed and is of correct 
molecular weight, a small-scale expression trial was performed. The recombinant 
plasmids (pEC6091, pVH6092 and pVH6093) were transformed into the E. coli 
expression strain BL21 and used in small scale expression trials. The expression trials 
were performed using 25 ml LB media in 100 ml flasks and cultures of E. coli BL21 
strains were grown at two temperatures, 25°C and 37°C. Expression of recombinant 
protein was induced by addition of 0.5 mM IPTG at an OD650 of 0.4-0.6. Growth was 
monitored by measuring OD650 after each hour starting from the time of induction and 
was continued for four hours post induction with a final reading taken after 24 hours 
(data not shown). None of the strains failed to grow or showed any obvious reduction in 
growth rate after induction indicating that the recombinant proteins are not toxic to the 
cell, assuming they were induced. At each hourly time point, 1 ml of culture was 
pelleted for analysis by SDS-PAGE. 
Synthesis of protein was checked by re-suspending the cell pellets in sample buffer and 
separating the proteins using SDS-PAGE as described in methods section 2.8. The 
protein accumulation profile of the strain carrying the Ec_mpaA construct, (Figure 6.3 
A) shows an IPTG inducible band at around 27 kDa as expected, with maximum 
accumulation of protein at 4 hours post-induction when grown at 37°C. The synthesis of 
Ec_MpaA was lower at each stage when grown at 25°C. 
The SDS polyacrylamide gel of the strain carrying Vh_mpaA construct (Figure 6.3B) 
shows induced synthesis of a 27 kDa protein with maximum accumulation of protein at 
24 hours post-induction when grown at 37°C. 
The protein accumulation profile of the strain carrying the Vh_mppA construct shows an 
intense band at around 58 kDa after induction with IPTG with almost the same 
expression at all stages when grown at 25°C and 37°C (Figure 6.3C). However the 
culture reaches a higher OD650 after 24 hours when grown at 37°C, so these conditions 
were chosen for future over production of Vh_MppA to maximise yield. 
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Figure 6.3 Expression of Ec_MpaA, Vh_MpaA and Vh_MppA  
Coomassie stained SDS-PAGE gels from expression trials conducted at 25°C (left) and 37°C 
(right). M is pre-stained protein ladder, time (t) is equal to number of hours post induction and 
arrow indicates the position of an over produced protein on the gel. 
A) Expression of Ec_MpaA from BL21 (DE3) pEC6091 B) Expression of Vh_MpaA from 
BL21 (DE3) pVH6092 C) Expression of Vh_MppA from BL21 (DE3) pEC6093 
A) 
B) 
C) 
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6.3 Large scale expression and purification of Ec_MpaA, Vh_MpaA and 
Vh_MppA 
Large scale production was performed in two litre flasks and cultures of E. coli BL21 
were grown under the optimum conditions determined during the small scale expression 
trials for each target. After induction, cells continued to grow for a specific time interval 
optimised in small scale expression trials and were harvested by centrifugation at 4430 
x g for 15 min. The cell pellet was resuspended in buffer A (50 mM Tris pH 8, 500 mM 
NaCl and 10 mM imidazole) and lysed by sonication. Cell debris was separated from 
the soluble fraction by centrifugation at 38000 x g for 30 min at 4°C. The supernatant 
was loaded onto a 5 ml nickel affinity column (GE Healthcare) connected to an AKTA 
purifier P-900. Recombinant protein containing the hexahistidine tag on the N-terminus 
was attached to Ni-NTA resin. Weakly bound contaminants were removed by washing 
the column with 20 CV of buffer A and the recombinant protein was eluted by applying 
a linear (0-500mM) gradient of imidazole. Fractions were collected throughout and the 
resulting A280 spectrum was used to identify the location of eluted protein. Selected 
fractions were analysed on SDS-PAGE gels. 
The chromatogram of elution of Ec_MpaA shows a clear peak (Absorption 280 nm) 
spanning fractions 25 to 30 (Figure 6.4A). Analysis of the selected elution fractions (25-
30) revealed an intense band in fractions 27 and 28 that corresponded to purified protein 
of around 28 kDa as expected (Figure 6.4B). An intense band was also present at around 
28 kDa in the whole cell lysate fraction, indicating that this band was over produced 
protein and was abundant enough to be visible in the whole cell lysate (Figure 6.4B). 
Similarly, analysis of the selected elution fractions (19-24) collected during purification 
of Vh_MpaA also revealed an intense band corresponding to purified protein and thus 
suggesting successful purification of Vh-MpaA (Figure 6.5). 
The chromatogram of elution of Vh_MppA shows a small peak (Absorption 280 nm) 
corresponding to fractions 30-34 (Figure 6.6A). Analysis of the selected fractions (30-
34) using SDS-PAGE showed no band for the purified protein (Figure 6.6B). An intense 
band was however present in the whole cell lysate fraction at around 58 kDa suggesting 
that synthesis of protein occurred after induction with IPTG. This suggested either that 
the protein was insoluble in buffer A or that it was unable to bind to the Ni
2+
-column 
153 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 Purification of Ec_MpaA 
A) Chromatogram of the elution of Ec_MpaA from Ni
2+
-column (Abs 280 nm in blue and % of 
buffer B containing 0.5 M imidazole is in red). B) Coomassie stained SDS-PAGE of the whole 
cell lysate (WCL) and elution fractions (25-29) for the peak in the chromatogram.  
B) 
A) 
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Figure 6.5 Purification of Vh_MpaA 
A) Chromatogram of the elution of Vh_MpaA from Ni
2+
-column (Abs 280 nm in blue and % of 
buffer B containing 0.5 M imidazole is in red). B) Coomassie stained SDS-PAGE of the whole 
cell lysate (WCL) and elution fractions (19-24) for the peak in the chromatogram.  
A) 
B) 
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Figure 6.6 Purification of Vh_MppA 
A) Chromatogram of the elution of Vh_MppA from Ni
2+
-column (Abs 280 nm in blue and % of 
buffer B containing 0.5 M imidazole is in red). B) Coomassie stained SDS-PAGE of the whole 
cell lysate (WCL) and elution fractions (30-34) for the peak in the chromatogram. C) 
Coomassie stained SDS-PAGE of soluble cell lysate (SCL) and flow through (FT) from column 
A) 
B) C) 
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and flowed through the column. This was investigated by analysing the soluble cell 
lysate fraction and flow-through fractions. SDS-PAGE gel of the soluble cell lysate 
showed that an intense band for over produced protein was absent proving that the 
recombinant protein was insoluble in buffer A (Figure 6.6C). Many efforts were made 
to improve the solubility of Vh_MppA by trying different buffers of various 
compositions without success. Thus we decided to drop Vh_MppA from the list of 
targets and focussed on the putative amidase enzyme (MpaA). 
The elution fractions containing purified protein (Ec_MpaA and Vh_MpaA) were 
pooled together and the concentration of protein was determined using a NanoDrop 
ND-1000 spectrometer as described in methods section 2.9.2. The total yield obtained 
after Ni
2+
-affinity chromatography was 9 mg/l and 13 mg/l for Ec_MpaA and 
Vh_MpaA, respectively. At this stage proteins were approximately 99 % pure as judged 
by SDS-PAGE (Figure 6.7, inset for Ec_MpaA). Four residues from the affinity tag 
(GPAM) remain attached to the protein following HRV 3C cleavage. Fractions 
containing purified protein were pooled and dialysed in an appropriate buffer for mass 
spectrometry.   
6.4 Mass spectrometry of purified protein 
Mass spectrometry was used to ascertain whether the recombinant protein expressed 
and purified is the one expected and it is not modified in any way during synthesis. ES-
MS was used to determine the molecular weight of the proteins as described previously 
(Result section 3.6). MpaA is suggested to cleave Mtp from its C-terminus liberating a 
free dipeptide (L-Ala- -D-Glu) and Dap as reaction products (Uehara and Park, 2003). 
Thus we also used mass spectrometry to check the presence of any co-purified reaction 
product. This was done by recording the spectrum under native conditions, where 
proteins remain associated to non-covalently attached peptide species (Maqbool et al., 
2011). 
For Ec_MpaA, the spectrum recorded under denaturing conditions shows a peak at 
26783 ± 1 Da. This is very close to the predicted molecular weight of Ec_MpaA after 
removal of the hexahistidine tag (26782 Da) (Figure 6.7A).  
We used ES-MS under native conditions to see if Ec_MpaA co-purifies with its 
substrate or a reaction product as was previously observed for a related protein (Xu et 
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al., 2010). We could not see any peptide species bound to Ec_MpaA under native 
conditions. However we obtained a peak at 26846 Da, this being 64 Da larger than the 
predicted mass of Ec_MpaA (26782 Da) suggesting that a species of 64 Da is bound to 
protein (Figure 6.7B). As MpaA belongs to a family of metal dependent peptidoglycan 
amidases and these proteins are Zn
2+
dependent, with a single Zn
2+
 in the active site 
(Firczuk and Bochtler, 2007), we propose that the Ec_MpaA has co-purified with a Zn
2+
 
(molar mass of Zn
2+ 
being 65.38 Da) and the 26846 peak in the native condition 
corresponds to Ec_MpaA bound to a Zn
2+
. Under native conditions we also saw an 
additional small peak at 53692 Da, which is very close to the predicted mass of a dimer 
of Ec_MpaA bound to two Zn
2+
 (53694.76 Da) (Figure 6.7B) suggesting that Ec_MpaA 
may exist as a dimer in solution. The dimerization of Ec_MpaA was further investigated 
by SEC-MALLS. 
The molecular weight of Vh_MpaA was determined to be 26313  1 Da using 
denaturing ES-MS which is in agreement with the theoretical mass of Vh_MpaA after 
removal of the hexahistidine tag (26314 Da) (Figure 6.8 A). A native spectrum of 
purified Vh_MpaA showed that like Ec_MpaA, it is also bound to a species of 64 Da. 
Again we assigned this species a Zn
2+
 which was possibly co-purified with protein. The 
native spectrum also showed a peak at 52756 Da corresponding to a dimer of Vh_MpaA 
bound to two Zn
2+
 (Figure 6.8B)  
6.5 SEC-MALLS of MpaA to study dimerization 
As mass spectrometry data suggested that Ec-MpaA can also exist as a dimer, we 
investigated the ability of Ec_MpaA to form a dimer in solution by another method 
called SEC-MALLS. A sample of Ec_MppA (120 µl of 1.5 mg/ml in 20 mM Tris buffer 
pH 8) was applied to a Superdex 200 10/300 GL SEC column (GE Healthcare) at 0.5 
ml/min with an HPLC system (Shimadzu), linked to a Wyatt Dawn Heleos MALLS 
detector and a Wyatt Optilab rEX unit, to determine the refractive index. The buffer was 
150 mM NaCl, 20 mM Tris, pH 8. Data were analyzed with the program Wyatt ASTRA 
version 5.3.4.14. The molecular weight measured by light scattering was 54 kDa  
1kDa which is close to the calculated molecular weight for the dimer of 53.5 kDa, based 
on the amino acid sequence and suggests that Ec_MpaA exists as a dimer in solution 
(Figure 6.9A). Dimers of Vh_MpaA were also observed using the same procedure 
(Figure 6.9B). 
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Figure 6.7 ES-MS spectrum of Ec_MpaA 
A) ES-MS spectrum of 5 μM Ec_MpaA under denaturing conditions. The molecular mass of the 
Zn
2+
 free protein (U) is indicated at 26783 atomic mass units (amu). Inset: Coomassie stained 
SDS-PAGE gel containing 6 µg of purified Ec_MpaA (lane 1) and pre-stained molecular weight 
markers (M). (B) ES-MS spectrum of Ec_MpaA under native conditions in water. Peak (L) 
gives the molecular weight of Ec_MpaA bound to zinc and peak (D) gives the molecular weight 
of Ec_MpaA dimer bound to two zinc. 
A) 
B) 
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Figure 6.8 ES-MS spectrum of Vh_MpaA 
A) ES-MS spectrum of 5 μM Vh_MpaA under denaturing conditions. The molecular mass of the 
Zn
2+
 free protein (U) is indicated at 26313 atomic mass units (amu). (B) ES-MS spectrum of 
Vh_MpaA under native conditions in water. Peak (L) gives the molecular weight of Vh_MpaA 
bound to zinc and peak (D) gives the molecular weight of Vh_MpaA dimer bound to two zinc. 
A) 
B) 
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Figure 6.9 Molecular mass of Ec_MpaA and Vh_MpaA determined by SEC-MALLS   
A SEC-MALLS trace of Ec_MpaA (A) and Vh_MpaA (B) showing the relative absorbance at 
A280 trace normalized to 1 (thin line) and the molar mass of the species present in the sample 
(thick line). 
 
A) 
B) 
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6.6 Biochemical characterization of MpaA 
The work in section 6.6 was performed by Dr. Mireille Herve (University of Paris-Sud, 
France) as a part of collaboration. Purified enzyme was sent to her lab and she 
performed the enzymatic assays to check the substrate specificity and to measure 
activity of the enzyme.  
6.6.1 Enzymatic assays 
MpaA is an amidase that hydrolyses the -D-Glu-meso-Dap bond in L-Ala- -D-Glu-
meso-Dap tripeptide. The standard MpaA activity assay consisted in following the 
hydrolysis of the tripeptide in a reaction mixture (25 µl) containing: 100 mM Tris-HCl 
buffer, pH 8, 0.2 mM tripeptide L-[
14
C]Ala- -D-Glu-meso-Dap (40 Bq) and MpaA 
enzyme (5 ng of protein in 5 µl of 50 mM Tris buffer, pH 8, containing 0.5 mg.ml
-1
 of 
BSA). After 30 min of incubation at 37°C, the reaction was stopped by adding 5 µl of 
acetic acid. Radiolabeled substrate and reaction product L-Ala- -D-Glu-meso-Dap and 
L-Ala-D-Glu were separated by thin layer chromatography (TLC) on silica gel plates 
LK6D (Whatman), using ethanol/1M ammonium acetate pH 3.8 (5/2) as a mobile 
phase. The radioactive spots were located and quantified with a radioactivity scanner 
(model Multi Tracemaster LB285; Berthold). When other compounds were tested as 
substrates, assay conditions were modified: the amount of MpaA enzyme was 
appropriately adjusted (from 5 ng to 10 µg), as well as the time of incubation (from 30 
min to 16 h). Some enzymatic assays used unlabelled compounds as substrates; in that 
case, reaction mixtures were analyzed by HPLC, using a C18 ODS Hypersil 3 µm 
column (250  4.6 mm; Grace). Elution was performed either using isocratic conditions 
(0.05% TFA) or by applying a gradient of acetonitrile in 0.05% TFA (from 0 to 20% 
acetonitrile in 30 min) at a flow rate of 0.6 ml.min
-1
. Detection was at 214 nm. In some 
cases, the enzymatic digestion of tripeptide derivative compounds was also analyzed by 
measuring the release of the C-terminal amino acid residue (Dap or lysine) using a 
Hitachi L8800 amino acid analyzer (ScienceTec). 
6.6.2 Enzymatic activity and kinetic parameters of MpaA 
Preliminary assays were carried out to determine the optimal conditions for enzyme 
activity. Determination of Ec_MpaA activity as a function of pH in the standard assay 
conditions (substrate: tripeptide L-Ala- -D-Glu-meso-Dap) showed a low pH 
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dependence between pH 7.2 and pH 9, with an optimum value around 8.0 (Figure 6.10). 
Ec_MpaA seems to require a divalent cation since the activity of the enzyme was 
inhibited by incubating it with 10 mM EDTA. Although we did not perform any metal 
analysis to exactly determine the nature of divalent cation, however, considering our 
mass spec data we proposed it to be a Zn
2+
. The kinetic parameters of Ec_MpaA 
towards L-Ala- -D-Glu-meso-Dap were determined at substrate (Mtp) concentrations 
ranging from 0.07 to 0.7 mM. The data were fitted to the equation v = VmaxS/(Km +S),  
using the Simplex algorithm (MDFitt software developed by M. Desmadril, IBBMC, 
Orsay, France). Based on a 26,453 molecular mass value for MpaA, the kcat was 
estimated at 2300 ± 600 min
-1
 and the Km at 0.52 ± 0.05 mM. 
6.6.3 Substrate specificity of MpaA 
The activity of Ec_MpaA was tested on a series of potential substrates including 
peptidoglycan precursors and their analogues, as well as intermediates generated during 
maturation of the cell-wall polymer. As indicated in Table 6.1, Ec_MpaA was able to 
hydrolyze a tripeptide containing L-Lys instead of meso-Dap at the third position, 
although with a much lower efficiency (specific activities of 0.17 and 12 µmoles.min
-1
. 
mg
-1
, respectively). Ec_MpaA does not hydrolyze a synthetic tripeptide in which meso-
Dap is bound to the -carboxyl group of D-Glu, indicating that the enzyme specifically 
cuts -D-Glu-meso-Dap bonds. The dipeptide -D-Glu-meso-Dap was very poorly 
hydrolyzed by Ec_MpaA (0.4 nmole. min
-1
. mg
-1
), indicating that the presence of the N-
terminal L-Ala residue was essential but not absolutely required for activity. The 
tetrapeptide L-Ala- -D-Glu-meso-Dap-D-Ala was not digested, showing that Ec_MpaA 
does not exhibit endopeptidase activity. A very low activity was detected with 
MurNAc-tripeptide (0.3 nmole. min
-1
. mg
-1
) but neither the nucleotide precursor UDP-
MurNAc-tripeptide nor the peptidoglycan recycling product GlcNAc-MurNAc 
(anhydro)-tripeptide, whose size is greater, were hydrolyzed by Ec_MpaA. The activity 
of Vh_MpaA was tested in the same way as that for Ec_MpaA. Vh_MpaA was able to 
hydrolyze Mtp, liberating free Dap and a dipeptide (L-Ala- -D-Glu) (specific activity of 
9.4 µmoles.min
-1
. mg
-1
) but it could not hydrolyze tetrapeptide proving that Vh_MpaA 
is a functional orthologue of Ec_MpaA.  
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Table 6.1 Substrate specificity and kinetic parameters of Ec_MpaA   
 
            Substrate                                 Specific Activity             Km               kcat 
                                                            nmoles. min
-1
.mg
-1
       (mM)            min
-1 
  
L-Ala- -D-Glu-meso-Dap (Mtp)   12,000            0.52 ± 0.05      2300± 600  
L-Ala- -D-Glu-L-Lys (AEK)   170 
L-Ala-D-Glu-meso-Dap    NC 
L-Ala- -D-Glu-meso-Dap-D-Ala  NC 
GlcNAc-MurNAc(anhydro)-tripeptide  NC 
GlcNAc-MurNAc(anhydro)-tetrapeptide  NC 
MurNAc-tripeptide    0.3                    
UDP-MurNAc-tripeptide   NC 
UDP-MurNAc-pentapeptide   NC 
L-Lys-L-Glu-L-Lys (KEK)   NC 
L-Pro-L-Phe-L-Lys (PFK)   NC 
-D-Glu-meso-Dap    0.4 
 
 
NC-No cleavage detected 
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Figure 6.10 L-Ala- -D-Glu-meso-Dap hydrolyzing activity of Ec_MpaA as a function of 
pH 
The optimum pH for MpaA activity was evaluated by incubating 26 ng of MpaA with 0.5 mM 
[
14
C] tripeptide in Tris-HCl buffer at pH from 7.2 to 9.0, for 30 min at 37°C, in a final volume 
of 25 µl.   
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6.7 Crystallization of MpaA 
Crystals of Ec_MpaA and Vh_MpaA were grown in 96 well plates using the hanging 
drop vapour diffusion method. Protein was dialysed in 50 mM Tris pH 8 and 
concentrated to 30 mg/ml. Initially crystallization trials were set up at two 
concentrations of protein (15 mg/ml and 30 mg/ml) using a Mosquito Nanolitre 
Pipetting robot. Both His-tagged and untagged versions of the proteins were used for 
crsytallization. A range of commercially available screens; Hampton I, II, PACT, Index 
and Clear Strategy Screens CSSI and CSSII were used in the crystallization trials. The 
plates were sealed to avoid evaporation and then incubated at 20 ºC and examined 
regularly for the appearance of crystals. No crystals were observed for Ec_MpaA but 
the Vh_MpaA (His-tagged version only) produced crystals with 1 M lithium sulphate 
and 2% PEG 8000 (Hampton I condition 49). However these crystals were in the form 
of clusters (Figure 6.11A,B,C) and efforts to obtain single crystals by crushing the 
cluster were not successful due to their small size and poor diffraction. Thus the 
condition was optimised in order to get single crystals. Optimization experiments were 
performed by setting crystal trials manually in 24 well plates as described in methods 
section 2.12. Optimization involved varying the concentration of lithium sulphate (0.8 
M to 1.3 M) and adding dioxane (1 %) which is known to reduce clustering of crystals 
(Personal communication with Elena Blagova). These efforts resulted in production of 
single crystals (Figure 6.11D). One of the crystals was transferred to a precipitant 
solution containing 30 % glycerol for cryoprotection, flash cooled in liquid nitrogen and 
tested for X-ray diffraction on the YSBL home source (Rigaku MicroMax 007HF 
generator). The crystal diffracted to 3Å spacing and was stored in a Dewar flask 
containing liquid nitrogen and later on sent to the Diamond Light Source Synchrotron 
facility, Oxford, UK for X-ray data collection. The native crystal diffraction data were 
collected to 2.3 Å at Diamond Light Source on the beam line I03 at 100 K at a 
wavelength of 0.97630 Å. 
As native mass spectrometry showed that zinc is bound to the protein, a fluorescence 
scan was also performed at the synchrotron to establish whether zinc is present in the 
crystal. It could allow collecting anomalous data for phasing, the fluorescence scan 
showed no zinc bound. 
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Figure 6.11 Crystals of Vh_MpaA 
A-C) Images of crystals for target protein Vh_MpaA obtained from 96-well plate preliminary 
screens (well condition 1 M lithium sulphate and 2 % PEG 8000). D) Image of the crystal for 
target protein Vh_MpaA obtained from 24 well plate grown with 0.9 M lithium sulphate 2 % 
PEG 8000 and 1% dioxane) 
 
A) B) 
D) C) 
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Although there are structures of carboxypeptidases in the PDB, none had sufficient 
amino acid sequence identity with Vh_MpaA to allow solution of phase problem using a 
molecular replacement method. Thus it became a priority to produce the 
selenomethionine derivative (SeMet) of Vh_MpaA in order to get phases and solve the 
structure.  
6.8 Selenomethionine derivative of Vh_MpaA 
6.8.1 Expression trials of SeMetVh_MpaA 
Selenomethionine labelled Vh_MpaA was produced in a methionine auxotroph strain, 
B834 (DE3) of E. coli. The recombinant plasmid (pVH6092) was transformed into the 
expression strain B834 (DE3) and used in small scale expression trials. The expression 
trials were performed using 25 ml enhanced minimal medium containing 
selenomethionine as sole source of methionine in 100 ml flasks and cultures of E. coli 
B834 (DE3) were grown at two temperatures, 25 °C and 37 °C. Expression of 
recombinant protein was induced by adding 0.5 mM IPTG at an OD650 of 0.4-0.6. 1 ml 
of culture was pelleted after 4 hours of induction for analysis by SDS-PAGE. The cells 
was re-suspended in buffer A (50 mM Tris pH 8, 500 mM NaCl and 10 mM imidazole) 
and lysed by sonication while using a micro tip. The lysed cells were centrifuged at 
38000 x g for 5 minutes to get a soluble fraction. Total and soluble fractions were 
analysed by running SDS-PAGE gels (Figure 6.12). An intense band could be seen at 
around 28 kDa in both fractions suggesting that like native protein SeMet labelled 
protein is also soluble in buffer A. The cells achieve high OD650 after 4 hours when 
grown at 37 °C, so these conditions were chosen for future over production of 
SeMetVh_MpaA to maximise yield. 
6.8.2 Large scale production and purification of SeMetVh_MpaA 
Large scale production was performed in two litre flasks and cultures of E. coli B834 
(DE3) strain were grown under the optimum conditions determined during the small 
scale expression trials. After induction, cells were grown for 4 hours and harvested by 
centrifugation at 4430 x g for 15 min. The purification of the SeMetVh_MpaA was 
performed using a 5 ml nickel affinity column and following same procedure as for 
native protein. Selected fractions obtained during the course of purification were 
analysed on SDS-PAGE gels (Figure 6.13). 
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Figure 6.12 Expression of SeMetVh_MpaA 
Coomassie stained SDS-PAGE gel showing the accumulation of SeMetVh_MpaA from B834 
(DE3) grown at 25°C and 37°C for four hours after induction with IPTG. M is pre-stained 
protein ladder, WCL is whole cell lysate after sonication and SCL represents the soluble cell 
lysate. Arrow shows the position of over produced protein on the gel. 
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Figure 6.13 Purification of SeMet Vh_MpaA 
A) Chromatogram of the elution of SeMetVh_MpaA from Ni
2+
-column (Abs 280 nm in blue 
and % of buffer B containing 0.5 M imidazole is in red). B) Coomassie stained SDS-PAG of the 
whole cell lysate (WCL) and elution fractions (29-32) for the peak in the chromatogram. 
 
A) 
B) 
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6.9 Crystallization of SeMetVh_MpaA and data collection 
Purified SeMetVh_MpaA was dialysed into 50 mM Tris pH 8 and concentrated to 20 
mg /ml for crystallization. Initial crystallization trials of purified, His-tagged SeMet 
Vh_MpaA were carried out in sitting-drop 96-well plates using the Mosquito robot. A 
range of commercially available screens; Index, Hampton I and II, Newcastle and 
PACT were used in crystallization trials. Crystallization trials were set at two 
concentrations of protein (10 mg/ml and 20 mg/ml). Due to the absence of 
crystallization hits from initial crystallization trials, similar conditions where native 
crystals were obtained were repeated for the SeMet derivative crystals. This gave very 
small crystals which could not be used in a diffraction experiment (Figure 6.14A). 
Optimization experiments by changing concentration of precipitant, protein etc gave no 
success in terms of getting large crystals. At this point all the screens available in the 
laboratory were used for setting up of crystallization experiment. Fortunately small 
crystals appeared with 0.12 M MES/imidazole pH 6.5, 0.02 M mix of monosaccharides 
and a mix of PEG 8000 and ethylene glycol (Morpheus condition F2) but they were also 
very small (Figure 6.14B) and gave no / poor diffraction. The exact concentration of 
reagents in Morpheus condition F2 are not available, so optimization experiments were 
performed using various concentrations of PEG 8000 and ethylene glycol as a mix of 
precipitant. This was done manually in 24 well plates as described in methods section. 
This exercise resulted in the production of single crystals with well conditions of 0.12 
M MES/imidazole pH 6.5, 0.01 M D-glucose, 8% PEG 8000 and 20 % ethylene glycol 
(Figure 6.14C). Ten crystals were transferred to a cryoprotectant solution (0.12 M 
MES/imidazole pH 6.5, 8 % PEG 8000 and 40% ethylene glycol), flash cooled in the 
liquid nitrogen and tested for X-ray diffraction at YSBL home source (Rigaku 
MicoMax 007HF) using actor sample changer. Two of the crystals gave diffraction to 
2.6 Å and were chosen for X-ray data collection at synchrotron. 
Selenomethionine labelled crystals diffracted to 2.17 Å at Diamond Light Source and a 
SAD dataset was collected on the beam line I02 at 0.97970 Å wavelength. Diffraction 
data were processed by Xia2 autoprocessing (Winter, 2010). The crystal belongs to 
point group P6/mmm and absences were consistent with space group P6122 or P6522 
with the unit cell dimensions a=b=73.6 Å, c=208.7 Å, α=β=90 , γ=120 . Data collection  
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Figure 6.14 Crystallization of SeMetVh_MpaA 
Images of the crystals of SeMetVh_MpaA grown during the process of crystallization 
A) 0.9 M lithium sulphate 2 % PEG 8000 and 1% dioxane 
B) 0.12 M MES/imidazole pH 6.5, 0.02 M mix of monosaccharides and a mix of PEG  8000 
and ethylene glycol (Morpheus condition F2) 
C) 0.12 M MES/imidazole pH 6.5, 0.01 M D-glucose, 8% PEG 8000 and 20 % ethylene glycol 
A) 
B) 
C) 
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and processing statistics are summarised in Table 6.2. A Mathews coefficient of 3.14 
corresponds to one protein molecule in asymmetric unit plus 60 % solvent (After 
structure solution we found that the crystalllographic symmetry generated a dimer as 
expected from the SEC-MALLS results). 
6.9.1 Structure solution 
ShelxCDE automatic pipeline (Sheldrick, 2010) was used to solve the structure of 
Vh_MpaA using the SAD dataset collected from a SeMet crystal. ShelxD could locate 
the two Se atom positions expected from one molecule of Vh_MpaA. The location of 
the two Se atoms allowed phasing of the Vh_MpaA structure and the space group 
ambiguity was clearly resolved in the density modification step performed by ShelxE, 
showing a better result for P6522. The resultant electron density map was of sufficient 
quality for Buccaneer (Cowtan, 2006) to build 244 residues out of a total of 258 
residues. The Vh_MpaA model produced by Buccaneer was then refined by subsequent 
cycles of model building and refinement in REFMAC5 (Murshudov et al., 1997) and 
COOT (Emsley and Cowtan, 2004), respectively to give Rfactor and Rfree values of 19.6% 
and 23.2% respectively. The refinement statistics are given in the Table 6.3. 
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Table 6.2 X-ray data statistics for the crystal of SeMetVh_MpaA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
The outer shell corresponds to 2.23 – 2.17 Å. 
b
Rmerge = ∑hkl∑i|Ii - <I> | / ∑hkl∑i <I> where Ii is the intensity of the ith measurement of a 
reflection with indexes hkl and <I> is the statistically weighted average reflection intensity. 
 
 
Data collection and processing statistics 
X-ray source I02, Diamond 
Wavelength (Å) 0.97970 
Temperature (K) 100 
Space group P6122 / P6522 
Unit cell parameters (Å) 
a=b=73.6 Å, c=208.7 Å          
α=β=90 , γ=120  
Resolution range (Å) 69.57-2.17 
Number of unique reflections, 
overall/outer shell
a 
18606 (1339) 
Rmerge
b
 (%), overall/outer shell
a 
10.5 (78.5) 
Completeness (%),  overall/outer shell
a 
100 (100) 
Multiplicity / Redundancy, 
overall/outer shell
a 
40.8 (42.7) 
I/ (I), overall/outer shell
a 33.5 (7.4) 
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Table 6.3 Vh_MpaA structure refinement statistics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
Rfactor = Σ‖Fo|−|Fc‖ / Σ|Fo|, where Fo and Fc are the observed and calculated structure factor 
amplitudes, respectively. 
b
Rfree is the Rfactor calculated with 5% of the reflections chosen at random and omitted from 
refinement. 
c
Outer shell for refinement corresponds to 2.172–2.228 Å. 
d
Root mean square deviation of bond lenths and bond angles from ideal geometry 
e
Percentage of residues in most favored/additionally allowed/generously allowed/disallowed 
regions of the Ramachandran plot, according to PROCHECK. 
  
Refinement statistics 
Rfactor
a
 (Rfree
b
) 19.6 (23.2) 
Reflections (working / free) 17580 / 948 
Outer shell
c
 Rfactor
a
 (Rfree
b
) 20.3 / (26) 
Outer shell
c
 reflections (working / free) 1093 / 61 
Molecules / asymmetric unit 1 
Number of protein nonhydrogen atoms 1933 
Number of zinc 1 
Number of water molecules 46 
rmsd bond lengths(Å)
d 
0.02 
rmsd bond angles(Å)
d 
2.11 
Average B-factor (Å
2
) 33 
Ramachandran plot
e 
90/10/0.0/0.0 
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6.10 Overall structure of Vh_MpaA 
We crystallized a hexahistidine tagged version of Vh_MpaA which consists of 258 
amino acid residues out of which the first 22 residues belong to the His tag. The 
structure of Vh_MpaA shows continuous electron density from Val-16 to Asp-257. The 
first 15 residues (MGSSHHHHHHSSGLE) are not visible in the electron density maps and 
are assumed to be disordered. There is one Zn
2+
 and 46 water molecules associated with 
each molecule of Vh_MpaA. A ribbon drawing of the Vh_MpaA molecule is shown in 
the Figure 6.15. 
The overall fold is similar to eukaryotic carboxypeptidases. A DALI search of the 
protein data bank revealed that Vh_MpaA shares the highest structural similarity with 
duck carboxypeptidase D (PDB code 1H8L; Z-score = 20.5, with 207 equivalent Cα 
atoms superimposing with an rms  of 2.7 Å). Two other high scoring matches are the 
catalytic domain of human carboxypeptidase N (PDB code 2NSM; Z-score = 20.2, with 
200 equivalent Cα atoms superimposing with an rms  of 2.6 Å) and Drosophila 
melanogaster carboxypeptidase D (PDB code 3MN8; Z-score = 20, with 206 equivalent 
Cα atoms superimposing with an rms  of 2.8 Å).  
A sequence alignment of Vh_MpaA with duck CPD, human CPN and D. melanogaster 
CPD is shown in Figure 6.16. The three eukaryotic structures have an additional C-
terminal domain which is absent in Vh_MpaA. The human CPN structure consists of 
two domains, namely a classical CP domain and a transthyretin (TT) domain which is 
characteristic of CPN/E subfamily members and is absent in Vh_MpaA (Keil et al., 
2007). Vh_MpaA superposes on the CP domain of human CPN that contains the 
catalytic residues. A loop in Vh_MpaA spanning residues from Thr-124 to Lys-152 
(Figure 6.15) folds away from the human CPN structure and is involved in forming a 
dimer interface.  
Another important high scoring match from the DALI search is human 
carboxypeptidase A (PDB code 2PCU; Z-score = 19.4, with 213 equivalent Cα atoms 
superimposing with an rms  of 2.9 Å). The structure of human capboxypeptidase A 
(human_CPA) has been solved in the presence of a product complex with a cleaved 
hexapeptide (Bayés et al., 2007). 
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Figure 6.15 Crystal sructure of Vh_MpaA 
A ribbon representation of the Vh_MpaA structure. The amino (N) and carboxyl (C) termini are 
indicated. A zinc is shown as grey sphere. The loop proposed to be involved in dimerization is 
coloured black.  
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Figure 6.16 Sequence alignment and topological superposition of Vh_MpaA with other CP 
domain-containing proteins 
Sequence alignment of Vh_MpaA, duck carboxypeptidase D (Duck_CPD), human 
carboxypetidase N (Human_CPN) and drosophila carboxypeptidase D (Drosophila_CPD) based 
on an alignment of the 3D structures of the proteins generated using ESPript. The residues 
involved in dimer interface are underlined. The residues involved in hydrogen bond interactions 
for stabilizing two subunits in a dimer are marked by red triangles. 
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6.10.1 Dimerization of Vh_MpaA 
A striking feature of Vh_MpaA is its isolation with higher order quaternary structure. 
Consistent with mass spec and SEC-MALLS data, analysis of the crystal structure of 
Vh_MpaA showed that it is a dimer (Figure 6.17). Two molecules interact to bury  
2052 Å
2
 of surface area. The dimer interface includes residues which are highly 
conserved among the closely related structures of CPs and also the residues which are 
unique to Vh_MpaA (Figure 6.16). However out of 25 hydrogen-bond interactions that 
stabilize the dimer interface none involves highly conserved residues (Figure 6.16). 
6.10.2 Active centre 
Residues important for catalysis and binding of substrate have been determined in a 
number of studies on carboxypeptidases A (Bayés et al., 2007). The active side residues 
of human carboxypeptidase A include Arg 
127
, Arg 
145
, Glu 
270
 and the Zn coordinating 
triad His
69
, Glu
72
 and His
196
. Superposition of human_CPA and Vh_MpaA revealed that 
the structural organization of the active centre is essentially the same in both proteins 
(Figure 6.18). Amino acid residues directly involved in catalysis and substrate binding 
are strictly conserved suggesting that the catalytic mechanism proposed for 
human_CPA is also applicable to Vh_MpaA. 
6.11 Conclusion 
The genome context of mppA reveals that it is closely linked to a gene encoding a 
putative Mtp carboxypeptidase (MpaA) and thus involved in a peptide scavenging 
pathaway, which is conserved in  proteobacteria. The E. coli putative carboxypeptidase 
(Ec_MpaA) and its orthologue from Vibrio harveyi were purified and characterized 
biochemically for their activity and substrate specificity. Our mass spectrometric data 
shows that this enzyme binds to zinc and belongs to family of metallocarboxypeptidase. 
The structure of Vh_MpaA was solved to 2.17 Å. The structure shows that zinc is co-
ordinated by a catalytic triad which is conserved in closely related carboxypeptidases. 
The structure also shows that the enzyme was crystallized as dimer which is in 
agreement of our data of native mass spectrometry and SEC-MALLS. 
 
179 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.17 Cartoon representation of the Vh_MpaA dimer.  
Two monomers of Vh_MpaA make a dimer. Monomers A and B are coloured as green and 
magenta respectively.The N and C termini  of both monomers are labeled. A zinc is present in 
each monomer and represented by a grey sphere. 
180 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.18 Structural superposition of Vh_MpaA with human_CPA  
A) The proteins were superposed in ccp4mg and are shown in cartoon representation with 
Vh_MpaA in green and human_CPA in cyan. The peptide ligand in human_CPA is shown in 
stick representation. B) The active centre residues of human_CPA are compared to that of 
Vh_MpaA. The active centre residues are represented as ball and stick format, numbered and are 
coloured same as in A. Zinc is shown as small spheres and coloured according to proteins.  
 
A) 
B) 
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Oligopeptides present in the environment of bacteria are often recognized and 
transported by ABC transporters. OppABCDF is a well known ABC transporter 
of oligopeptides in bacteria where a peptide-binding SBP (OppA) captures the 
extracellular peptides and delivers them to membrane components (OppBCDF) 
for translocation (Detmers et al., 2001). It has been established from previous 
studies that showed that OppA binds oligopeptides irrespective of their amino 
acid sequence and acts as a general peptide-binding SBP (Tame et al., 1994, 
Sleigh et al., 1999, Berntsson et al., 2009). However genetic studies suggested the 
presence of peptide-binding SBPs which are involved in the transport of a specific 
peptide. These SBPs are paralogues of OppA, for example E. coli has two, namely 
MppA and YgiS, which are both thought to use the OppBCDF subunits. MppA 
was thought to transport murein tripeptide, a cell wall derived component (Park et 
al., 1998) whereas YgiS is a putative peptide-binding SBP with unknown 
substrate specificity. E. coli also possesses an ABC transporter for the uptake of 
the tripeptide, glutathione. There is genetic evidence suggesting that the SBP of 
this transporter, GsiB is required for the uptake of glutathione (Suzuki et al., 
2005). 
We investigated a number of peptide transporters that had been predicted to bind 
and transport specific peptides. In this study we cloned expressed and purified 
three putative peptide-binding SBPs from E. coli namely MppA, YgiS and GsiB 
in order to characterize their ligand specificity both biochemically and 
structurally.  
Recombinant MppA was expressed intracellularly at very high levels which is 
often possible with soluble proteins. Co-purification of MppA with a unique 
peptide (Mtp) represents the first biophysical evidence of a peptide-binding 
protein binding to a specific peptide. Previously OppA from L. lactis was shown 
to co-purify with a mixture of peptides ranging in length from 7-26 amino acids 
(Berntsson et al., 2009). Recently, OppA from E. coli has been shown to co-purify 
a variety of peptides as well (Klepsch et al., 2011).  
The structure of MppA in complex with its cognate ligand allowed us to compare 
its binding mode with that of a general peptide-binding protein OppA. It has been 
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proposed by Tame et al. that OppA achieves sequence independent peptide 
binding by minimising the formation of direct interactions between the protein 
and the ligand side chains (Tame et al., 1994). This is because favourable 
interactions with one side chain type are likely to be unfavourable with a different 
side chain type leading to ligand discrimination (Tame et al., 1994). This binding 
model has been borne out in the structures of other general peptide-binding 
proteins (Levdikov et al., 2005, Berntsson et al., 2009). It is striking that in MppA 
the peptide is accommodated in an almost identical location in the protein to that 
used by OppA with conservation of some important protein/ligand interactions 
(Figure 4.8). Despite this overall conservation, there is in addition a specific 
electrostatic interaction between Mtp and the protein, namely the interaction 
between Arg-402 and the carboxylate of the D-Glu. MppA has most likely 
evolved from a general peptide-binding protein OppA, and one of the sequence 
changes that appears to be important in the transformation from a generalist to a 
specialist is the replacement of Glu-276 by Ala, that would release Arg-404 (now 
Arg-402 in MppA) so that it can adopt a conformation that would enable it to 
form a direct side-chain interaction with the ligand and so restrict the range of 
peptides that can be recognised by this SBP. In addition, the Lys-20 residue that 
coordinates the first meso-Dap carboxylate via its side chain is a glycine in OppA 
so this particular contact to the ligand is unique to MppA. Our mutagenesis 
studies demonstrate that residues Ala 274 and Arg 402 are essential for the 
binding of Mtp by MppA, which supports the predictions that the contacts to the 
free carboxylate of the D-Glu are important for binding. Further studies can be 
done by mutagenizing other amino acids involved in ligand binding, e.g. Lys-20 
and Ser 413. It would be interesting to mutagenize Glu-276 of OppA to Ala and 
analyzing the mutant for binding to Mtp. Moreover some other residues of OppA 
can be mutated in order to investigate the transformation of a generalist (OppA) to 
a specialist (MppA). 
Despite the fact that MppA has unique interactions with the ligand which are 
absent in OppA, the most striking feature of the MppA:Mtp complex is that Mtp 
adopts a similar conformation to a conventional -linked peptide, KEK in OppA 
(Figure 4.8). Mtp is an unusual peptide ligand as it contains an L-Ala linked to a 
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D-Glu, which in turn has a γ-linkage to the diaminopimelate (meso-Dap) moiety 
at the C-terminus. It is synthesised non-ribosomally using the MurC-F ligases 
(Park and Uehara, 2008). Intuitively, one would not expect a peptide with D-
stereochemistry at position 2 to be accommodated within an OppA-like protein 
fold. A change in amino acid chirality at an internal position in a peptide is a 
major alteration which would be expected to have dramatic structural 
consequences. In Mtp, the residue-2 carboxylate projects in the direction 
otherwise occupied by the side chain and vice versa. In the MppA:Mtp complex, 
extension of such a peptide through a -linkage would lead to clashes with Arg-
402. Similarly, a peptide with a -linkage to a Glu will differ markedly from a 
conventional peptide. In Mtp, the -linkage to Glu-2 on its own would cause 
clashes with the MppA in the vicinity of Arg-402. Remarkably, as the structure of 
Mtp in the MppA:Mtp complex shows, the combination of these two changes 
within one peptide represents a much smaller structural perturbation than either 
change alone, and the murein tripeptide is readily accommodated in the OppA 
protein framework. The changes are in fact compensating. The free main chain 
carboxylate of Glu-2 is accommodated by MppA in what would be the position-2 
side chain binding pocket of OppA, while the side chain of this Glu takes the 
direction followed by the main chain in OppA.  
As Mtp is slightly longer than a conventional tripeptide chain due to the presence 
of meso-Dap at position 3, the pocket of MppA has evolved to accommodate the 
longer peptide compared to OppA, which is reflected by the small displacement of 
a common loop lining the binding site to accommodate Mtp (Figure 7.1). Very 
recently it has been revealed that OppA of E. coli has a strong preference for 
positively charged peptides and does not bind or binds very weakly to peptides 
containing acidic residues (Klepsch et al., 2011). Clearly Mtp has more acidic 
residues and thus does not bind to OppA. This is consistent with our results 
demonstrating that OppA does not bind to Mtp. 
Our in vitro analysis of ligand binding to MppA, clearly supports the hypothesis 
that Mtp is the physiological ligand for this protein, however, a number of other 
studies have suggested additional substrates for MppA using a range of genetic 
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Figure 7.1 Structural superposition of MppA with OppA and displacement of a loop 
in MppA to accommodate Mtp 
The proteins were superposed in PyMol and are shown in cartoon representation with 
MppA in green and OppA Salmonella Typhimurium in cyan. The ligands Mtp for MppA 
and KEK for OppA are shown in stick representation. Mtp is longer than a conventional 
tripeptide (KEK) and highlighted by red circle at its C-terminus. Clearly a loop in MppA 
structure lining the binding cavity around the C-terminus of Mtp is positioned away to 
accommodate a longer peptide as indicated by the arrow. The position of corresponding 
loop in OppA is also indicated by arrow. Only the part of structural superposition around 
binding cavity is shown and the rest is omitted for clarity. 
 
 
MppA OppA 
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and biochemical approaches. It has been suggested that MppAOppBCDF can 
transport the standard tripeptide Pro-Phe-Lys (PFK) (Park et al., 1998, Letoffe et 
al., 2006). However, we were unable to detect binding of PFK by fluorescence 
spectroscopy and could detect only weak binding by ITC. It is possible that PFK 
binds to a site on the protein distinct from that to which Mtp is bound as the 
thermodynamics of PFK binding were quite different from that which we saw for 
Mtp. Whereas Mtp binding to MppA and tripeptide binding to OppA are entropy 
driven, PFK binding to MppA is enthalpy driven. Certainly, we could see no 
evidence for high affinity binding of PFK to MppA which does not agree with the 
previous studies (Letoffe et al., 2006, Park et al., 1998). Also the binding 
stoichiometry was odd (N = 1.63) indicative of weak interactions between MppA 
and PFK. Probably PFK is sticking to MppA on its surface away from a defined 
binding cavity. It has also been reported that MppA can bind haem and its 
precursor δ aminolevulinic acid (ALA), however, whether this is of physiological 
relevance is unclear as haem cannot diffuse across the outer membrane of E. coli 
and its binding is competitive with PFK, which we have already demonstrated 
binds much more weakly to MppA that Mtp. Indeed we were unable to observe 
binding of ALA to MppA using tryptophan fluorescence spectroscopy. Also, the 
significant drop in binding affinity that we observed with the AEK peptide, which 
alters only the water mediated hydrogen bond network in the binding site, 
suggests that recognition of Mtp is very specific. Together these data suggest that 
MppA substrates are restricted to Mtp under normal conditions in the cell, which 
is consistent with our simple observation that MppA co-purifies from E. coli with 
Mtp bound.  
While the specificity of MppA for Mtp is clearly established, the physiological 
role of the MppA protein is not so well understood, although it most likely serves 
to allow E. coli to scavenge Mtp that is either released during turnover of its own 
cell wall or which is available in the environment. This suggestion is supported by 
the fact that E. coli is known to secrete Mtp during growth (Goodell and Schwarz, 
1985). It is also clear that there must be a free pool of Mtp inside E. coli as 
cytoplasmically produced recombinant MppA was purified in high yield as a 
complex with Mtp. This is consistent with the suggestion that Mtp is the ultimate 
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breakdown product of murein which is recycled as a building block for further 
synthesis (Park and Uehara, 2008). While the majority of murein is recycled via 
AmpG in the form of the muropeptide, there is a known outer membrane localised 
amidase, AmiD, that releases free tetrapeptide and tripeptide (Uehara and Park, 
2007).  
Our efforts to find a possible physiological role of MppA revealed that it can also 
bind to a murein tetrapeptide with two fold higher affinity than Mtp. A 
cytoplasmic peptidase called LdcA is known to degrade murein tetrapeptide into 
Mtp thus converting the free tetrapeptide pool into Mtp. As we produced MppA in 
the cytoplasm, it is possible that LdcA utilizes all the tetrapeptide so that only Mtp 
is available to bind to MppA. This hypothesis can be checked by expressing 
MppA in an LdcA deficient strain and then analysing the purified protein. 
Another possibility is that the MppA:tetrapeptide complex ionizes poorly and is 
unable to fly during native mass spectrometry. However latter possibility was 
ruled out by in vitro mixing of ligand free MppA and murein tetrapeptide and 
observing MppA:tetrapeptide complex under native conditions during mass 
spectrometry (data not shown).  
It will be interesting to crystallize MppA in presence of murein tetrapeptide and 
solve the structure to see how a tetrapeptide is accommodated in the binding 
cavity. We could not perform this due to limited substrate availability. 
Thus it is realistic to propose that MppA scavenges free Mtp and tetrapeptide 
present in the periplasm. MppA can combine with OppBCDF to form a complete 
transporter for the translocation of cell wall derived peptides. There is genetic 
evidence that it can function with both the Opp and Dpp membrane components 
(Park et al., 1998, Letoffe et al., 2006). This is an interesting phenomenon where 
a substrate-binding protein interacts with membrane components of multiple 
transporters and could be investigated further biochemically. 
It is likely that mppA evolved by gene duplication and diversification from an 
ancestral oppA gene. To identify orthologues of MppA, the amino acid sequence 
of E. coli K-12 MG1655 MppA was used with a BlastP search. The matches were 
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found within the Enterobacteriaceae family members including Salmonella, 
Shigella, Yersinia, Klebsiella and Erwinia species. This suggested that MppA is 
restricted to the Enterobacteriaceae family. However a quick look in TransportDB 
revealed that orphan peptide-binding SBPs were found in distantly related bacteria 
including Vibrio and Bacillus. These SBPs being orphan could be considered as 
homologues of MppA but the high sequence identity with OppA complicates their 
identification. To try to determine if these are true homologues of MppA, The 
Seed was used to identify their genome context. The orphan peptide SBPs from 
Vibrio species were present near an amidase encoding gene mpaA and were 
considered true homologues of MppA as the genes mppA and mpaA were always 
present together in Enterobacteriaceae. However in Bacillus the gene encoding the 
amidase is absent and thus the criteria of genome context analysis to identify 
MppA homologues are not applicable in Bacillus. These orphan peptide SBPs 
may be homologues of MppA, or of YgiS, or a similar protein with different 
specificity. As MppA of Vibrio is different from MppA of the Enterobacteriaceae 
it can be speculated that MppA evolved multiple times during the process of 
evolution (Figure 7.2). 
We were able to achieve high levels of expression and purification of GsiB 
suggesting that like MppA, it is a soluble protein. We demonstrated that GsiB co-
purified with endogenously bound glutathione, a finding consistent with the 
previous genetic data suggesting transport of GSH by an ABC transporter takes 
place in a GsiB-dependent manner (Suzuki et al., 2005). Cells maintain high 
concentrations of GSH as it plays an important role in protecting against reactive 
oxygen species and peroxides. It also acts against xenobiotics and drugs by the 
formation and excretion of glutathione conjugates. Within the cell glutathione 
exists predominantly as the reduced form (GSH) (>98%) (Dalle-Donne et al., 
2009). Interestingly our FT-MS data showed that an oxidized form of glutathione 
(GSSG) can also bind to GsiB. Unlike the reduced GSH the oxidized form GSSG 
does not act as antioxidant and thus its uptake may not be advantageous for cell. 
Thus the evidence of GSSG binding to GsiB can either be an artefact or it 
suggests that GSSG performs a different biological role in the  
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Figure 7.2 Phylogenetic tree based on maximum likelihood method using MppA and 
OppA protein sequences  
The amino acid sequences were collected from NCBI and aligned in ClustaW. 
Phylogenetic tree was made using MEGA5 software. Clearly OppAs of Vibrio and 
Enterobacteriaceae family fall into separate clusters suggesting that they evolve 
independently from a common ancestor. Similarly MppAs of Vibrio and 
Enterobacteriaceae fall into separate clusters suggestive of their independent evolution. 
Node support is provided by bootstrap values. 
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cytoplasm. Recently Haemophilus influenzae glutathione binding protein has been 
shown to bind and facilitate the uptake of GSH and GSSG to provide a source of 
sulphur (Vergauwen et al.). It can be speculated that E. coli uses GSSG as source 
of nutrients under starvation conditions. 
The ygiS gene encodes an orphan SBP that has 44 % sequence identity with OppA 
and 42 % sequence identity with MppA. The identity between YgiS and MppA or 
OppA is similar, providing no clues to the specificity of YgiS. This suggests that 
YgiS binds a specific peptide or at the very least a different set of peptides to 
OppA so that the physiological ligand specificity of the three SBPs, OppA, MppA 
and YgiS, are not overlapping. Our mass spectrometric analysis showed no ligand 
bound to YgiS. This suggests that either YgiS is not a peptide-binding protein or it 
binds to a specific non-endogenous peptide not present in the medium. The ligand 
could be a signaling peptide from a different strain or species of bacteria present 
in the environment.  
Further work to identify the ligand of YgiS may involve growing bacteria using 
different media and growth environments and then purifying the protein for 
biophysical analysis. A library of oligopeptides can also be used to screen peptide 
ligands.  
It would also be interesting to study the interactions of the two orphan SBPs with 
transmembrane components of Opp and Dpp. Do these SBPs interact with 
transmembrane components of one transporter or multiple transporters and do 
they have equal affinity or does the general peptide-binding protein, OppA, take 
precedence over the other two. 
The peptide-binding SBPs can potentially be used in the diagnosis of disease and 
infection. Many pathogens and diseases like prostate cancer produce specific short 
peptides that are indicative of their presence. These peptides can be detected using 
SBPs fused to a reporter gene that will be able to measure the levels of peptides in 
biological samples. The peptide-binding SBPs can also be used in the elimination 
of toxic peptides from biological samples for example, several venoms are toxic 
peptides (Favreau et al., 2007). The SBPs can be immobilized on a gel or some 
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other material from which they can capture and sequester the toxin from a 
contaminated sample. 
Catabolism of murein tripeptide 
Cell wall turnover is an enzymatic process that results in the loss of peptidoglycan 
components and has been reported in many bacteria (Park and Uehara, 2008). The 
turnover products are generally re-utilized through a process known as cell wall 
recycling (Park and Uehara, 2008). In E. coli the main turn over product 
(Muropeptide, GlcNAc-anhMurNAc-L-Ala- -D-Glu-Dap-D-Ala) is known to be 
taken up by AmpG  permease and further processed by lytic enzymes to release 
free murein tripeptide (Mtp) in the cytoplasm which then re-enters the 
peptidoglycan biosynthetic pathway (Park and Uehara, 2008). In addition we 
propose that free Mtp and tetrapeptide present in the preiplasm can be taken up 
via MppA:OppBCDF transporter for recycling. 
We discovered another fate of free murein tri- and tetrapeptide by studying the 
genome context of mppA in E. coli and then carrying out a comparative genomics 
study. Under nutrient limiting conditions, the bacterium is likely to catabolise Mtp 
and murein tetrapeptide and uses them as a source of nutrient. Genetic linkage of 
mppA with the gene encoding a putative amidase (mpaA) in several -
proteobacteria is suggestive of a related function for mppA and mpaA in transport 
and catabolism of Mtp and murein tetrapeptide in these organisms. There are 
many examples in nature where the genes encoding a complete transporter are 
situated next to the genes involved in the downstream metabolism of the solute 
such that transport of a ligand is coupled to the expression of genes involved in 
the metabolism of that ligand (Severi et al., 2007). Here we show that a gene 
encoding an orphan SBP is situated next to one encoding an amidase and the two 
genes appear to be divergently transcribed from an overlapping promoter. This 
genome organization where a gene encoding an orphan SBP is situated next to 
one encoding an amidase enzyme is the first example in the literature.  
In the present work, the E. coli MpaA protein was successfully over produced and 
the recombinant protein purified to homogeneity and its substrate specificity and 
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kinetic parameters were investigated in detail. Previously efforts were made to 
overproduce MpaA in E. coli with no success (Uehara and Park, 2003). The 
possible reason for this failure was selection of wrong start codon which resulted 
in the expression of an additional 20 residues upstream of the MpaA sequence. 
We chose the correct start codon as determined from the EcoGene database of E. 
coli (Rudd, 2000) resulting in successful over production of MpaA. 
Our results show that MpaA is a carboxypeptidase that specifically hydrolyzes the 
-D-Glu-Dap amide bond of Mtp, a finding consistent with previous data (Uehara 
and Park, 2003), which suggested that the MpaA activity was involved only at a 
very late step in the peptidoglycan recycling process, i.e. for the degradation of 
the free tripeptide into L-Ala-D-Glu and meso-Dap.  
As the dipeptide meso-Dap-D-Ala had been detected in cell extracts of E. coli 
(Goodell and Schwarz, 1985), it was suggested that MpaA would also be able to 
hydrolyze murein tetrapeptide (Uehara and Park, 2003) and may act as an 
endopeptidase as well. Our results show that MpaA does not hydrolyze murein 
tetrapeptide and cannot act as an endopeptidase. The presence of meso-Dap-D-Ala 
in cell extracts of E. coli strongly suggests that hydrolysis of murein tetrapeptide 
is catalyzed by another as yet un-identified endopeptidase in E. coli, which 
warrants further investigation  
Bacillus subtilis produces a protein named YkfC which contains a C-terminal 
NIpC/P60 cysteine peptidase domain. Characterized NIpC/P60 enzymes are 
almost all -D-Glu-Dap or -D-Glu-Lys endopeptidases (Xu et al., 2010). In a 
search of the E. coli database to find a homologue of Bs_YkfC, a region of YdhO 
was found to display significant homology to the catalytic domain of Bs_YkfC. 
YdhO is encoded by an uncharacterized open reading frame and appears to have a 
signal peptide (Misra et al., 2005). It is predicted that YdhO is responsible for 
production of m-Dap-D-Ala in the periplasm by cleaving murein tetrapeptide.  
Uehara and Park tested the activity of cell extracts prepared from E. coli mpaA-
over producing cells on several substrates and observed that MpaA was not active 
on UDP-MurNAc-pentapeptide (Uehara and Park, 2003). We confirmed that the 
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purified MpaA does not act on the tri-and pentapeptide-containing nucleotide 
precursor. This confirms that MpaA does not interfere with the peptidoglycan 
biosynthetic pathway. Uhera and Park also observed that the over production of 
mpaA did not abolish the accumulation of MurNAc (anhydro)-tripeptide that 
occurs in ampD mutant cells, suggesting that MpaA was not active when the 
tripeptide was bound to a MurNAc residue. We show here that MpaA has very 
low activity towards MurNAc-tripeptide (specific activity being 0.3 vs 12,000 
nmoles.min
-1
.mg
-1
) and is inactive towards a disaccharide (anhydro)-tripeptide.  
It has been reported previously that MpaA is inactive against synthetic tri-, tetra- 
and pentapeptides containing L-Lys at the third position (Schmidt et al., 2001). 
However here we observe that MpaA is active towards L-Ala- -D-Glu-L-Lys, 
although the activity is much lower (70-fold) than that for the Dap-containing 
tripeptide. This suggests that MpaA can also hydrolyze the Lys-containing cell 
wall tripeptide present in most Gram-positive bacteria. L-Lys is present instead of 
m-Dap in the cell wall peptides of most Gram-positive bacteria (Schleifer and 
Kandler, 1972). Whether this property of MpaA provides any physiological 
benefit to E. coli needs to be investigated. It can be speculated that E. coli may get 
growth advantages over other Gram-positive bacteria present by catabolizing their 
cell wall peptides. In the light of our experimental data we were able to propose a 
new scavenging pathway for peptidoglycan derived peptides in -proteobacteria 
(Figure 7.3).  
On the basis of amino acid sequence similarity, MpaA was grouped in the family 
of metalloproteases which require a divalent cation (zinc) for function. This is 
consistent with our mass spectrometry data suggesting that MpaA co-purifies with 
zinc. The requirement of a divalent metal ion for MpaA function was further 
confirmed when its activity was inhibited in the presence of EDTA. 
In the study we also cloned, expressed and purified a homologue of MpaA from 
Vibrio harveyi. Our results showed that Vh_MpaA hydrolyzes Mtp but not murein 
tetrapeptide and thus is a true functional orthologue of Ec_MpaA.  
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Figure 7.3 Proposed pathway for uptake and catabolism of Mtp and murein 
tetrapeptide 
Murein hydrolases break down peptidoglycan into muropeptide (GlcNAc-anhMurNAc-L-
Ala- -D-Glu-mDap-D-Ala), Mtp and murein tetrapeptide. Muropeptides are taken up by 
AmpG permease and enter the recycling pathway. Mtp and murein tetrapeptide are taken 
up via MppA:OppBCDF. Murein tetrapepide is hydrolyzed by LdcA to Mtp in the 
cytoplasm. Mtp either enters into the recycling pathway by the action of murein peptide 
ligase enzyme (Mpl) or hydrolyzed into its component amino acids by the concerted 
actions of an amidase (MpaA), an epimerase (YcjG) and a peptidase (PepD).  
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The crystal structure of Vh_MpaA revealed that, in spite of the relatively low 
amino acid similarity, the polypeptide fold of Vh_MpaA is the same as those of 
the eukaryotic carboxypeptidases. This confirms the notion that structure and fold 
space is more limited compared to sequence space and nature tends to adapt 
conserved structural modules for different functions. The conserved nature of the 
active site residues suggests that the mechanism proposed for human CPA is 
applicable to Vh_MpaA and probably to the whole family of Zn 
carboxypeptidases. The difference in the substrate specificity of MpaA might be 
ascribed to a loop in Vh_MpaA that covers the active site and restricts the length 
of peptide that can extend into the catalytic centre (Figure 7.4). Identification of 
residues likely to be involved in binding metal and substrate and those involved in 
dimerization provide a basis for further experimentation to explore the structure 
and function of MpaA. 
Although MpaA seems to have true orthologues in -proteobacteria, there are 
enzymes in Bacillus and Cyanobacteria that are unrelated to MpaA in amino acid 
sequence that have equivalent function. An example is YkfC from Bacillus 
subtilis. YkfC contains a C-terminal NIpC/P60 cysteine peptidase domain and is 
known to cleave tri, tetra and penta peptides containing L-Lys at the third 
position. The genome context of ykfC in B. subtilis reveals that it is present next to 
the dipeptide ABC transporter operon and an L-Ala-D/L-Glu epimerase gene. 
This gene clustering suggests that a similar catabolic pathway for cell wall 
peptides may exist in B. subtilis and other bacteria albeit one that uses a different 
set of proteins. 
The proposed pathway for uptake and catabolism of cell wall derived peptides 
(Figure 7.3) can be studied and validated by performing in vivo experiments. A 
simple experiment can be done by growing wild type and mutant strains of a 
bacterium (E. coli) in M9 minimal medium containing cell wall derived peptides 
as a sole source of carbon and nitrogen, and comparing the growth of wild type 
and mutant strains. The mutant strains can be constructed by deleting the genes 
involved in uptake and catabolism of cell wall derived peptides, e.g. ampG, mppA, 
oppD, mpaA, ldcA, ycjG and pepD etc. The mutant strains being unable to uptake 
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and/or catabolise cell wall derived peptides should exhibit a growth phenotype. 
The phenotype exhibited by mutant strains can be restored by providing a copy of 
the deleted gene to the mutants. 
In another experiment a double mutant strain of E. coli (that have deletions of two 
genes viz mpl and mpaA) can be grown in enhanced M9 minimal medium and 
accumulation of Mtp in the cytosol can be measured using the analytical 
procedures described previously. (Mengin-Lecreulx et al., 1982). Later on, 
cleavage of Mtp can be studied by providing a copy of functional mpaA to the 
double mutant strain. Various mutants of mpaA can be constructed to produce 
partially active MpaA or one with low turnover rate. These mutants can be 
transformed into the double mutant strain in order to study the turnover of Mtp. 
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Figure 7.4 Surface representation of human_CPA and Vh_MpaA 
A) Surface representation of human_CPA (coloured in cyan) in complex with a cleaved 
hexapeptide. The peptide is present in a groove above active site and represented as stick 
format. B) The structure of human_CPA is superposed on Vh_MpaA. Human_CPA is 
shown as cyan surface and Vh_MpaA is shown as cartoon representation (green). A loop 
of Vh_MpaA covers the groove above active site and possibly restricts the length of 
peptide that enters the catalytic centre for cleavage.C) same as B except Vh_MpaA is 
represented by surface coloured in green. 
A) 
B) 
C) 
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Abbreviations 
ABC – ATP Binding Cassette 
ATP – Adenosine 5 -triphosphate 
bp – base pairs 
BSA – Bovine Serum Albumin 
CBB – Coomassie Brilliant Blue 
CD – Circular Dichroism 
CV – Column Volume 
Da – Dalton 
DNA – Deoxyribonucleic Acid 
EDTA – Ethylenediaminetetraacetic acid 
ES-MS – Electrospray Mass Spectrometry 
ESRF – European Synchrotron Radiation Facility 
FT – Fourier Transform 
HRV – Human rhinovirus 
ICR – Ion Cyclotron Resonance 
IPTG – Isopropyl β-D-1-thiogalactopyranoside 
ITC – Isothermal Titration Calorimetry 
KPi – Potassium Phosphate 
LB – Luria-Bertani 
LIC – Ligation Independent Cloning 
MALLS – Multi-Angle Laser Light Scattering 
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m-Dap – meso diaminopimelate 
MES – 2-(N-morpholine)-ethane sulphonic acid 
Mtp – Murein tripeptide 
MWCO – Molecular Weight Cut-Off 
NDB – Nucleotide Binding Domain 
PAGE – Polyacrylamide Gel Electrophoresis 
PCR – Polymerase Chain Reaction 
PEG – Polyethyleneglycol 
SBP – Substrate-binding Protein 
SDS – Sodium Dodecyl Sulphate 
SEC-MALLS – Size Exclusion Chromatography in line with MALLS 
SeMet – Selenomethionine derivative 
TMD – Transmembrane domain 
YSBL – York Structural Biology Laboratory 
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